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ABSTRACT 
Gene therapy has a great potential for the treatment of a wide range of 
diseases. However, the development of a safe and efficient delivery vector 
is the major obstacle for gene therapy. Recently synthesized 2 -
(dimethylamino ) ethyl methacrylate 2-(methacryloxloxyethyl 
phosphorylcholine) (DMA-MPC) diblock copolymer was investigated in 
this work as a novel non-viral vector for gene delivery. It has been 
previously demonstrated that the cationic DMA block can condense DNA 
efficiently. The zwitterionic PC head groups are found naturally in the 
outer leaflet of biomembranes and are extremely biocompatible. It is thus 
proposed here that the MPC can act as a new steric stabilizer to the system. 
Different compositions of DMA-MPC diblock copolymers were evaluated. 
The MPC block with minimum length 30 monomeric units can 
successfully provide steric stabilization to the system, and reduce non-
specific cellular interaction by providing a steric barrier to the DNA 
complexes. However, long MPC chain can hinder the interaction between 
cationic DMA and DNA, leading to the formation of loosely condensed 
complexes which were more susceptible to enzymatic degradation. 
Therefore the composition of the copolymer must be carefully adjusted so 
that the DNA condensing and steric stabilization effect are well balanced. 
In order to investigate the cellular uptake mechanism DMA homopolymer-
DNA complexes, the effect of different endocytosis inhibitors was 
examined. Microtubules and actin filaments were involved in the uptake of 
DNA complexes, suggesting that the complexes were internalised by 
endocytosis. Both the clathrin- and caveolae- mediated pathway were 
responsible for the uptake of DNA complexes, and the former appeared to 
be the main route of entry. 
.. 
\,11 
Finally, folic acid ligand was incorporated into the DMA-MPC copolymer 
in order to improve the specific targeting. Initial data showed that there 
was selective uptake of the folate conjugated system in folate receptor 
expressing cells possibly via receptor mediated endocytosis. However, 
parameters such as the optimum length of MPC component, number of 
ligands per DNA complex and the composition of the system need to be 
further investigated in order to maximize the specificity and transfection 
efficiency. 
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Chapter 1: Introduction 
CHAPTER! 
INTRODUCTION 
1.1 BASIC CONCEPTS OF GENE THERAPY 
Since the discovery of the structure of deoxyribonucleic acid (DNA) by 
James Watson and Francis Crick over 50 years ago (Watson and Crick, 1953), 
the understanding of how DNA controls and affects our health has improved 
rapidly. The use of DNA as a therapeutic tool became theoretically possible 
after the successful identification and cloning of the gene responsible for 
inherited single genetic disorder, such as cystic fibrosis (Riordan et aI., 1989) 
and adenosine deaminase (ADA) deficiency (Orkin et aI., 1983). Gene 
therapy was introduced and initially regarded as an approach for treating the 
single genetic disorder by replacing the defective gene(s) with a normal 
healthy gene (Orkin, 1986). 
However, very few diseases are caused by a single gene mutation, and thus 
the benefits of gene therapy are very limited. The potential of gene therapy 
was soon expanded to the treatment of a wide range of other genetic disorder, 
as well as diseases of non-genetic origin, such as cardiovascular diseases 
(Yla-Herttuala and Martin, 2000), infectious diseases (Bunnell and Morgan, 
1998), neurological diseases (Suhr and Gage, 1993) and cancer (EI-Aneed, 
2004). The definition of gene therapy has become boarder and is no longer 
only restricted to the correction of defective genes. Other approaches, for 
example, the delivery of suicide genes to kill cancer and infected cells 
(Mullen, 1994), the delivery of oligonucleotides to block the expression of a 
particular protein (Stein and Cheng, 1993), or the use of DNA as vaccines by 
introducing DNA encoding for antigenic components in order to induce an 
1 
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immunological response (Ulmer et aI., 1993), are all regarded as gene 
therapy. In recent years, gene therapy is broadly redefined as the transfer of 
genetic materials into human cells in order to generate a therapeutic effect. 
A successful gene therapy requires the delivery and the expression of the 
therapeutic gene in the human target cells. With the completion of the 
human genome project in 2003 (Collins et aI., 2003), the identification and 
design of a suitable therapeutic gene for a particular disease is no longer a 
major obstacle. The biggest challenge for gene therapy nowadays is the 
development of a suitable vehicle (or vector), which is capable of delivering 
the therapeutic gene into the target cells safely and efficiently. 
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1.2 GENE THERAPY CLINICAL TRIALS 
The first human gene therapy clinical trial was performed in 1989 by 
Rosenberg et al. (1990) who used retrovirus in the attempt to treat advanced 
melanoma. Since then, over 1000 clinical trials have been carried out 
worldwide (Edelstein et al., 2004). Two-thirds of all trials have been 
conducted in the United States, whereas United Kingdom is the second 
leading country in gene therapy trials, accounting for 11 % of the total 
number of trials in the world. 
Like all other pharmaceutical clinical trials, gene therapy trials are conducted 
in phases. Phase I trials are the first stage of testing in human and are 
designed to assess the safety and tolerability of the new therapy. They are 
normally conducted in a small group (20 to 80) of healthy volunteers. Phase 
II trials are performed in larger groups of patients and volunteers (20 to 300) 
and are designed to evaluate the clinical efficacy as well as the safety of the 
therapy. Phase III trials involve a larger group of patients (100 to 3000) and 
are aimed at evaluating the efficacy of the new therapy, in comparison with 
current 'Gold Standard' treatment. Phase IV trials involve the post-marketing 
studies to provide additional information including long term effects of the 
treatment. Disappointingly, there has been limited clinical success in gene 
therapy over the last 15 years. The majority of clinical trials performed were 
stopped at early stage. Phase I or IIII represent 84% of all gene therapy trials 
(completed or ongoing); 13% are phase II trials, with less than 3% are phase 
II/III or III trials. 
In terms of therapeutic indication, most of the clinical trials in gene therapy 
have been aimed at the treatment of various types of cancer (66% of all trials). 
followed by inherited monogenic diseases and cardiovascular diseases. Viral 
vectors are the most frequently used vectors to deliver genes into human cells. 
They have been used in about 70% of the trials performed to date. In non-
viral system, 'naked DNA' is the most popular system which accounts for 
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14% of all trials, followed by lipofection (cationic lipidlDNA complexes) 
which have been involved in just over 90/0 of all trials. 
The biggest breakthrough of gene therapy came in 2003 when a gene therapy 
product was approved to be used in human for the very first time (Peng 2005, 
Wilson 2005). China's State Food and Drug Administration approved 
Gendicine for the treatment of head and neck squamous cell carcinoma after 
it achieved promising results in clinical trial. Gendicine consists of an 
adenovirus designed to insert a p53 tumour suppressor gene. The results 
from the clinical trial studies showed there was complete regression of 
tumours in 64% of patients after eight weekly intratumoral injections of 
Gendicine in combination with radiotherapy, a rate three times higher than 
those in the radiotherapy only group (Peng 2005). As of July 2005, 
Gendicine has been used to treat over 2600 patients and the same product is 
currently in late-stage clinical trials for a variety of other cancer treatments 
(Wilson 2005). The result is very encouraging and marks an important 
milestone in gene therapy. 
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1.3 METHODS OF GENE DELIVERY 
The success of gene therapy relies essentially on the development of safe and 
efficient vectors. Ideally, a gene delivery vector should be able to provide 
protection from gene degradation and deliver the therapeutic gene to the 
target cells only without triggering host immune response. In addition, it 
should be non-toxic, able to accommodate therapeutic DNA of any size, and 
easy to produce at an acceptable cost. Unfortunately at present, no single 
vector exhibits all of the above characteristics. Each vector currently being 
investigated has its own advantages and limitations. 
There are several possible routes for administration of the therapeutic gene. 
The choice of administration routes depends on the type of delivery vector 
and the cells to be targeted. In general, two major approaches are studied, 
including in vivo and ex vivo (Hauser et al., 2000). With the in vivo gene 
therapy, the therapeutic DNA is transferred directly into cells within a patient. 
The process is direct and involves less manipulation than that of the ex vivo 
approach, in which the target cells are removed from the patient, transfected 
in vitro and returned to the patient. 
A number of gene delivery vectors have been developed and can be broadly 
divided into two categories - viral and non-viral vectors. 
1.3.1 Viral vectors 
Viral vectors refer to the use of viruses as a tool for gene delivery. They are 
the vehicles of choice for gene delivery in clinical trials in the United 
Kingdom and worldwide. In March 2004, 74% of all ongoing gene therapy 
trials in the United Kingdom involved the use of viral vectors, most of these 
are for cancer treatment (Relph et al., 2004). Viruses are extremely efficient 
vectors to deliver genes to target cells, as they have evolved to enter the host 
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cells and express their genes there. Therefore it is possible to take advantage 
of this by introducing a therapeutic gene into the viruses and using their 
properties to deliver the therapeutic gene with high efficiency into the target 
cells (Walther and Stein, 2000). Before viruses can be used to deliver the 
genes into human cells, they must be genetically modified with care so that 
the pathogenicity of the virus is eliminated and the uncontrolled replication 
of the engineered virus is prevented, while the efficiency of gene transfer and 
expression is retained. 
In general, viral vectors are broadly divided into two groups, integrating and 
non-integrating vectors (Kootstra and Verma, 2003). Integrating viruses 
include retrovirus (Weber et aI., 2001) and adeno-associated virus 
(Rabinowtz and Samulski, 1998), which have the ability to integrate their 
viral genome into the chromosomal DNA of the host cell so that long- lasting 
gene expression could be achieved. The non-integrating viruses include 
adenovirus (McConnell and Imperiale 2004) and herpes simplex virus 
(Lachman, 2001), which deliver their genomes into the nucleus of the target 
cell where they remain episomal. 
Each of the viral vectors has its own characteristics. The choice of viral 
vector in gene therapy approach depends largely on the types of cells to be 
targeted by the therapy, the size of therapeutic DNA and the desired duration 
of expression of the therapeutic gene. 
Although viral vectors are currently the most efficient gene delivery system 
being investigated, several safety issues have led to a reconsideration of their 
use in human gene therapy. In 1999, I8-year old Jesse Gelsingec who took 
part in a gene therapy clinical trial in United States, died from multi-organ 
failure only four days after the treatment (Lehrman, 1999, Thomas et at.. 
2003). His death was directly attributed to the administration of the 
adenovirus which was used to treat ornithine transcarbamylase (OTe) 
deficiency a rare metabolic disease that can cause a dangerous build up of 
- , 
ammonia in the body. An autopsy showed that although the viral vector had 
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been infused directly into the liver, substantial amounts of the virus had 
spread into the circulation and accumulated into the spleen, lymph nodes and 
bone marrow. The virus triggered a massive inflammatory response that led 
to intravascular coagulation, respiratory distress and multi-organ failure 
(Marshall, 1999). 
The nightmare of adverse events caused by viral vector in gene therapy did 
not end there. In 2000, an 18 month-old boy with the fatal X-linked severe 
combined immunodeficiency (X-SCID), a rare immune disorder caused by a 
defective gene on the x chromosome, was the first patient saved by gene 
therapy using retrovirus (Cavazzana-Calvo et aI., 2000). The results appeared 
to be encouraging in the beginning. However, within a year, two out of 10 
children treated in France for X-SCID had developed leukaemia-like disease 
(Hacein-Bey-Abina et aI., 2003). It was found that the retrovirus, which was 
used to carry a therapeutic genome into bone marrow stem cells, had inserted 
into the patients' DNA and activated an oncogene, triggering the cause of 
leukaemia. 
The mam concerns regarding the safety of viral vectors include the 
possibility of insertional mutations, high immune response and problems of 
toxicities. Furthermore, weakened viruses can conceivably change inside the 
patient's body and regain their pathogenic activity. In fact, the X-SCID and 
Gelsinger cases have brought the attention of the safety with the use of viral 
vectors, leading to the development of non-viral vectors as potentially safer 
alternative. 
1.3.2 Non-viral vectors 
Non-viral delivery systems offer many advantages over viral vectors, 
including their relatively safe profile and potentially lower immune response. 
Furthermore, they can be produced in large quantities at a relatively low cost 
and provide virtually unlimited capacity to accommodate therapeutic DNA 
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(Schatzlein, 2001). However, the major drawback of non-viral methods is 
poor efficiency, which holds back their use in gene therapy. Improvements 
in the efficiency of non-viral DNA delivery systems are being studied 
intensively in order to make these systems competitive options over viral 
vectors in the near future. In general, non-viral gene delivery involves the 
use of naked DNA, liposomes and cationic polymers. 
1.3.2.1 Naked DNA 
The direct transfer of naked DNA is the most straightforward mode of gene 
delivery. Naked DNA can be administered via two possible routes, ex vivo or 
in vivo delivery. The ex vivo delivery of naked DNA provides a precise but 
time consuming method to transfer therapeutic DNA to the target cells. Its 
reliance on the culture of harvested cells renders it unsuitable for many cell 
types. 
In vivo delivery of naked DNA is the simplest way for administration of 
DNA to a patient (Herweijer and Wolff 2003). This method was used in 
several pre-clinical and clinical trials (Nishitani et al., 2003). It was first 
described in 1990 and was demonstrated that direct injection of DNA into 
skeletal muscle could result in local transient gene expression (Wolff et al., 
1990). Gene expression was also detected when naked DNA was directly 
applied to liver (Hickeman et al., 1994, Zhang et al., 1997), solid tumours 
(Yang and Huang, 1996, Baque et al., 2002), and epidermis (Yu et al., 1999). 
The therapeutic DNA can be introduced through either intravascular or 
intramuscular injection, with the latter demonstrating better results (Gardlik 
et al., 2005). However, the level of gene expression was low and short term 
in both cases. Nevertheless, the level of expression may be sufficient for use 
in DNA vaccination (Smith et al., 1998, Youssef et al., 1998). 
Several methods have been employed to improve the level of gene expression 
with naked DNA. One of them is electroporation (Wong and Neumann, 1982. 
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Rols et al., 1998, Tupin et al., 2003). It involves the use of high voltage 
electrical pulses to temporarily permeabilise cell membranes, allowing the 
DNA to enter the cell easily. This can be done by injecting naked DNA 
followed by electric pulses from electrodes that are located in situ in the 
target tissues. Successful use of electroporation in vivo was observed in 
tissues such as muscle and skin (Rols et al., 1998, Rizzuto et al., 1999). 
However, a large percentage of cells may die following this technique, 
limiting its application in vivo. 
Another technique to enhance the delivery of naked DNA is called "the gene 
gun' (Fynan et al., 1993, Kuriyama et al., 2000). With this approach, the 
DNA is transferred by colloidal-sized particles of gold on which the DNA is 
bound. These particles are then shot directly into the cells under great 
pressure and high velocity, with the help of compressed helium. The gene 
gun was originally developed for gene transfer to plant cells. Its use was 
soon expanded to gene delivery in mammalian cells, and it has great potential 
for the delivery of DNA vaccines (Qiu et al., 1996, Surman et al., 1998). 
1.3.2.2 Liposomes 
The idea with the use of liposomes to deliver DNA was based on the 
experience with liposomal delivery of conventional small molecule drugs 
(Nicolau and Cudd, 1989, Chonn and Cullis, 1995, 1998). Liposomes have 
been well studied in the last few decades for the controlled and site-specific 
delivery of drugs, peptides and proteins. Anionic or uncharged liposomes 
have been used to deliver encapsulated drugs, and are adapted to deliver 
genes in the same fashion. They act as closed vesicles, which separate the 
internal compartment from the external medium by the lipid bilayer, with the 
potential to protect the encapsulated DNA from enzymatic degradation. In 
early years, methods used to encapsulate DNA always yield relatively large 
multilamellar vesicles with low DNA encapsulating efficiencies. resulting in 
poor gene transfer capabilities (Nicolau et al.. 1983. Baru et al.. 1995). In the 
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last two decades, there have been significant advances in the formulation of 
plasmid DNA into relatively small, stable DNA-containing liposomes for 
gene delivery. The use of cationic liposomes to deliver DNA was introduced 
in the late 1980s (FeIgner et aI., 1987). The ability of cationic Iiposomes to 
interact with DNA to form complexes (lipoplexes) is dependant on several 
physical conditions, such as pH and charge, as well as structural 
characteristics of the liposomes. Two processes are involved in lipoplex 
formation: a fast exothermic process is attributed to the electrostatic binding 
of DNA to the liposome surface (FeIgner and Ringold, 1989, Pector et al.. 
2000). A subsequent slower endothermic reaction is caused by fusion of the 
two components and their rearrangement into a new structure. During this 
process, the homogenous and physically stable suspensions are formed (Hong 
et aI., 1999). 
Liposomes can be formed from a variety of cationic lipids. The best known 
is DOTMA (Dioleoyl propyl trimethylammonium chloride), which is often 
formulated with a neutral helper lipid such as DOPE (Dioleoylphospatidyl 
ethanolamine). Liposomes formulated without neutral lipids always have 
poor transfection efficiency (Lasic and Pearlman, 1996). The role of the 
neutral helper lipid is to facilitate membrane fusion and improve transfection 
efficiency by assisting endosomal escape (FeIgner et al., 1987, Farhood et al.. 
1995). In addition, these supporting lipids help to stabilise the cationic 
liposome suspension (Zuidam and Barenholz, 1998). Other commonly used 
cationic lipids include DOTAP (1 ,2-bis( 0Ieoyloxy)-3(trimethylammonio) 
propane) (McLachalan et al., 1994) and DC-Chol (3j3-(N,N-
dimethylaminoethane) carbamoyl) cholesterol) (Gao and Huang, 1991). 
Liposomes are the most efficient non-viral gene delivery vector currently 
available and have become the standard for in vitro transfection of plasmid 
DNA. Many commercially available transfection kits. such as lipofectin (.Y-
(1-(2,3- di-olyloxy) propyl)- N, N, N- trimethylammonium chloride. 1.2-
dioleoylphosphatidylethanol-amine-DOPE, 1: 1) and lipofectamine (.\'-(2-
(2,5-bis((3-aminopropyl)amino )-l-oxpentyl)amino) ethyl)-XX-dimethyl-2.3-
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bis(9-octadecenyloxy)-I-propanaminium trifluoroacetate-DOPE 3: 1) are 
developed from liposomes. To date, almost 50% of the non-yiral gene 
therapy clinical trials worldwide involve the use of lipoplexes. which 
contribute to about 9% of all on going gene delivery clinical trails (Edelstein 
et al., 2004). However, they are not without drawbacks. Their in vivo use is 
limited by their inherent instability, poor biodistribution, lack of cell 
specificity and cytotoxicity (Mahato et al., 1997, Filion and Phillipsm 1998, 
Hope et al., 1998, Tousignant et al., 2000). Strategies such as introduction of 
ligands and alternations in the chemical composition of the liposomes are 
being investigated to tackle these problems (Lee and Huang, 1996, Martin 
and Boulikas, 1998, Kawakami et al., 2000). 
1.3.2.3 Cationic polymers 
The interest in using cationic polymers as gene delivery vectors is growing in 
recent years due to their relatively safe profile and the flexible chemical 
design, which allows the incorporation of various functional components to 
overcome delivery barriers. In addition, they are relatively simple to 
manufacture at a low cost. 
Cationic polymers typically contain protonable amines. The relative numbers 
and pK(a) of the protonable amines differ between polymers. Some of the 
cationic polymers have the positive charges on the backbone whereas some 
have the positive charge on the side groups. Cationic polymers are able to 
condense DNA to form polymer - DNA complexes (polyplexes) through 
electrostatic interaction between the positively charged amine groups of 
polycations and negatively charged phosphate groups of DNA. This can be 
explained by polyelectrolyte theory (Kabanov and Kabanov, 1995a, Kabano\ 
et al., 1995b). 
According to the polyelectrolyte theory, when aqueous solutions of 
polycations and polyanions are mixed together, they spontaneously interact to 
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form a complex coacervate, which is also known as a polyelectrolyte 
complex (PEC). The composition of PEC can be defined by the charge ratio 
<p, the ratio of the positive charge (amine groups of polycations) to the 
negative charge (phosphate bases of nucleic acid). At low values of <p «I). 
soluble PEC with a net negative charge exist. Aggregates of PECs start to 
form when the concentration of polycations increased. The largest 
aggregates exist at a value of <p close to 1. As the value of <p further increases 
(> 1), the size of PEC reduces due to electric repulsion. 
Several variables affect the formation mechanisms and the stability of PECs, 
such as the strength of the polyelectrolyte in terms of acid or base. the 
molecular weight of the polyions and the conditions of solvent (e.g. pH and 
ionic or salt condition) (Kabanov et aI., 1985, Dautzenberg and Karibyants, 
1999, Dragan and Cristea, 2002, Leclercq et aI., 2003, Zintchenko et al., 
2003, Becheran-Maron et aI., 2004). For example, when PECs are formed at 
a very low salt concentration, there is repulsion between high concentration 
of ionic groups in the polyelectrolyte, resulting in bigger and less compact 
PECs. As salt concentration increases, it competes with polyelectrolyte 
binding, thus reducing interaction between polyelectrolyte, and allows salt 
bonds and polyelectrolyte to arrange more easily, leading to the formation of 
tighter and more compact PECs. Further increase of salt concentration leads 
to precipitation of PECs. When the salt concentration is high enough, the 
presence of salt shields the charge of polyelectrolyte, preventing the 
formation of PECs at all. Therefore, the properties of polymer - DNA 
complexes are heavily dependent on the types and properties of the cationic 
polymer, the ratio of each component as well as the conditions under which 
they are formed. It will be important to define the optimum compositions of 
the complexes, which will eventually affect their prospects as effective gene 
delivery system. 
Commonly used cationic polymers for gene delivery include poly(L-Iysine) 
(PLL), polyethylenimine (PEl), chitosan, dendrimers and polyt2-
dimethylamino )ethyl methacrylate (DMA). each of them have its O\\"n 
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characteristics. PLL is one of the first polymers being studied in non-viral 
gene delivery. As a polypeptide, PLL is biodegradable. The epsilon amino 
group of lysine is positively charged at physiological pH 7.4. thus PLL is 
able to interact and form complexes with the negatively charged DNA 
through electrostatic interaction (Laemmli, 1975, Reich et at.. 1990. Wolfert 
and Seymour, 1996). The transfection efficiency of PLL - DNA complexes 
is relatively poor but strategies such as incorporation of targeting ligands 
(Wu and Wu, 1987, Mislick et aI., 1995, Zauner et aI., 1998) or 
endosomolytic agents (Kichler et aI., 1999) can improve its efficiency. 
However, the chain length heterogeneity of commercially available PLL 
preparations and the resulting variability in size distribution of the polyplexes 
has adversely affected the reproducibility of PLL mediated gene delivery 
(Wolfert and Seymour, 1996). In addition, PLL displays high to severe 
toxicity as the lysine homopolymers are not rapidly metabolized by the body, 
discouraging its use in vivo (Wolfert and Seymour, 1996, Anwer et aI., 2003). 
With the lack of promising results and toxicity issues regarding the use of 
PLL, other cationic polymers are being investigated and developed as 
potential gene delivery vectors. PEl is one of the most extensively studied 
cationic polymers in gene delivery due to its excellent transfection efficiency 
against a wide selection of cells in vitro (Boussif et aI., 1996). Its use in 
gene delivery has been reviewed in many publications (Godbey et aI., 1999a, 
Kircheis et aI., 2001 b, Neu et aI., 2005). The most attractive property 
regarding the use of PEl is the ability to act as an effective buffer through a 
wide pH range. This property, also known as 'proton sponge' property 
(Boussif et aI., 1995), facilitates the endosomal escape of PEl - DNA 
complexes and is in fact a crucial factor for the high transfection !e\'el 
obtained with this polymer. However. toxicity is still a major problem 
associated with the use of PEl (Godbey et aI., 2001). 
Dendrimers are also popular in gene delivery area. A range of 
polyamidoamine (PAMAM) dendrimers have been \\-idely studied (Haensler 
and Szoka, 1993, Kukowska-Latallo et at.. 1996. Hudde el al.. 1999. 
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Bielinska et aI., 2000, Brauen et aI., 2005). P AMAM dendrimers contain 
both tertiary amines at branch points as well as primary amines at the termini. 
The terminal amines are responsible for DNA condensation and 
complexation through electrostatic interaction, whereas the inner amines 
provide buffering capacity at low pH, allowing the complexes to escape from 
the endosomes / lysosomes through proton sponge mechanism (Tang et aI., 
1996). There are two major types of dendrimers, the intact dendrimers, 
which bear two new polymers arms at each point of branching, and fractured 
dendrimers, in which either one or two arms originate or the polymer is 
terminated at this point. The fractured form of dendrimer is far more 
effective than the intact form, with transfection efficiency significantly 
enhanced by over 50-fold (Tang et aI., 1996). This is possibly due to the 
higher flexibility of the fractured dendrimers, which gives rise to better DNA 
condensation and more efficient endosomal escape. Although P AMAM was 
reported to be less toxic than PLL, toxicity remains an important issue with 
their in vivo application. 
While most of the cationic polymers face the problem of toxicity, chitosan 
seems to be an attractive candidate compared to the others. Chitosan is a 
natural basic polysaccharide derived from the common biopolymer chitin. It 
is rapidly degraded in the body, non-toxic and of low immunogenicity (Brine 
et al., 1992). It displays a significantly better biocompatibility than other 
cationic polymers such as PEL With the optimum molecular weight, 
chitosan exhibits gene expression level that is comparable to PEl (Koping-
Hoggard et aI., 2001). Interestingly, chitosan appears to control the release 
of DNA, prolonging its action in vitro (Erbacher et al.. 1998). However, 
chitosan lacks the buffering capacity at low pH, causing the endosomal 
escape to be a major limiting factor for this polymer. Approaches such as 
incorporation of endosomolytic agents into chitosan can enhance the 
transfection efficiency both in vitro and in vivo (MacLaughlin et at., 1998). 
2-( dimethylamino )ethyl methacrylate (DMA) is a water soluble cationic 
polymer that has also been extensively investigated in recent years as a gene 
---------------;-;--------- - •.. 
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delivery vector (Cherng et aI., 1996, van de Wetering et aI., 1999, Zuidam ef 
aI., 2000, Rungsardthong et aI., 2001, Deshpande et aI., 2002). DMA can 
efficiently bind and form complexes with DNA, and is able to transfect a 
variety of cell types in vitro (van de Wetering et al., 1997). It is also found to 
be less toxic than PLL. One of the major problems associated with DMA is 
the formation of large insoluble aggregating DNA complexes (Varbaan et al.. 
2003). Modification of the polymer by incorporating hydrophilic 
components such as poly( ethylene glycol) (PEG) has been investigated to 
order to improve colloidal stability (Rungsardthong et al., 2001, Funhoff et 
aI., 2005). 
Since DMA is only partially protonated at physiological pH, it has been 
proposed that DMA might possess buffering capacity and act as a proton 
sponge similar to PEl, facilitating the endosomal escape of the DNA 
complexes (Zuidam et al., 2000). However, a recent study has suggested that 
DMA actually lacks the ability to escape from endosomes (Jones et al., 2004), 
leading to a reconsideration of this hypothesis. 
In general, a number of physicochemical characteristics such as the size, 
surfaces properties (hydrophobicity / hydrophilicity) and solubility of the 
polyplexes affect their efficiency as gene delivery vectors. All the polypi exes 
encounter similar barriers, either inside or outside the body, which are 
described in the following section. While each of the barriers affects 
different polymers to a different extent, the development of a successful gene 
delivery system requires the optimisation of the polymer accordingly. While 
a lot of research has been focused on the design and engineering of the 
polymeric vectors, it must be stressed that the toxicity of polymers must not 
be ignored. 
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1.4 BARRIERS TO NON-VIRAL GENE DELIVERY SYSTEM 
Non-viral gene delivery systems have considerable advantages over viral 
vectors, such as low immunogenicity and a relatively safe profile. In order 
for the non-viral delivery systems to be developed into true therapeutic 
products for humans use, several major barriers are needed to be overcome. 
These barriers can be broadly divided into three classes: physical stability, 
extracellular barriers and intracellular barriers. 
1.4.1 Physical stability 
Once the polyplexes or lipoplexes are produced, either on a laboratory bench 
or clinical scale, their physical and chemical characteristics must be 
successfully preserved in order to maintain their maximum biological activity. 
i.e., the transfection efficiency. Since the formation of polycation - DNA 
complexes is due to electrostatic interaction between the polycations and the 
negatively charged DNA, aggregation of the complexes could be a potential 
problem. Although the complexes are usually prepared with an excess of 
positive charge, the local regions of charge neutrality may promote 
interaction between complexes, resulting in aggregation (Tang and Szoka, 
1997). This problem may be aggravated when highly concentrated 
suspensions are required for clinical studies (Zelphati et al.. 1998). Structural 
alteration with DNA complexes that do not affect the size of the complexes 
may also affect biological activity (Anchordoquy et al., 1998). In addition, 
the complexes must also be formulated to resist any chemical modification or 
degradation (Middaugh et al., 1998), such as attack by free radicals and or 
singlet oxygen. 
To avoid instability of lipid - DNA suspensions in early clinical trials. the 
lipoplexes were usually prepared at the bedside immediately prior to injection 
(Nabel et al., 1992 and 1993). This is undesirable and impractical \\'hen it 
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comes to large scale manufacturing. In order to improve long term stability 
and extend the shelf life of the suspensions, one of the strategies is to employ 
sucrose gradients to isolate a stable fraction of complexes that could be stored 
at 4°C for 3 months (Gao and Huang, 1996, Hofland et ai, 1996). It has been 
demonstrated that these complexes can effectively deliver gene in vivo 
(Hofland et aI., 1997). However, it is uncertain whether this method of 
sucrose density gradient fractionation could be sufficiently scaled up for bulk 
manufacturing. Another approach is to incorporate a steric stabilizer such as 
PEG to the system (Hong et aI., 1997). Although the efficiency of the 
complexes can be preserved at 4°C for 2 months, it is unclear whether liquid 
formulations can be rendered sufficiently stable to withstand stresses 
associated with shipping and prolonged storage (Anchordoquy and Koe. 
1999). 
Due to the relatively low stability of liquid formulation, freeze drying, also 
referred to as lyophilization, is an alternative strategy to stabilize the 
complexes. Lyophilization is carried out using a simple principle of physics 
called sublimation, by which a substance is transited from solid to vapour 
state, without first passing through an intermediate liquid phase. 
Lyophilization is often used to stabilize various pharmaceutical products. 
including virus vaccines, protein and peptide formulations. liposome, and 
small-chemical drug formulations (Friede et aI., 1993, Wang 2000). 
Studies have been carried out on both lipoplexes and polyplexes to evaluate 
the feasibilities of freeze-drying for providing long term stability of non-viral 
gene delivery systems (Molina et aI., 2001, Anchordoquy et aI., 1998, Li et 
ai., 2000, Cherng et ai., 1999, Kwok et aI., 2000, Seville et aI., 2002). The 
main concern with the freeze-dried complexes is whether they can retain the 
same properties as the freshly prepared complexes. 
When the DNA is complexed with polycations, the transfection level of 
freeze-dried complexes is significantly reduced (Zelphati et aI., 1998. 
Anchordoquy et aI., 1998). Since the DNA is protected during complexation 
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by the polycations, the level of DNA damage during freeze-thawing would be 
too low to affect the transfection efficiency. Instead, the structural alterations 
within the complexes and / or aggregation are the main reasons for the 
reduction of transfection level. Several studies have shown that complex size 
increases dramatically following freeze-thawing, suggesting that aggregation 
of complexes are responsible for the reduction of transfection level (Cherng 
et al., 1997, Anchordoquy et al., 1998). During the freezing process, 
formation of ice crystals causes solutes and suspended particles to be 
concentrated in the unfrozen fraction. As the temperature is further reduced, 
the growth of ice crystals causes particles to be further concentrated in the 
unfrozen fraction, and aggregation is facilitated (Allison et al., 2000). 
In order to develop efficient freeze-dried formulations. it is essential to 
maintain the particle size throughout the freeze drying process. Many studies 
have demonstrated that sugars, including glucose, sucrose, trehalose and 
dextrose, can be used as effective lyoprotectants to preserve particle size of 
lipoplexes (Anchordoquy et al., 1998, Molina et al., 2001) and polyplexes 
(Cherng et al., 1999), and hence their transfection efficiency in vitro. 
However, the mechanism by which a sugar preserves the complexes property 
is not clearly understood. Currently there are two hypotheses explaining the 
stabilizing effect of sugar, namely vitrification (glass formation) 
(Anchordoquy et al., 2001) and particle isolation hypothesis (Allison et al., 
2000). In the vitrification hypothesis, it is suggested that the presence of 
sugar increases the volume of unfrozen fraction, and thereby reduces the 
concentrating effect of ice formation. As temperature decreases, the unfrozen 
solution will either crystallize or form an amorphous glass at T g (glass 
transition temperature). The formation of viscous glass might have 
contributed to size preservation by immobilizing the complexes in a glassy 
matrix and thus preventing aggregation. However, some studies indicate that 
sugar (e.g. glucose) can preserve particle size effectively even in the lack of 
glass formation under certain conditions (Allison et al.. 2000). 
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In the second hypothesis, it is proposed that sugar isolates individual particles 
in the ,unfrozen fraction, thereby preventing aggregation during freezing 
(Allison et aI., 2000). According to this hypothesis, vitrification is not 
required to maintain particle size. 
It has also been proposed that incorporating steric stabilizer such as PEG can 
prevent aggregation during freeze drying. This approach could potentially 
eliminate the need for sugar as lyoprotectant. However, the results observed 
by Armstrong et al. suggest that incorporation of PEG alone does not 
preserve complexes size following freeze drying. In contrast when 
PEGylation is combined with the use of sucrose as lyoprotectant, transfection 
efficiency is fully preserved following freeze-drying (Armstrong et aI., 2002). 
1.4.2 Extracellular barriers 
Extracellular barriers to the systemic delivery of DNA are referred to the 
obstacles that the delivery system encounters from the point of injection into 
the human body to the uptake of the system by the target cells, as 
demonstrated in figure 1.1. Blood contains many proteins, lipids and other 
molecules than can bind and destabilize the delivery system. Therefore, a 
successful delivery system must show ability to remain colloidally stable in 
the blood, evade the adaptive immune system, minimize interactions with 
plasma proteins (opsonisation) and non-targeted cell surfaces. The in vivo 
activity of the non-viral delivery system is still difficult to predict due to the 
lack of correlation between in vitro and in vivo results (Wells et at., 2000). 
To allow the design of an efficient system, the underlying principle of each 
potential barrier must be clearly understood. 
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Figure 1.1 Schematic diagram of major extracellula r ba rriers to successful 
non-viral gene delivery . After inj ection, the therapeut ic DNA must be protected 
from the enzymatic activity in plasma. The DNA complexes have to remain 
co ll oidally stable in the blood, and escape from opsonisation and phagocytos is by 
the ce ll s of the reticuloendothelial system (RES) in the circu lati on. The complexes 
must also be spec ific to and able to reach to target cell s. 
Degradation of DNA in plasma 
Once the lipoplexes or polyplexes are present inside the systemic circulation. 
they are intermediately exposed to enzymatic activities . Experiment u ing 
naked DNA in vivo have demonstrated that the fate of th D I i afTcctcd by 
its rapid clearance fro m the blood via nuc lease degradati on (Lecocq C! / 01. . 
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2003). Nuclease is an important biological enzyme that can be found in the 
serum (Cox and Gokcen, 1976, Wickstrom 1986, Eder et al.. 1991, French-
Anderson, 1998). It catalyses the hydrolysis of phosphodiester bonds in both 
RNA and DNA. Nucleases usually show chemical specificity and are either 
deoxyribonucleases (DNase) or ribonucleases (RNase). Introduction of a 
single break in DNA phosphodiester backbone leads to conversion of 
supercoiled to open circular and ultimately linear forms of DNA with further 
breakage (Middaugh et aI., 1998). Although the conversion of DNA from a 
supercoiled to an open circular form usually has a minor effect on 
transfection efficiency, the subsequent conversion to linear forms can 
substantially reduce the level of gene expression (Adami et al.. 1998). In 
order for successful transfection to take place, the therapeutic DNA must be 
effectively protected from any enzymatic degradation. 
The ability of a delivery system to protect DNA from enzymatic degradation 
appears to be highly dependent on DNA condensation ability and the nature 
of the DNA complexes formed. With better DNA binding and condensation 
ability, and the subsequent formation of tighter structures of DNA complexes, 
it is expected that the system can offer better DNA protection capacity 
(Richardson et aI., 2001). No specific strategy is currently available to 
improve DNA protection from enzymatic degradation, apart from the choice 
of an effective DNA condensing agent as the delivery vector or optimizing 
the polycation to DNA ratios. 
1.4.2.2 Reticuloendothelial system and opsonisation 
The human immune defence system provides an excellent protection against 
any foreign or potentially harmful substances. As part of the defence system, 
the cells of the reticuloendothelial system (RES) can rapidly remove 
intravenously administered particulate carriers from the systemic circulation 
(Davis et aI., 1984, Stolnik et aI., 1995). The RES is composed of monocytes 
and macrophages located in reticular connective tissues, e.g. the spleen. li\cr 
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and bone marrow. These cells are responsible for engulfing (phagocytosis) 
and removing cellular debris, old cells, pathogens, and foreign substances 
from the bloodstream. Before any foreign substances are engulfed by 
phagocytes, they are marked and differentiated by being coated with 
chemical mediators generated by the immune system. Such endogenous 
chemicals that make foreign substances more susceptible to phagocytosis are 
known as opsonins. Opsonins provide extrinsic ligands for specific receptors 
on the phagocyte membrane, which dramatically increases the rate of 
adherence and ingestion of the opsonised foreign substances (Horwitz, 1982). 
The most important opsonins are immunoglobulins and one of the activated 
components of complement system, C3b. Without opsonins, the foreign 
substances will not normally be removed by the RES. In order to prolong 
circulation of the non-viral gene delivery system, it must be able to escape 
from opsonisation effectively. 
Several factors, such as surface charge and surface characteristics 
(hydrophilicity / hydrophobicity) are known to have a major influence on 
opsonin -lipoplex or polyplex interactions (Young et aI., 1988, Choun et aI., 
1991, Stolnik et aI., 1995, Semple et aI., 1998). Several reports have 
suggested that overall positively charged polyplexes or lipoplexes show 
considerably more complement activation in an in vitro human complement 
assay when compared to their neutral counterparts (Senior et aI., 1991, Oku 
et aI., 1996). Generally, surfaces with negative or neutral charge are less 
likely to activate the complement system, as compared to positively charged 
surfaces (Freitas Jr., 2003). This is because the majority of plasma proteins 
carry a net negative charge at physiological pH. On the other hand, strong 
negative charge on the particle surface can cause scavenging by phagocytosis 
via the macrophage polyanion receptors, which recognise a wide range of 
anionic molecules, thus enhancing the clearance of the particles from the 
systemic circulation (Juliano and Stamp, 1975, Krieger et al.. 1993). 
Therefore, it is desirable for the complexes to have a surface charge that is 
close to neutral. 
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The hydrophilicity and hydrophobicity of the particle surface affects their 
attractive forces, therefore affecting the opsonisation process. Hydrophobic 
particles are usually opsonised and taken up by cells in the RES within a fe\\ 
minutes following intravenous administration (Patel, 1992). In generaL 
higher protein adsorption is observed on hydrophobic surfaces than on 
hydrophilic surfaces, resulting in a higher uptake of hydrophobic particles by 
phagocytes in vitro and rapid removal in vivo (IlIum and Davis, 1986, 
Golander and Pitt, 1990, Muller et al., 1997, Gessner et al., 2000). A 
hydrophilic component can be incorporated into the delivery system to create 
a hydrophilic corona on the surface of the complexes. 
1.4.2.3 Specificity to target cells 
Lack of specificity is another obstacle to non-viral gene delivery. Specificity 
is based on the recognition and exploitation of differentials between the 
diseased or target site and the healthy tissues. It is an important factor in 
determining the efficacy and safety of a delivery system. In order to avoid 
any unwanted effects in healthy or non-target cells, it is necessary to address 
the delivery system to the specific cell types while minimizing any non-
specific interaction. 
Specificity targeting can be achieved by incorporating specific ligands which 
facilitate the exclusive uptake of the system in certain tissues or cell types 
(e.g. in receptors expressing tissues or cells). This strategy is described in 
further details in section 1.4.5. Another method to achieve gene expression 
in specific tissues involves the use of cell type specific promoters or 
enhancers, which can be activated by induction factors, such as hormones, 
growth factors and cytokins, via responsive elements. This strategy has been 
shown to successfully increase cell specific efficiency in several targets 
(Walther and Stein, 1996, Kurane et al., 1998. Nettelbeck et al., 2000, Shi el 
al., 2001, Varda-Bloom et al., 2001). 
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1.4.3 Intracellular barriers 
Reaching the surface of the targeted cell is only half way to successfu l gen 
delivery . The therapeutic DNA has to overcome another series of barri ers 
inside the cells to reach its site of action, the nucleus, in order to generate the 
desired therapeutic effect. These barriers include cellular uptake. escape 
from the endosomes / lysosomes, unpacking or dissociation of the DNA 
complexes and nuclear entry. The intracellular barriers that are needed to be 
overcome by the delivery system are demonstrated in figure 1.2 . 
DNA complexes 
• 
endosome 
~ ~ ~~ ~ ________ lysosome 
/endosomal ~ ~ ~ ~
escape 
• • 
Figure 1.2 Schematic diagram of the major intracellular barriers to success ful 
non-viral gene delivery. First, the DNA complexes must be ab le to enter the 
targeted cells by endocytosis. In side the ce ll s, the complexes are de livered into 
endosomes and subsequently into the Iysosomes for degradati on. For sllcce flll 
gene deli very, the DNA complexes must rapidly escape from the en do omes. 
followed by dissociation of the complexes to release DNA \\hi ch 11111 t enter into th e 
nuc leus. 
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l.4.3.1 Cellular Uptake 
The plasma membrane is composed of a lipid bilayer and contains various 
integral proteins, which selectively screen all foreign substances entering the 
cell. Non-viral gene delivery systems are often too large and too polar for 
rapid passive diffusion into the cell, making cellular uptake a potential 
obstacle. 
The mechanism of cellular uptake varies with the nature of the complexes 
and the types of cell into which they will be delivered. It is generally 
believed that the majority of the non-viral gene delivery systems enter the 
cells via endocytosis (Farhood, 1995, Klemm et aI., 1998, Kichler et aI., 
2001). Cell surfaces are negatively charged due to their content of 
glycoproteins, proteoglycans and glycerolphosphates (Singh et aI., 1992). 
Adsorptive endocytosis is a plausible mechanism of entry for DNA 
complexes with positive surface charges (Godbey et aI., 1999c, Remy-
Kristensen et aI., 2001). Alternatively, receptor - mediated endocytosis of 
the delivery system can be achieved by attachment of a ligand that binds to 
specific cell surface receptors. 
1.4.3.2 Endosomal escape and lysosomal degradation 
Once within the cells through endocytosis, DNA complexes will follow the 
endosomal / lysosomal pathway, leading from the early to late endosomes, 
and eventually ending in the lysosomal compartment where the pH drops to 
approximately 5. With the presence of aggressive nucleases in the lysosomes, 
the DNA complexes are eventually degraded. Therefore, the DNA 
complexes must be able to escape from the endosomes rapidly and 
effectively in order to avoid destruction. 
A few cationic polymers such as PEl have the ability to escape from the 
endosomes efficiently. PEl has buffering capacity at a pH range of 5-7 
------------------=--=----------- --------
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(Fischer et al., 1999). The buffering capacity of the polymer allows the 
increased influx of protons and chloride ions during endosomal / lysosomal 
acidification, which results in an increase of osmotic pressure in the vesicle. 
As a consequence, the passive diffusion of water into the vesicle increases, 
leading to swelling and eventually rupture or leakage of the vesicle. This is 
known as the 'proton sponge' hypothesis (Boussif et al., 1995). Howeyer, 
not all gene delivery systems have such buffering capacity. Strategies such 
as the employment of endosomolytic agents have been developed to enhance 
endosomal escape and / or prevent lysosomal degradation. These strategies 
are described in section 1.4.4. 
1.4.3.3 DNA unpacking 
DNA unpacking or the dissociation of DNA complexes is essential in the 
transfection process, because only released and intact DNA can be 
transcribed into RNA. In fact, it is a critical step in the success of gene 
delivery (Arigita et al., 1999, van de Wetering et al., 1999, Schaffer et al., 
2000). This problem is often overlooked especially when the gene delivery 
system is designed to have good stability. 
The release of therapeutic DNA from the delivery system could take place 
either in the cytosol or in the nucleus. The dissociation characteristic of non-
viral vectors is directly related to the interaction between the polycations and 
DNA. When the strength of interaction is weak, the complexes may 
dissociate too easily at an early stage, exposing the therapeutic DNA to 
enzymatic degradation before they can reach the target cells. However. when 
the strength of interaction is too strong, the complexes may be incapable of 
dissociation, and the therapeutic gene will be unable to express. It is 
generally believed that the DNA is released from the DNA complexes in "iro 
by exchanging with anionic biological macromolecules such as sulphated 
glycosaminoglycans, hyaluronan and mRNA (Ruponen et al., 1999). The 
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optimal complex dissociation rate or location are unclear and are currently 
being investigated (Schaffer et al., 2000). 
Recently, a strategy has emerged to assist the release of DNA by developing 
vectors with linear reducible polycations using PLL that can be cleaved 
(disulfide reduction) in the intracellular environment to facilitate the release 
of DNA (Read et al., 2003). The initial results are very encouraging as the 
transfection level of the reducible system is increased by 187-fold compared 
to the non-reducible counterparts. A similar approach has been employed by 
Funhoff et al. who designed a novel polymeric delivery system that can be 
degraded within a few days at physiological pH and temperature, hence 
releasing the DNA in the cytosol of the cell (Funhoff et al., 2004a). However, 
the design of such system has to be careful so as not to jeopardize the 
stability of the DNA complexes. 
1.4.3.4 Nuclear entry 
In order for the therapeutic genes to be expressed, they must be efficiently 
delivered inside the nucleus of the target cells. However, nuclear uptake is 
one of the major limitations for successful gene delivery (Zabner et al., 1995). 
Microinjection studies have demonstrated that gene expression can be 
achieved by direction injection of less than 100 plasmids into the nucleus. 
However, to achieve a comparable effect by microinjection of DNA into the 
cytoplasm, it is necessary to inject 100 to 1000 times more DNA (Pouton, 
1998), showing that nuclear entry is an extremely inefficient process. 
The nucleus is separated from the cytoplasm by two membranes, which form 
the nuclear envelope. Like the plasma membrane, each nuclear membrane 
consists of a water-impermeable phospholipid bilayer and various associated 
proteins. The nuclear envelope is perforated by nuclear pores. Nuclear pores 
are cylindrical channels formed by a protein structure called the ·nuclear pore 
complex' (NPC), which allows the passage of selected molecules between 
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cytosol and nucleus. There are two possible routes for the transport of DNA 
into the nucleus. The DNA can either pass into the nucleus through the 
nuclear pores, or it can become physically associated with chromatin during 
mitosis when the envelope breaks down. 
Nuclear pores are embedded in the nuclear envelope at fairly high surface 
densities (3000-4000 / nucleus) (Walter, 1999). They exist in at least two 
conformation states. The closed state permits the passive diffusion of small 
molecules of less than 9 nm in diameter, such as ions and globular proteins 
(40-60 kDa). The open state facilitates the active transport of larger proteins 
or molecules which are less than 26 nm (Mattaj and Englmeier, 1998, Ryan 
and Wente, 2000). All proteins that are actively imported through the nuclear 
pore contain a short polypeptide sequence called a nuclear localization signal 
(NLS) sequence. 
NLS sequences were first discovered during the analysis of mutants of simian 
virus 40 (SV 40) that produced an abnormal form of the early protein called 
large T-antigen (Jans and Hiibner, 1996). The wild type form of this protein 
is localized in the nucleus in virus-infected cells, whereas mutated forms of 
large T -antigen accumulate in the cytoplasm. This suggests the existence of 
a peptide sequence that may govern the transportation across the nucleus. 
Numerous NLS sequences have been identified (Moroianu, 1999). The rate 
of NLS sequence - mediated transportation is likely to be directly 
proportional to the number of functional nuclear signals, and the NLS content 
determines nuclear targeting efficacy (Jans and Hiibner, 1996). 
Apart from the transport through the nuclear pore, DNA may also gain access 
to the nucleus by association with nuclear material on breakdown of the 
nuclear envelope during the process of mitosis. This association has been 
observed on numerous occasions on both lipoplexes and polypi exes by 
comparing transfection efficiencies for cells at various stages in the cell cycle 
(Wilke et al.. 1996, Tseng et al., 1999. Mortimer et a!.. 1999, Fasbender et a!.. 
1997. Brunner et a!., 2000, 2002. Brisson et al., 1999. Tait et a!.. 2004. 
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Parker et ai., 2005, Mannisto et ai., 2005). DNA is typically observed as 
localized in the perinuclear region of the cell where it presumably awaits the 
breakdown of nuclear membrane (Zabner et ai., 1995). However. this route 
of nuclear uptake is only effective when the target cells are rapidly dividing. 
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1.5 STRATEGIES TO IMPROVE POLYMER BASED GENE 
DELIVERY SYSTEMS 
1.5.1 Design of a multifunctional delivery system 
Successful gene delivery requires the efficient transport of therapeutic DNA 
into the nucleus of the target cells, overcoming all the barriers as discussed in 
the previous section. Unfortunately, most of the currently available non-viral 
gene delivery systems have very low efficiency. Poor stability, lack of 
specificity, inadequate cellular uptake, ineffective intracellular trafficking 
and limited nuclear import are all responsible for the poor performance. In 
fact, the in vivo gene delivery is too complex and multifaceted to be achieved 
successfully using a single carrier molecule in most instances. Nowadays, 
DNA complexes without any supplementary components are rarely used in 
vivo. A common strategy to improve the efficiency of non-viral delivery 
system is to design a multifunctional delivery system with various 
components, each of them serving one or two different specific roles. Figure 
1.3 shows a schematic diagram of a proposed multifunctional gene delivery 
based on a cationic polymer as the non-viral vector. Each of the potential 
components of such a system is examined in greater details in the following 
section. 
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Plasmid DNA 
++++++ Cationic polymer 
Hydrophilic polymer 
Targeting ligand 
Cell penetrating peptide 
Endosomolytic agent 
Nuclear localization signal 
Figure 1.3 Schematic diagram of a multifunctional non-viral gene deli\'en 
vector using cationic polymer. 
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1.5.2 Hydrophilic polymer 
In order to improve stability and biocompatibility, as well as to prolong the 
circulation of the DNA complexes, hydrophilic polymers may be 
incorporated with the cationic polymer as a copolymer. The binding 
interaction between the copolymer and DNA occur in an orientated manner 
, 
allowing the hydrophilic block to displace from the polyelectrolyte 
interaction, forming a hydrophilic corona on the surface of the complexes, 
thereby providing steric stabilization to the delivery system, as well as 
decreasing potential adsorption of opsonins. 
A number of polymers have been used in formulations of polyplexes to 
confer steric stabilization on the gene delivery system. Poly( ethylene glycol) 
(PEG) polymers are at present the most popular materials used to modify 
particulate surfaces in order to provide steric stabilization and to avoid 
recognition by cells from the RES. PEG is one of the few family at polymers 
that are approved by FDA for clinical use. They have been successfully 
grafted to surfaces of biomedical devices to increase biocompatibility and to 
reduce thrombogenicity (Holmberg et al., 1993, Ista et al., 1996, Deible et al., 
1998, Jo and Park, 2000, Otsuka et al., 2001). 
In gene delivery, PEG polymers are usually used to form either block or graft 
copolymers with the cationic polymers such as PLL, PEl and DMA (Wolfert 
et al., 1996, Katayose and Kataoka, 1997, Choi et al., 1998, Ogris et al.. 1999, 
Rungsardthong et al., 2001, Petersen et al., 2002,). Both types of copolymers 
(block or graft) form DNA complexes with similar properties. The PEG 
polymers normally form a hydrophilic corona surrounding the polyplexes. 
This flexible hydrophilic layer exhibit rapid chain motion in aqueous medium 
and has a large excluded volume. The steric repulsion resulting from a loss 
of conformational entropy of the bound PEG chains upon the approach of 
other substances and the low interfacial free energy of PEG in water 
contribute to the excellent biocompatibility properties of materials or 
particles covered with PEG (Gref et al., 1994, Otsuka et aI., 2003). PEG 
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polymers not only effectively reduce the self aggregation of polyplexes, but 
also significantly reduce interactions between polyplexes and plasma proteins, 
hence prolonging circulation (Ogris et al., 1999, Harada-Shiba et al., 2002, 
Kichler et al., 2002, Petersen et al., 2002, Merdan et al., 2005). 
Despite its stabilization effect on the delivery system, PEG has been reported 
to affect DNA condensation, probably due to the local crowding effect 
(Wolfert et al., 1996b, Erbacher et al., 1999, Rungsardthong et al., 2001). 
Therefore, an alternative method has emerged. Instead of using block 
copolymers, PEG can be coated on the surfaces of the polyplex after 
complex formation. This approach allows more efficient condensation of 
DNA with cationic polymers (Kircheis et al., 1999, 2001, Blessing et al., 
2001, Lee et al., 2001). 
Another hydrophilic polymer, poly-N-(2-hydroxy)- propylmethacrylamide 
(HPMA) (Oupicky et al., 1999, Oupicky et al., 2000a,b, Carlisle et al., 2004) 
has also been employed as a steric stabilizer in gene delivery. HPMA has 
long been used as a soluble polymeric drug carrier for peptide and other 
anticancer drugs (Duncan, 1992, Morgan et al., 1996, Vasey et al., 1999, 
Kopecek et al., 2000). This polymer is water soluble and shows excellent 
biocompatibility. Since HPMA shares similar properties with PEG, 
including flexibility, hydrophilicity and low immunogenicity, it may also 
function as an efficient steric stabilizer and prolong circulation (Torchilin and 
Trubetskoy, 1995, Toncheva et al., 1998). 
HPMA has been incorporated on to the surface of liposomes in drug delivery. 
The HPMA-modified liposomes were able to provide strong steric protection 
for liposomes, increasing their circulation time and decreasing liver 
accumulation in experimental mice (Whiteman et al., 2001). In polymer 
based gene delivery systems, HPMA can either form block or graft 
copolymers with a cationic polymer such as PLL (Toncheva ef al., 1998) and 
2-(trimethylammonio)ethyl methacrylate (TMAEMA) (Oupick)'. ef al.. 1999. 
Howard et al.. 2000). The presence of HPMA in the copolymer appears to 
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have no significant effect on its ability to form complexes with DNA 
(Oupicky, et al., 1999, 2000). In addition, HPMA is able to provide steric 
stabilization to the DNA complexes and significantly reduce their association 
with phagocytic cells in vitro (Toncheva et al., 1998). However, an in "iva 
study showed that DNA complexes with PLL - HPMA copolymer are 
cleared from the circulation in the mouse rapidly (Oupicky, et al., 2000a). 
Lateral stabilized multivalent polymers based on HPMA are a recent 
development and this modified gene delivery system can significantly 
prolong circulation in mice (Dash et al., 2000, Oupicky et al., 2002). The 
HPMA polymer therefore remains an excellent alternative to PEG. 
In recent years, dextran has also been introduced as a potential steric 
stabilizer in non-viral gene delivery. Dextran is a branched polymer 
consisting of repeating units of glucose. Because of its hydrophilic property 
and lack of toxicity to biological systems (Amiji, 1996), dextran is used in 
drug delivery systems to escape from the RES and consequently increase the 
circulation time of the drug (Patel, 1983). Its branched structure might 
provide better shielding effect than linear polymers, such as PEG, to 
minimize charge interactions with serum proteins (Tseng and long, 2003). 
Conjugation of dextran on a cationic polymer has been shown to improve the 
stability of DNA complexes in the presence of serum (Toncheva et aI., 1998, 
Erbacher et al., 1999, Tseng and long, 2003). However, the experience with 
the use of dextran in gene delivery is still very limited. Various parameters 
such as the molecular weight of dextran and the optimum ratio of dextran to 
cationic polymer must be defined for further development of this system. 
1.5.3 Cell penetrating peptides 
The lipophilic nature of biological membranes has prevented the direct entry 
of any large hydrophilic molecules. This is a particular problem \\"hen 
polyplexes are sterically stabilized by a hydrophilic polymer at the surface of 
the complexes. A novel approach to increase the cellular uptake of such 
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complexes involves the attachment of peptides that can translocate through 
the cellular membranes (Derossi et al., 1998, Lindgren et al., 2000, Deshayes 
et al., 2005, Gupta et al., 2005). These peptides are called cell penetrating 
peptides (CPPs). They are short peptides that are usually fewer than 30 
residues. Many CPPs were designed from sequences of membrane 
interacting proteins, such as fusion proteins, signal peptides, transmembrane 
domains and antimicrobial peptides. These peptides sequences contain short 
sequences called protein transduction domains (PTD) which can efficiently 
cross the biological membranes without the need for receptor and deliver 
peptides or protein into intracellular compartments (Schwarze and Dowdy. 
2000). 
CPPs are divided into two classes, the amphipathic helical peptides, such as 
transportan and model amphipathic peptide (MAP) and arginine-rich peptides. 
such as trans-activating transcriptional activator (T A T) and penetratin 
(Hall brink et al., 2001). The mechanisms of CPPs entering the cells are 
currently poorly understood. Since CPPs can enter the cells at 4°C, it is first 
believed that they are internalized through an energy-independent pathway 
(Derossi et al., 1994, Vives et al., 1997, Pooga et al., 1998). However, 
results from more recent studies have held back this assumption (Console et 
al., 2003, Letoha et al., 2003, Saalik et al., 2004). It is currently believed that 
there is more than one mechanism for CPP-mediated cellular uptake. For 
example, TAT -mediated cellular uptake occurs via energy-dependent 
macropinocytosis (Snyder and Dowdy, 2004, Wadia et al., 2004), whereas 
some other CPPs penetrate cells via electrostatic interactions and/or hydrogen 
bonding between CPPs and proteoglycans on the cell surface, and do not 
seem to require energy (Rothbard et al., 2004, Shen et al., 2004). In any case, 
the direct contact between the PTD and cell membrane or cell membrane 
interacting proteoglycans is required for successful intracellular delivery. 
The employment of CPP to improve gene delivery has already been reported 
by linking PLL to TAT (Hashida et al., 2004). The initial results are 
promising as the novel system promotes the delivery of DNA in vitro \\ithout 
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affecting DNA binding ability. However, the weakness of using CPPs to 
enhance gene delivery is the lack of specificity towards the target site as they 
tend to trigger internalization in many cell types. Modification of CPP 
sequences that can improve their specificity (Deshayes et aI., 2005) is 
therefore desirable in designing a targeting gene delivery system. 
1.5.4 Endosomolytic agent 
Once the delivery systems have entered the cells through endocytosis, they 
are immediately transported to endosomes and then lysosomes for 
degradation. PEl is well known to be able to escape from the endosomes 
through the 'proton sponge' mechanism (Boussif et aI., 1995). However, not 
all the cationic polymers possess this beneficial characteristic. In order to 
enhance the endosomal release of these systems, an additional endosomolytic 
agent is required. 
There are several types of endosomolytic agents. The most common agent 
employed is chloroquine, an anti-malarial drug. It prevents the acidification 
of endosomes, promotes swelling of endosomal vesicle and destabilizes 
endosomal membranes, thus enhancing endosomal release of the delivery 
system (Luthman and Magnusson, 1983, Erbacher et al., 1996, Pouton et aI., 
1998, Ciftci and Levy, 2001). However, due to toxicity problems with 
chloroquine in vivo, the applicability of this agent is limited to the 
enhancement of transfection in vitro. 
Peptides with pH dependent membrane lytic activity have also been used to 
enhance endosomal escape of gene or drug delivery system (Wagner. 1998). 
This concept is based on the pore-forming proteins used by both viruses and 
bacteria to facilitate lysosomal escape of their contents to host cells in order 
to avoid destruction. Analogous peptides have been synthetically developed 
to exploit this pH dependent activity for endosomal / lysosomal e s c a p ~ . .
These peptides include GALA, KALA and JTS 1 (Parente el at.. 1990. 
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Gottschalk et aI., 1996, Turk et aI., 2002). They are designed to exhibit 
random coil structures at physiological pH 7.4, transforming back to a 
membrane active, penetrating helix to prompt membrane leakage in the 
acidic environment. Disadvantages of using these peptides include low 
stability of the peptides, high costs for peptide synthesis and the 
immunogenic potential of these structures. 
1.5.4 Targeting Ligand 
Non-viral vectors generally lack specificity. One of the widely employed 
approaches to achieve specific targeting in the pharmaceutics area is coupling 
of a targeting ligand to the therapeutic agent. The most frequently used pre-
existing targeting ligands are based on endogenous molecules, which are 
already present in the body. Specific targeting not only can enhance the net 
uptake of genes to the target cells, but also reduces gene deposition into 
normal healthy cells, thereby minimising cytotoxicity. 
The main criterion to be an efficient targeting ligand is that its receptor 
should only be highly expressed in the target tissues and no others. For that 
reason, the choice of ligand heavily depends on the types of tissues to be 
targeted. After coupling to the delivery vector, the ligand should retain full 
binding affinity for its receptor. In addition, the targeting ligand must be 
available on the surface of the delivery system for effective ligand - receptor 
interaction. Other desirable features of a targeting ligand include high 
affinity to the receptor with low immunogenicity (Schazlein 2003, Marcucci 
and Lefoulon, 2004). 
The use of targeting ligands is popular in the delivery of cancer therapy due 
to the high toxicity of anti-cancer agents. The development of gene delivery 
has adopted this approach to achieve specific delivery. This concept was first 
described over 20 years ago by Cheng et al. (Cheng et at., 1983). \\"ho linked 
a2-macroglobulin directly to DNA for gene delivery. The use of targeting 
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ligand attached to a polycationic vector was developed later. Such a system 
was first reported with PLL conjugated with asialoglycoprotein for 
hepatocytes targeting (Wu and Wu, 1987, 1988). Since then, 
asialoglycoprotein (Stankovics et aI., 1994, Park. et aI., 2000, Kim et at., 
2005) and many other receptors have been targeted by gene delivery systems 
using different targeting ligands such as folic acid (Mislick et aI., 1995, 
Wang and Low, 1998), transferrin (Wagner et aI., 1990, Cotton et aI., 1996, 
Lee et aI., 2005), and epidermal growth factor (EGF) (Cristiano and Roth, 
1996, Kloeckner et aI., 2004). Each of these ligands has its own advantages 
and limitations. 
Asialoglycoprotein is useful in targeting hepatocytes as its receptor was 
found to be selectively expressed by these cells (Kawasaki and Ashwell 
1976). However, Asialoglycoprotein - PLL - DNA complexes are 
immunogenic when repeatedly administered to mice (Stankovics et aI., 1994). 
A similar problem is faced by EGF, when incorporated in PLL and PEl 
(Cristiano and Roth, 1996, Kloeckner et aI., 2004). Transferrin is another 
commonly used ligand for gene delivery. Its receptors are upregulated in 
many tumours (Huebers and Finch, 1987) and are therefore suitable for 
targeting a variety of cells. Transferrin has been reported to conjugate with 
PLL (Cotton et aI., 1990), PEl (Kircheis et aI., 1997, Orgis et aI., 1999, Lee 
et at., 2005) and chitosan (Mao et aI., 2001). However, the presence of 
transferrin receptors on various cell types has potentially limited the 
specificity of transferrin conjugated system, (Simoes et aI., 1999). Folic acid 
is also employed to target tumour tissues due to overexpression of folate 
receptors in most cancer cells (Ross et aI., 1994, Weitman et aI., 1994). It 
has been conjugated to polycations such as PEl (Guo and Lee, 1999, 2001) 
and PLL (Mislick et aI., 1995, Ward et at., 2002). 
The results from most of the in vitro studies of these ligand-conjugated 
polymer - DNA complexes appear to be promising. However, the 
experience with their use in vivo is still very limited. Further optimization of 
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these targeted delivery systems in vivo is required for the development of 
therapy in humans. 
1.5.5 Nuclear localization signals 
In order to be actively transported through the nuclear pores, DNA 
complexes must carry a NLS. Many NLS sequences have been discovered, 
with the most widely used being the sequence derived from the SV 40 large T 
antigen (Boulikas, 1993, Christophe et al., 2000, Hodel et al., 2001). The 
sequence that is responsible for the transportation across the nucleus is a 
seven amino acid sequence: 'PKKKRKV' (Pro-Lys-Lys-Lys-Arg-Lys-Val) 
(Gorlich and Mattaj, 1996, Jans and Hiibner, 1996). This sequence has often 
been referred as the 'classical' NLS. 
Attempts have been made to enhance nuclear entry by designing NLS peptide 
bearing vectors (Sebestyen et al., 1998, Branden et al., 1999, Ciolina et al., 
1999, Neves et al., 1999). The size limit for active transport through the 
nuclear pore is about 25 run. Unfortunately, polyplexes are generally far too 
large to cross the nuclear pore even when towed by the NLS sequences. 
Therefore, one has to assume that the polyplexes are (or at least partly) 
disassembled in the cytoplasm so that the NLS sequence containing DNA can 
be taken up through the nuclear pores. 
Covalent modification of DNA for the attachment of NLS sequences has 
been demonstrated to increase nuclear translocation of DNA (Zanta et al., 
1999). In that study, the transfection level in vitro was enhanced from 10- to 
1000- fold as a result of the NLS peptide. Interestingly, the degree of 
labelling with NLS to the DNA is found to be the major factor affecting the 
level of DNA uptake. A single NLS per reporter gene is sufficient to carry 
DNA into the nucleus, whereas too many signals per DNA would lead to the 
inhibition of nuclear entry by simultaneously interacting with multiple 
nuclear pores. 
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1.6 PHOSPHORYLCHOLINE BASED GENE DELIVERY 
SYSTEM 
It is well understood that the major criteria of the use of biomaterials in l'il'o 
is to be biocompatible. They must be non-thrombogenic and show minimal 
interactions with plasma proteins. Introduction of phosphorylcholine (PC) 
containing materials has been suggested to enhance biocompatibility. PC is a 
zwitterionic head group that can be found naturally in the outer leaflet of 
biomembranes in the form of phospholipids. It has demonstrated an ability to 
resist adsorption of proteins (Lewis, 2000, Murphy et al., 2000). This 
attractive property has led to the development of synthetic polymers bearing 
the PC group, such as 2-methacryloyloxyethyl phosphorylcholine (MPC) 
polymers (Lewis et aI., 2000, Konno et al., 2001) 
PC-based polymers have been shown to reduce the surface adsorption of 
many important proteins, e.g. albumin, immunoglobulins and fibrinogen etc., 
which are found in high concentrations in human blood plasma, by over 50% 
compare to relevant controls (Lewis, 2000). As a result, the body is less 
likely to detect these foreign materials and immune response may not be 
activated. The mechanism of how PC-based polymers reduce protein 
adsorption is not fully understood. It is suggested that the high water affinity 
of the polymer plays an important role (Ishihara et al., 1998). Some studies 
show that the hydrophilic PC-based polymer has a large free water fraction 
when compared to other materials. With high level of free water fraction on 
the polymer surface, proteins are allowed to contact the surface reversibly 
without much conformational change (Ishihara and Iwasaki, 1998). Other 
factors, such as flexibility and mobility of PC group may also contribute to its 
resistance to protein adsorption (Lewis, 2000). 
The biocompatible PC-based polymers have been employed in \anous 
biomedical applications, such as surface coatings for coronary stents (Le\\is 
et al., 2001 a, 2002, Lewis and Stratford, 2002), thoracic drain catheters 
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(Hunter and Angellini, 1993), and vascular grafts (Chen et al.. 1997). There 
are data to support the safety uses of these materials. Recently, the PC-based 
polymers have been investigated in controlled drug delivery (Lewis et al.. 
2001 b, Salvage et aI., 2005). The initial results are very encouraging. 
Perhaps it is possible to extend its application to gene delivery systems. Due 
to its excellent biocompatibility and hydrophilic property, we propose here 
that the PC-based polymer can be used as a steric stabilizer to improve the 
stability and possibly prolong circulation of gene delivery systems . 
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1.7 AIMS 
Cationic polymer - DNA complexes have been investigated by many 
researchers in recent years as potentially safer gene delivery systems 
compared to the viral system. However, the major obstacle faced by cationic 
polymer systems remains poor efficiency. The efficiency of these systems 
can be improved by designing a multifunctional gene delivery system based 
on a cationic polymer, with functional components that address system 
properties including colloidal stability (steric barrier), reduction of non-
specific interaction and specific cellular targeting and entry. 
The cationic 2-( dimethylamino )ethyl methacrylate (DMA) homopolymer has 
been shown previously to condense DNA efficiently. However, problems 
associated with colloidal instability of the homopolymer - DNA complexes 
and their non-specific cellular interactions have held back their in vivo use. 
The hydrophilic 2-(methacryloxyloxyethyl phosphorylcholine) (MPC) 
polymer, which has been successfully employed as a biocompatible coating 
of many biomedical applications, is currently proposed as a potential steric 
stabilizer for the delivery system, and to reduce any non-specific cellular 
interaction. Thus, a novel synthetic A-B type diblock copolymer, DMA-
MPC, was introduced here as a candidate for gene delivery, with folic acid 
incorporated into the system as a targeting ligand to improve specificity. 
The primary aim of this thesis was to evaluate the potential of this DMA-
MPC diblock copolymer system in gene delivery. First of all, it is crucial to 
find out whether the hydrophilic MPC is indeed an effective steric barrier to 
prevent aggregation of the system. The characterisation of DNA complexes 
prepared from various diblock copolymer composition was needed, including 
DNA binding ability, particle size and morphology etc .. in order to determine 
the optimum composition at which both DNA condensation and stcric 
stabilization could be achieved simultaneously. The next step was to assess 
the biological properties of the systems, including their ability to protect 
42 
Chapter 1: Introduction 
DNA from enzymatic degradation, membrane and cellular interaction. and in 
vitro transfection efficiency. These results would also be valuable to reveal 
whether the hydrophilic MPC could successfully reduce any undesirable non-
specific cellular interaction. In addition, the cellular uptake mechanism and 
the intracellular trafficking of the DNA complexes were examined to 
improve our understanding and to assist the design of a more efficient 
delivery system. Finally, in order to improve specific targeting and cellular 
entry, folic acid conjugated DMA-MPC system was introduced. and both 
physicochemical and biological properties of this system examined. 
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CHAPTER 2 
GENERAL MATERIALS AND METHODS 
2.1 MATERIALS 
Unless otherwise specified, all reagents and buffer salts were obtained from 
Sigma, UK. Water used was obtained from an ELGA purification system 
(resistivity 15MQcm, Maxima USF ELGA, High Wycombe, UK) while that 
used for cell culture was of tissue culture grade. Phosphate buffered saline 
(PBS), containing 0.14 M NaCI, 0.01 M phosphate at pH 7.4, was prepared 
from tablets, with any further dilutions for reduced strength buffers being 
made with ELGA water. 
2.1.1 DNA 
gWizTM luc plasmid (6732 bps) containing the luciferase reporter gene was 
purchased from Aldevron, Fargo, USA. The plasmid was supplied at a 
concentration of 5.6 mg/ml, which was diluted to 1 mg/ml with water before 
use. It was used for all experiments unless otherwise specified. gWizTM GFP 
plasmid (5757 bps) containing the green fluorescent protein reporter gene 
was purchased from Aldevron, Fargo, USA. The plasmid was supplied at a 
concentration of 4.23 mg/ml, which was diluted to 1 mg/ml with water before 
use. gWizTM GFP plasmid was used for enzymatic degradation assay. Calf 
thymus DNA was purchased from Sigma (Poole, UK) and was purified 
before use for the membrane models interaction study. Calf thymus DNA 
was purified by ethanol precipitation and reconstituted prior to use by using 
dry ice-cold ethanol / 3 M sodium acetate (90/1 0) to 1 ml of DNA solution (1 
mg/ml). Relative purity can be determined by calculating the ratios of 
absorbance at 260 and 280 nm using UV spectroscopy. Pure DNA has the 
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ratio of 1.8, therefore the purity of the calf thymus DNA can be determined 
from (A26o/A28o)I1.8. The actual concentration of the calf thymus DNA 
solutions can be determined using the following equation (1): 
. A260/ A280 
concentratIOn = (50 x x A260) x Dilution factor (Ilg/ml) (1) 
1.8 
2.1.2 Polymers 
DMA homopolymers, l\1PC homopolymers and DMA-MPC diblock 
copolymers were all synthesised within the group of Professor S. Armes 
(Department of Chemistry, The University of Sheffield, UK) according to the 
methods described in literature (Armes et aI., 2001, Ma et aI., 2003). All 
polymers were supplied as freeze-dried solids which were subsequently 
dissolved in ELGA water (1-10 mg/m!) and stored at -20°e. The chemical 
structures of the polymers are shown in Figure 2.1. Their relevant physical 
and chemical properties are shown in Table 2.1. 
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Figure 2.1 Chemical structures of 2-(dimethylamino)ethyl methacrylate 
(DMA), 2-(methacryloyloxyethyl phosphorylcholine) (MPC) and 
(dimethylamino) ethyl methacrylate -(methacryloyloxyethyl phosphorylcholine) 
(DMAm - MPCn ) diblock copolymer. 
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Table 2.1 Summary of properties for DMA homopolymer, MPC homopolymer 
and DMA-MPC diblock copolymers. 
MPC% 
Polymer DMA(m) MPC (n) Mn MwlMn 
(\\1 %) 
DMA 
81 12.700 1.07 0 
homopol ymer 
MPC homopolymer 30 8,300 1.21 100 
DMA40MPC lO 40 10 9,000 1.21 32 
DMA40MPC2o 40 20 12,000 1.25 48 
D M ~ o M P C 4 0 0 40 40 18,000 1.26 65 
DMA4oMPCso 40 50 21,000 1.23 70 
DMA10MPC30 10 30 10,000 1.28 85 
DMA20MPC30 20 30 12,000 1.26 74 
DMA40MPC3o 40 30 15,000 1.26 58 
DMA60MPC3o 60 30 18,000 1.29 48 
DMA1ooMPC30 100 30 24,000 1.32 36 
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2.2 GENERAL METHODS 
2.2.1 Preparation of polymer - DNA complexes 
Unless stated otherwise, all polymer - DNA complexes were prepared by the 
addition of a single aliquot of polymer solution to DNA in buffer solution, 
followed by vortexing of the mixture for 30 s. The amount of polymer 
required to produce complexes of a given monomeric unit: nucleotide ratio 
was calculated according to the equation below. It is noted that the 
monomeric unit of the polymer refers to the number of monomer of the 
cationic polymer, i.e. DMA polymer. In the case of DMA-MPC diblock 
copolymers, the proportion ofMPC (by weight) has been taken into account 
of the calculation. 
Polymer monomer Mw x ratio x Amount of DNA (2) 
Amount of polymer = ---=------------------
DNA nucleotide Mw 
The DNA nucleotide molecular weight was taken as 308. 
2.2.2 Cell lines and routine subculture 
A549 cells (human lung carcinoma) were provided by the Experimental 
Cancer Chemotherapy Group, University of Nottingham, UK. The cells were 
routinely cultured in RMPI-1640 medium supplemented with 10% newborn 
calf serum and antibiotic antimycotic solution (100 units/ml penicillin G, 
O.lmg/ml streptomycin sulphate and 0.25Jlglml amphotericin B) at 37°C 
under 50/0 C02 in humidified air. The cells were sub-cultured twice a week at 
a 1: 10 ratio, using Trypsin - EDT A as the dissociating agent. 
48 
Chapter 2: General Methods and Materials 
2.2.3 Statistical analysis 
Statistical analyses were performed to establish the significance of variation 
between sets of data using Prism Version 4 (GraphPad Software). 
Significance was set at P < 0.05 using Unpaired Student's t test. 
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2.3 INSTRUMENTATION AND BASIC THEORY 
2.3.1 Ethidium bromide displacement assay 
Ethidium bromide (EtBr) displacement assay is frequently used to assess a 
compound's ability to bind with DNA by measuring the changes in the 
fluorescence of EtBr - DNA complexes (Le Pacq & Paoletti, 1967). EtBr is 
an intercalating agent commonly used as a nucleic acid stain in molecular 
biology. It is weakly fluorescent in water, but its intensity increases about 
30-fold upon binding to DNA (Lokowicz, 1999). This is likely due to rigid 
stabilization of the phenyl moiety. EtBr binds with DNA by intercalation of 
the planar aromatic rings between the base pairs of DNA. When a cationic 
polymer is added to bind with DNA, the intercalated EtBr is displaced and 
the level of fluorescence decreases accordingly. The reduction of 
fluorescence therefore corresponds to the affinity of polymer - DNA binding. 
2.3.2 Gel retardation assay 
The gel retardation assay involves the use of electrophoresis technique to 
study the interaction between polymer and DNA. Electrophoresis refers to 
the movement of small ions and charged molecules in solution under the 
influence of an electric field. The rate of migrations depends on the size and 
charge of molecules. DNA has a negatively charged phosphate in every base 
in the sequence. It possesses a constant charge to size ratio. As a result, 
DNA molecules of all sizes migrate at a similar rate in liquid. Therefore, 
electrophoresis must be carried out in a medium with obstructive properties 
so that DNA molecules can be separated according to size. Agarose gel is a 
commonly used medium to perform electrophoresis of DNA. It consists of a 
solid matrix entrapping a buffer and exhibits a molecular sieving effect: 
smaller molecules experience fewer collisions with the matrix and pass 
through more rapidly. 
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When a cationic polymer is added to DNA, complexes are formed through 
electrostatic interaction. During electrophoresis, the negatively charged 
DNA migrates towards the positively charged anode whereas the positively 
charged polymer migrates towards the negatively charged cathode. EtBr is a 
commonly used fluorescent dye to visualize DNA bands in gel 
electrophoresis. It binds to free DNA so that DNA bands can be viewed 
under UV illumination. The polymer bands can also be viewed after being 
stained with the appropriate staining solution. 
2.3.3 Zeta Potential Theory 
Zeta potential is a physical property exhibited by any particle in suspension. 
It is not the actual surface charge of the particle, but is closely related to it. 
Factors which alter zeta potential will affect surface charge; therefore the 
magnitude of the zeta potential can be used as a reliable indication of the 
surface charge of the particle. As shown in figure 2.2, the liquid layer 
surrounding a particle exists as two parts; an inner region, the Stern layer, 
where the ions are strongly bound, and an outer region, the diffuse layer, 
where they are loosely associated. Within the diffuse layer there is a notional 
boundary inside which the ions and particles form a stable entity. When a 
particle moves, ions within the boundary move with it. Those ions beyond 
the boundary stay with the bulk solution. The potential at this boundary is 
called the zeta potential (Lyklema 2000). 
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Figure 2.2 Diagram showing the zeta potential of a charged particle. 
Electrophoresis is the most commonly used method to determi ne the zeta 
potential. When an electric field is applied to an electrolyte, charged 
particles are attracted towards the electrode of opposite charge. The mobil it y 
of the particles is dependent on the strength of electric field , the dielectri c 
constant of the medium, the viscosity of the medium and the zeta potential. 
Since the measurement of zeta potential is also dependent on the ionic 
strength of surrounding medium, as the ionic strength increases, the zeta 
potential decreases. In order to obtain zeta potential that are repre entative of 
the surface charge, it is best to perform measurements in low ionic trength 
buffers . 
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2.3.4 Photon correlation spectroscopy 
Photon correlation spectroscopy (peS) is a useful tool for particle size 
analysis for particles ranging from 10 nm up to a few micrometres in 
diameter. Its operation is based on the light scattering phenomenon. When 
small particles are illuminated by a beam of light, they will scatter it in all 
directions. The scattering intensity depends on the size of the particles and 
their optical properties. By measuring the intensity of light scattered, the 
particles size can be found by appropriate calculations (see below). 
Particles in dispersions move due to a phenomenon known as 'Brownian 
motions'. This motion occurs as the particles are bombarded by surrounding 
molecules. When a focused laser beam illuminates a small volume of the 
suspension of particles, due to the Brownian motion of particles, there are 
fluctuations in the scattering of light. Small particles move rapidly and so the 
fluctuations in the scattered light are rapid. In contrast, large particles move 
slowly and the scattered light fluctuations occur over a longer timescale. The 
movement of particles in suspension can be expressed in terms of' diffusion 
coefficient'. By knowing the change of scattering intensity over time, the 
diffusion coefficient could be obtained (Washington, 1992). According to 
the Stokes-Einstein equation (3), the diffusion coefficient is related to the 
particle diameter: 
D = diffuSion coefficient 
t = absolute temperature 
D = kt /31t1]d 
d = diameter of spherical particle 
(3) 
k = Boltzmann's constant 
17 = solvent viscosity 
Using the above equation, the diameter of particles can be found, with the 
assumptions that the particles are spherical in shape. 
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2.3.5 Transmission electron microscopy 
Transmission electron microscopy (TEM) has been long established as a 
powerful tool to visualise the morphology of DNA condensates. It was first 
used to investigate how DNA is packaged in cell nuclei and viral particles 
(Haynes et aI., 1970, Gosule and Schellman, 1976). Later, this technique was 
adopted to study the DNA condensation by non-viral gene delivery system 
(Bloomfield 1996). TEM operates by flooding the sample with an electron 
beam and generating an image on a photographic plate beyond the sample. 
In order to visualise a sample in the TEM, one must have contrasting regions 
of electron transparency and electron opacity. This can be achieved by the 
use of a heavy metal stain, which possesses the ability to stop or strongly 
deflect the electrons so that they do not contribute to the final image 
2.3.6 Atomic force microscopy 
Since the invention of AFM in 1986 (Bennig et aI, 1986), it has developed 
rapidly and become popular for biological research (Hansma et aI., 1997). 
AFM uses the attractive or repulsive forces between tip and sample which 
cause the cantilever to deflect (Bennig et aI., 1986). A photo detector 
measures the cantilever deflection and from this information a map of the 
sample topography can be created. There are three main modes of AFM 
operation: contact, non-contact and tapping. The tapping mode was used in 
this study. It operates in the repulsive force region, but touches the surface 
only for short periods of time, in order to reduce damage to potentially fragile 
samples, such as biological molecules. 
There are several advantages of AFM over TEM. First of all, it is possible to 
perform AFM imaging in aqueous environment, so that drying of the sample 
is not required. This aIIows the DNA complexes to be visualised in 
conditions much closer to the physiological environment. Also, staining is 
not necessary for AFM imaging. Thus, less sample manipulation is required 
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for AFM compared to TEM. Furthermore, three dimensional AFM images 
yield far more complete information than the two dimensional profiles 
provided by TEM images. However, there are still limitations with the use of 
AFM. The samples are needed to be adsorbed to a substrate; therefore the 
complexes that do not adhere cannot be imaged. 
2.3.7 Flow cytometry 
A flow cytometer is generally referred to an instrument for detecting and 
measuring the amount of fluorescent dye on particles (figure 2.3). When a 
suspension of particles is loaded into the flow cytometer, they flow rapidly in 
a liquid stream which is regulated by the sheath fluid. The sheath fluid 
provides the supporting vehicle for directing particles through the flow 
system, so that the particles will be uniformly illuminated as they pass 
through the focused laser light beam. One unique feature of flow cytometry 
is that it measures fluorescence per single particle. This contrasts with the 
spectrophotometer in which the percent absorption and transmission of 
specific wavelengths of light is measured for a bulk volume of sample. 
When the fluorescent particles intercept the laser beam, the scattered and 
emitted light from the particles are converted to electrical pulses by optical 
detectors. The signals are then processed and analysed by a computer system 
(Givan 1992). 
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Figure 2.3 Diagram showing the basic setup of a flow cytometry . One uniqu e 
feature of flow cytometry is that it measures fluorescence per cel l or particle. A 
focused beam of laser hits the movi ng cell and the light is scatte red in a ll directions . 
Detectors receive the pulses of scattered light and they arc convcrtcd into a form 
suitable for computer analysis and interpretation . Some tlo\Y cytometers are a l 0 
"cell sorters" instruments which have the ab ili ty to se lecti\ 'e ly deposit ce ll s frolll 
part icular populations . 
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2.3.8 Laser scanning confocal microscopy 
Confocal microscope has been frequently used in biological research (Amos 
and White, 2003), mainly because the technique enables visualisation deep 
within both living and fixed cells and tissues, and affords the ability to collect 
sharply defined optical sections without physically sectioning the cells or 
tissues. In addition, three-dimensional (3D) images of the specimens can be 
constructed. A schematic diagram of a typical confocal microscopy setup is 
shown in figure 2.4. When fluorescent specimens are imaged using a 
conventional widefield optical microscope, secondary fluorescence emitted 
by the specimen that is away from the region of interest often interferes with 
the resolution of those features that are in focus. This situation is especially 
problematic for thick specimens which have a thickness greater than 2 
micrometers. The basic key to the confocal approach is the use of spatial 
filtering techniques to eliminate out of focus light or glare in specimens 
whose thickness exceeds the immediate plane of focus. This leads to a slight 
but significant improvement in both axial and lateral resolution. 
Confocal mIcroscopy offers several advantages over conventional optical 
microscopy, including the ability to control depth of field, elimination or 
reduction of background information away from the focal plane, and the 
ability to collect serial optical sections from thick specimens. With the 
confocal microscope, the z resolution, or optical sectioning thickness, 
depends on a number of factors: the wavelength of the excitation/emission 
light, pinhole size, numerical aperture of the objective lens, refractive index 
of components in the light path and the alignment of the instrument. The 
resolution of the confocal microscope is higher than in that found 
conventional optical microscope, but is still considerably less than that of the 
electron microscope. However, the electron microscope suffers from a lack 
of 3D information due to poor penetrating power of electrons. Therefore, 
confocal microscopy has become an important tool to bridge the gap between 
other microscopic techniques. 
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Figure 2.4 Diagram showing the basic setup of a confocal microscope. The kc\' 
feature of a confocal microscope is the ability to eliminate the out-of-focus 
information and collect serial optical sections from thick specimcns . By havi ng 
confocal pinholes, the microscope can effici ently rejecting the out of focus light 
Only the light within the focal plane can be detected . 
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CHAPTER 3 
PHYSICOCHEMICAL ANALYSIS OF DMA-MPC 
DIBLOCK COPOLYMER - DNA COMPLEXES 
3.1 INTRODUCTION 
For the development of non-viral gene delivery systems, it is essential to 
carry out the physicochemical characterisation in order to optimise the design 
of such a system for biological investigations. It also assists the 
understanding of the underlying mechanisms of the vector - DNA interaction. 
The first criterion to be a potential non-viral gene delivery system is the 
ability to bind and form complexes with DNA effectively. The 
physicochemical properties of the resulting DNA complexes, such as surface 
charge and particle size can have a major influence on the efficiency of the 
system to deliver gene into the cells. In addition, the long term stability of 
the complexes, and the potential development of dried products, are equally 
important when the non-viral delivery system is to be developed into a 
commercial therapeutic product. 
3.1.1 Surface charge 
The surface charge of a gene delivery system is a significant parameter 
affecting its ability to interact with cell surfaces. Since cell membranes are 
generally negatively charged, the overall positive charge of a delivery system 
can facilitate its association with cell membranes. and thus potentially 
enhance cellular uptake and transfection efficiency. In addition. charges on 
particles contribute to their colloidal stability. i.e., preventing aggregation of 
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DNA complexes. There is evidence suggesting that high positive zeta 
potential can facilitate the cellular uptake of DNA complexes and enhance 
their transfection efficiency in vitro (Godbey et aI., 1999, Gebhart and 
Kabanov, 2001, Choosakoonkriang et aI., 2003). 
However, strongly charged particles are prone to opsonisation, which is one 
of the major barriers to successful gene delivery in vivo. Therefore, 
successful gene delivery systems could benefit from having a surface charge 
which is close to neutral. This can be possibly achieved by shielding of the 
surface charge of the complexes by a hydrophilic polymer. However. it is 
noted that other surface characteristics such as hydrophilicity also have 
important roles in preventing opsonins activation. 
3.1.2 Particle size 
The particle size of DNA complexes plays an important role in cellular 
uptake. It is widely accepted that a small particle size is beneficial for 
efficient delivery of DNA into cells. Not only is endocytosis more efficient 
with particles size smaller than 150-200 nm, but the rate of movement in the 
cytoplasm was also found to be particle size dependent (Mahato et al.. 2000). 
In addition, particle size also plays a crucial role for biocompatibility, as 
small particles (around 100 nm) are more likely to evade from the RES 
(Harada-Shiba et al., 2002, Adams et al., 2003). Polyplexes have a tendency 
to aggregate in biological media even if they have an overall positive surface 
charge. Aggregation is also dependent on other parameters such as surface 
characteristics (hydrophilicity / hydrophobicity) of the polyplexes. Surface 
modification of DNA complexes by incorporation of a steric barrier can 
inhibit self - aggregation, reducing interactions between DNA complexes and 
blood components in the systemic circulation, and consequentl y pren.!nting 
rapid elimination by the RES (Woodle and Lasic. 1992. Dash et al.. 1999. 
Ward et al., 2002. Otsuka e( aL 2003). 
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3.1.3 Long-term stability 
The high instability of non-viral gene delivery systems in liquid formulations 
has led to studies on freeze-dried (lyophilization) formulations in order to 
improve their long term stability (Anchordoquy et ai., 2001). The main 
concern with the freeze-dried complexes is whether they can retain the same 
properties as the freshly prepared complexes. Previous studies have shown 
that freeze-drying promotes aggregation, hence resulting in reduced 
transfection efficiency (Anchordoquy et al., 1997, Talsma et al., 1997). The 
use of sugar as a lyoprotectant has been reported to be effective in 
maintaining complex size as well as transfection efficiency (Cherng et al., 
1997, Brus et ai., 2004). Retention of particle size is important because it is 
known to be a major determinant of transfection efficiency in freeze-dried 
formulations. (Anchordoquy et al., 1997, 1998). 
3.1.4 Aims 
The cationic DMA polymer has been previously demonstrated to bind and 
condense DNA effectively (van de Wetering et al., 1998, Rungsardthong et 
al., 2001). However, aggregation of the formed DNA complexes is the major 
problem associated with this system. A novel DMA-MPC diblock 
copolymer has been recently synthesized (Licciardi et al., 2005). The 
zwitterionic MPC polymer is extremely biocompatible and hydrophilic 
(Ishihara et ai., 1998, Lewis, 2000). It is proposed in this study that MPC can 
be used as a potential steric stabilizer to the DNA complexes, thereby 
reducing complexes self -aggregation and producing small colloidal DNA 
complexes with particle size that is suitable for efficient cellular uptake. 
Two series of DMA-MPC diblock copolymers were used in this study: (i) 
DMA
x
MPC30 series in which the MPC block is constant \\"ith 30 monomeric 
units while the length of DMA block "aries from 10 to 100 monomeric units. 
and (ii) DMA.toMPC) series in which the DMA block is constant with 40 
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monomer units while the length of MPC block vanes from 10 to 50 
monomeric units. The aims of the work presented in this section were to 
investigate the effect of the compositions of the DMA-MPC diblock 
copolymers on the interaction with DNA, and the colloidal stability of the 
resulting complexes. DNA binding ability of the copolymer at different 
monomeric unit: nucleotide ratio was judged by ethidium bromide 
displacement assay and gel retardation assay. The physicochemical 
properties of the DNA complexes including particle size, zeta potential and 
colloidal stability of the DNA - complexes were also examined. Furthermore, 
the prospect of long term stability of the system was assessed by particle size 
measurement following freeze-drying of the complexes with the use of 
different lyoprotectants. 
------------------
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3.2 MATERIALS AND METHODS 
3.2.1 Materials 
Materials used were as described in Chapter 2, Section 2.1 unless otherwise 
specified below. 
Tris acetate EDT A (T AE) buffer consisted of 40 mM Tris acetate, 20 mM 
glacial acetate acid and ImM EDTA in ELGA water, with pH adjusted to 7.4 
using glacial acetic acid. DNA loading buffer contained 0.25% w/v 
bromophenol blue in 40% w/v sucrose solution. The staining solution used 
in the gel retardation assay contained 0.1 % w/v coomassie blue in 10% v/v 
glacial acetic acid and 50% v/v methanol, and the destaining solution 
contained 10% v/v methanol and 10% v/v glacial acetic acid. 
3.2.2 Ethidium bromide displacement assay 
Ethidium bromide (EtBr) (2 /-Lg) was added to 10% PBS (l ml) in a 
fluorimetry cuvette and mixed by gentle agitation. The fluorescence of the 
solution was measured at an excitation wavelength of 560 nm and emission 
wavelength of 605 nm using Hitachi F -4500 fluorescence spectrophotometer 
(Hitachi Scientific Instruments, Finchampstead, UK). DNA (10 /-Lg) was 
added, the solution was mixed by gentle agitation and the fluorescence was 
measured again. Aliquots of the copolymer solution were then added in a 
stepwise manner. mixed gently and the fluorescence measured after each 
addition. The fluorescence readings for every sample were conducted m 
triplicate. The relative fluorescence was calculated as below (4): 
63 
Chapter 3: Physicochemical Analysis 
0/ R I t' FI Fluorescence (obs) - Fluorescence (EtBr) (4) 
/0 e a Ive uorescence = xl 00 
Flurescence (DNA + EtBr) - Fluorescence (EtBr) 
Fluorescence (obs) = Fluorescence of DNA + EtBr + polymer 
Fluorescence (EtBr) = Fluorescence of EtBr alone 
Fluorescence (DNA + EtBr) = Fluorescence of DNA + EtBr 
3.2.3 Gel retardation assay 
Aliquots of the copolymer solutions of different volumes were added to the 
DNA solution (l J.1g). T AE buffer was added to give the final volume (8 J.11). 
Complexes were prepared over the following range of monomeric unit: 
nucleotide ratios: 0.25:1, 0.5:1, 0.75:1, 1.0:1, 1.25:1, 1.5:1, 1.75:1, 2.0:1, 
5.0:1 and 10.0:1, while free polymer and free DNA served as controls. The 
samples were briefly mixed by vortexing and pulse-spun in a bench top 
microcentrifuge for 15 s. They were then incubated at room temperature for 
30 min. DNA loading buffer (2 J.1l) was added to the samples, which were 
mixed and respun again. Samples were then loaded into 0.8% agarose gel 
(w/v) containing ethidium bromide (l J.1g/ml). Electrophoresis was carried 
out at 70V in TAE buffer (pH 7.4) for 1 h. The DNA band was visualized 
under UV transillumination. Copolymers were stained by immersing the gel 
in staining solution for 1 h followed by washing with de staining solution 
overnight. 
3.2.4 Zeta potential measurement 
A solution of DNA (10J.1g) was added to 2% PBS solution (l ml). An aliquot 
of DMA-MPC diblock copolymer solution was added and the samples \\ ere 
mixed by vortexing briefly to form complexes at 1: 1. 2: 1. 5: 1 and 10: 1 
monomeric unit: nucleotide ratio (pH 7.4). A yerage zeta potential of the 
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sample was measured using Malvern Zetasizer 2000 (Malvern Instrument, 
Malvern, UK). Six measurements were made for each sample. 
3.2.5 Particle size analysis 
Solutions containing DNA (10 Ilg) were added to 10% PBS solution (500 Ill, 
0.2 11m filtered). An aliquot of DMA-MPC copolymer was added and the 
samples were mixed by vortexing briefly to form complexes at 0.2:1,0.3:1, 
0.5:1, 0.6:1, 0.7:1, 0.8:1, 0.9:1, 1.0:1, 2.0:1 and 5.0:1 monomeric unit: 
nucleotide ratios (pH 7.4). The average particle size, scattering intensity and 
polydispersity of the complexes were measured using a Malvern 4700 PCS 
system (Malvern Instrument, Malvern, UK). The measurements were 
performed at 25°C, using a 40.6 m W argon-ion laser at a scattering angle of 
90°. The data were obtained by using CONTIN analysis. Triplicate 
measurements were made for each sample. 
3.2.6 Long term stability of polymer - DNA complexes 
3.2.6.1 Preparation of lyoprotectant containing complexes 
Two approaches were adopted to prepare the lyoprotectant - containing DNA 
complexes solution. In the first approach, the lyoprotectant (sucrose or 
glucose) was added into the buffer before the formation of complexes. The 
solution of 40% w/v lyoprotectant was added to 10% PBS (pH 7.4) to give a 
final lyoprotectant concentration of 1% , 2% 5%, 10%, 15%, 20% and 25% 
w/v. The samples were mixed by brief vortexing for 1 min. DNA solution 
(20 Ilg) was then added, followed by the addition of the polymer solution. 
The samples were mixed again by brief vortexing for 1 min. In the second 
approach, the lyoprotectant was added after the formation of complexes. 
DNA solution (20 Ilg) was added to 10% PBS, followed by the addition of 
polymer solution. The samples \vere mixed by brief vortexing for 1 min. 
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40% w/v lyoprotectant was then added to give a final concentrations same as 
above. In this set of experiments, DMA6oMPC3o copolymer was used. All 
polymer - DNA complexes were prepared at 2: 1 monomeric unit: nucleotide 
ratio and the final volume of each sample was 1000 Jll. All the samples were 
allowed to stand at room temperature for 30 min before being subjected to 
analysis. 
3.2.6.2 Freeze-drying of complexes and particle size measurements 
The particle size of the polymer - DNA complexes prepared by both methods, 
as described in section 3.2.6.1 were measured using PCS as described earlier 
in section 3.2.5. Measurements were made both before and after freeze-
drying of the complexes. To freeze-dry the polymer - DNA complexes, the 
samples were cooled rapidly by plunging into liquid nitrogen for 2 min. The 
samples were then transferred into a freeze dryer (Modulyo, Edwards, UK) 
where they were placed under vacuum at temperature -40°C. The samples 
were allowed to dry in the freeze drier for 48 h. Following freeze drying, the 
samples were re-hydrated by adding 10% PBS (l000 JlI, 0.2 Jlm filtered). 
The samples were then mixed by brief vortexing and the particle size was 
determined using PCS. 
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3.3 RESULTS 
3.3.1 Ethidium bromide displacement assay 
As shown in figure 3.1 and 3.2, DMA homopolymer and all of the DMA-
MPC diblock copolymers were able to induce a reduction in EtBr 
fluorescence, indicating the ability of these copolymers to bind with DNA. 
For all systems, the fluorescence level was 100% before the addition of the 
polymer. Typically, there was a steep fall in fluorescence for monomeric unit: 
nucleotide ratios from 0 to 1:1, except for the DMA lOMPC3o diblock 
copolymer. As the ratios were further increased, the fluorescence continued 
to decrease gradually and eventually reached a plateau. For DMAIOMPC30, 
the reduction of fluorescence was only observed at ratio above 0.6: 1, 
suggesting its decreased DNA bindIng ability relative to the other copolymers. 
Interestingly, MPC homopolymer was also found to displace EtBr, albeit to a 
minor extent. A shallow decrease in fluorescence was observed starting from 
an approximate 1: 1 monomeric unit: nucleotide ratio, indicating that excess 
MPC homopolymer was required to promote interaction with DNA. 
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monomeric unit: nucleotide molar ratio 
I • DMA homopolymer ~ ~ DMA10MPC30 
{, DMA40MPC30 • DMA60MPC30 
o MPC homopolymer 
• DMA20MPC30 
~ D M A 1 0 0 M P P 3 0 0
10 
Figure 3.1 EtBr displacement assay of DMAxMPC30 copolymer series. DMA 
homopo ly mer, MPC homopolymer or a series of DMAx-MPC3o diblock copolymer 
was added to EtBr -DNA complexes at monomeric unit: nucleotide ratios of 0.2, OA, 
0.6, 0.8, 1.0, 1.2, l A , 1.6, 1.8, 2.0, 2.2, 2A, 2.6, 2.8 , 3.0, 4.0, 5.0 and 10: 1, and the 
fluorescence level was expressed in % . Initial relative fluorescence is equa l to 100% 
(n=3). 
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Figure 3.2 EtBr displacement assay of DMA40MPC y copolymer se ries. DM A 
homopo lymer, MPC homopolymer or a series of DMA'IO-MPCy dib lock copolymer 
was added to EtBr -DNA complexes at monomeric unit: nuc leotide ratios of 0.2 , OA , 
0 .6, 0.8, 1.0, 1.2, l A , 1.6, 1.8, 2 .0, 2.2, 2A, 2.6, 2.8, 3.0 , 4.0, 5 .0 and 10: 1, and the 
fluorescence leve l was expressed in %. In itia l re lative fluorescence is equal to 100% 
(n=3). 
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3.3.2 Gel retardation assay 
Figure 3.3 and 3.4 show the results obtained for the two series of DMA-MPC 
diblock copolymers, DMA and MPC homopolymer. The upper image shows 
the migration of free plasmid and the lower image shows the migration of 
free polymers. With the exception of the MPC homopolymer, the results 
follow the same general pattern: DNA bands were observed at low 
monomeric unit: nucleotide ratios, indicating the presence of free plasmid. 
As the amount of copolymer increased, the free plasmid bands gradually 
became dimmer, indicating that more plasmid became complexed with the 
copolymer, until the plasmid bands eventually disappeared. From this point 
onwards, although no free DNA migrated from the loading well, fluorescence 
could still be observed within the well. This indicates the presence of 
partially complexed DNA in the system, with some binding sites remaining 
available for EtBr complexation, but the high molecular weight and/or the 
overall neutrality of these complexes prevented their migration out of the 
well. In some systems, no fluorescence was detected within the loading well 
at high monomeric unit: nucleotide ratios, suggesting that the plasmid 
binding sites were almost completely occupied by the copolymer so that the 
EtBr - DNA interaction is prevented. Considering the copolymers behaviour 
in the system, free copolymer bands were absent at low ratios, indicating that 
the free copolymer is occupied in complexing with the DNA. However, free 
non-complexed copolymer could be detected at higher ratios, particularly for 
copolymers containing relatively high MPC portion, such as D M ~ o M P C 4 o o
and D M ~ o M P C 5 o . .
The effect of the copolymer composition on DNA binding is evident. For 
DMA homopolymer (figure 3.3), DNA bands disappeared at ratio of 0.5:1 
and excess polymer appeared at ratio 2: 1. "Full complexation' (no 
fluorescence in the well could be detected) occurred at as: 1 ratio. In the 
D M ~ o M P C x x copolymer series, the free DNA band disappeared at a 
relatively low molar ratio of 0.5: 1 for D M ~ o M P C l O O (which has the shortest 
MPC chain) and 'full complexation' was achieved at a 5: 1 molar ratio. since 
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no fluorescence was detected in the well under these conditions. At ratios 
between 0.5: 1 and 2: 1 the complexes remained in the well, as the overall 
charge of the complexes may be neutral and/or they were too large to move 
through the gel. Excess free copolymer appeared at a 5: 1 molar ratio. 
indicating the association of 'excess' polymer (not engaged in binding DNA) 
with the complex. In general, the performance of DMAtoMPC IO is very 
similar to that observed for DMA homopolymer. However, as the MPC 
length was gradually increased, the complexing ability of the copolymers 
appeared to be impeded. Thus free DNA bands were observed for 
D M ~ o M P C 2 0 , , D M ~ o M P C 3 0 0 and D M ~ o M P C 4 0 0 at ratios higher than for 
DMA homopolymer and 'full complexation' was not reached even at high 
ratios (fluorescence detected in the wells), suggesting that copolymers with 
higher MPC content were unable to complex DNA sufficiently to prevent 
EtBr intercalation. In addition, non-complexed copolymer appeared at lower 
molar ratios as the MPC block length was increased, indicating that the 
affinity of the copolymer molecules to associate with the complexes 
decreased. 
MPC homopolymer did not complex considerably with DNA, since free 
DNA bands were observed at all molar ratios (figure 3.4). In the copolymer 
series with a constant MPC size (DMAyMPC30), intermediate DNA bands 
were observed for DMAlOMPC30 at monomeric: nucleotide ratios up to 
1.25: 1, whereupon the DNA bands disappeared and the complexes remained 
in the loading well. 'Full complexation' was not achieved, as fluorescence 
could be still detected in the well at a high ratio of 10: 1. Similar behaviour is 
observed for the DMA20MPC30 diblock copolymer as fluorescence was 
observed in the well at all ratios, indicating that the DNA was not 'fully' 
condensed even when using a significant excess of copolymer. For 
DMA6oMPC3o and DMAlOOMPC3o copolymers, which consisted of longer 
DMA chain, free DNA bands disappeared at lower ratios and copolymer 
bands appeared at higher ratios, indicating higher complexing affinity. 
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Furthermore, an interesting phenomenon was observed in the gels for 
DMA10MPC3o and DMA2oMPC3o copolymers: fluorescence smears were 
seen towards the cathodic side of the gel ratios ranging from 1.25: 1 to 10: 1 
and 1: 1 to 10: 1, respectively_ This indicates formation of overall positively 
charged complexes of partially complexed DNA with the molecular size of 
the complexes being small enough to migrate out from the well. 
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Figure 3.3 Agarose gel retardation assay for DMAxMPC 30 copolymer series. 
Lane 1 is the DNA control. Lanes 2-11 correspond to 0.25: 1. 0.5:1. 0. 75: 1. 1: 1. 
1.25 :1, 1. 5:1, 1. 75: 1,2: 1, 5:1 and 10: lmonolT1eric unit : nucl eotide ratio . Lane 12 i 
the polymer control. (a) MPC homopolymer. (b) OMA1oMPC .1o. (c) OM 20 MPC ,O ' 
(d) OM A IO MPC30, (e) OMA 60MPC 30 and (f) OM AlOoMPC;o· 
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Figure 3.4 Agarose gel retardation assay for DMA-toMPCy copolymer se ries . 
Lane 1 is the DNA control. Lanes 2-11 correspond to 0.25: 1. 0.5: 1. 0.75: 1. 1: 1. 
1.25: 1, 1.5 :1, 1.75: 1,2 :1 , 5:1 and 10:1 monomeric unit: nucleotide rati o. Lane 12 i 
the polymer control. (a) DMA homopo lymer, (b) DMAlO MPC 1o• (c) D D A l l l M M C ~ ( ( . .
(d) D D A I O O P C C o o and (e) D M A A o M P P 5 5 . .
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3.3.3 Zeta potential measurement 
Figure 3.5 and 3.6 show the zeta potential measurements obtained for 
DMAxMPC30 and D M ~ o M P C y y complexed with plasmid DNA respectively. 
It is noted that the zeta potential measurement of DMA homopolymer - DNA 
complexes was not possible due to the formation of highly aggregating 
complexes. Both sets of results show a general trend that as monomeric units: 
nucleotide ratios increased, average zeta potentials increased. For all 
copolymer systems, apart from D M ~ o M P C 5 o , , the zeta potentials were 
around zero at 1: 1 monomeric unit: nucleotide. At ratio 2: 1 and onwards, the 
zeta potentials were around + 10m V, and the values were either increased 
slightly as ratios increased or remained relatively constant. For 
D M ~ o M P C 5 0 , , the zeta potential was around -5m V at ratio 1: 1. At ratio 2: 1, 
the zeta potential was around zero and increased gradually as the ratio 
increased. For the DMAxMPC30 copolymer series, zeta potentials of the 
complexes were not significantly different between the three different 
copolymers (p>O.05), indicating that the length of DMA did not have 
significant effect on the zeta potentials of the complexes. For the 
D M ~ o M P C y y copolymer series, there appears to be a trend whereby systems 
with longer chain of MPC have lower zeta potential compared with those 
with shorter MPC. This suggests that the hydrophilic stabilising layer formed 
by the MPC may contribute to the shielding effect of the of the DNA 
complexes. 
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Figure 3.5 Zeta potential measurements of DMAxMPC30 - DNA complexes. 
The complexes were formed between DMA4oMPC3o, DMA6o MPC3o or 
DMA IOOMPC30 and luciferase plasmid at 1:1 ,2: 1, 5:1 and 10:1 monomeri c unit: 
nucleotide ratios. Complexes were prepared and measured in 2% (v/v) PBS (11=6). 
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Figure 3.6 Zeta potential measurements of DMA40MPC y - DNA complexe . 
The complexes were formed between DMAlOMPC IO• DM A lO MPC 30 or 
DM AlOMPC
so 
and luciferase plasmid at 1: 1, 2: 1, 5: 1 and 10 : 1 monomeri c unit : 
nucl eotide rati os. Complexes were prepared and meas ured in 2% (\ \ ) PB S (11=6) . 
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3.3.4 Particle size analysis 
In this study, the particle size of polymer - DNA complexes was measured 
using photon correlation spectroscopy (PCS). The mean diameter, scattering 
intensity and polydispersity data for complexes prepared at various 
monomeric unit: nucleotide ratios are shown in tables 3.1 and 3.2. The DNA 
complexes formed by the DMA homopolymer had particle diameters of 
around 150 to 200 nm at low monomeric unit: nucleotide ratios. However, 
once the ratio reached 0.9: 1, the mean particle size increased dramatically to 
above 1 Jlm. The scattering intensity was also increased. These data suggest 
that colloidal aggregation occurred once the complexes are close to neutrality 
and charge stabilization of the complexes was insufficient. 
For DMA-MPC copolymers, the complex particle size depended critically on 
the copolymer composition. The behaviour of the D M ~ o M P C I O O copolymer 
was very similar to that of the DMA homopolymer. The mean particle 
diameter was around 150 nm and was well controlled up to a molar ratio of 
0.7:1. At higher ratios, the particle size increased to over 300 nm. With the 
exception of the DMA lOMPC30 and D M ~ o M P C 5 0 , , all other DMA-MPC 
copolymers typically produced complexes of around 140-160 nm diameters, 
with the size being well controlled at higher monomeric unit: nucleotide 
ratios. The polydispersities generally ranged from 0.2 to 0.4, and were 
significantly lower than that observed with DMA homopolymer. This 
indicates that discrete colloidal complexes were formed with relatively 
narrow size distributions. 
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Table 3.1 Particle size, scattering intensity and polydispersity of DNA complexes with DMA homopolymer and DMAxMPC30 measured by PCS 
Particle size ± SD (nm) (Polydispersity ± SD) 
Monomer: Scattering intensity (KCps) ± SD 
:\'ucleotide molar 
ratio DMAIOMPC30 DMA20MPC30 DMA40MPC30 DMA60MPC30 DMAIOOMPC30 
566±5 (1.0±0) 175 ± 8.7 (0.50±0.02) 145 ± 1 (0.26±0.02) 162 ± 12 (0.62±0.09) 131 ± 12 (0.34±0.16) 
0.2: 1 38 ± 3 70± 12 1801 ± 31 149 ± 12 556 ± 261 
130 ± 7 (0.36±0.02) 245 ± 17 (0.59±0.05) 145 ± 17 (0.35±0.12) 137 ± I (0.37±0.01) 119 ± 2 (0.24±0.0 I) 
0.3: I 88± 6 92± 7 256 ± 3 520±6 456 ± 10 
151 ± 23 (0.65±0.11) 250 ± 19 (0.68±0.05) 180 ± 3 (0.35±0.02) 144 ± 11 (0.46±0.10) 149 ± 13 (0.24±0.04) 
0.5: I 68± 4 130±6 270± 7 770 ± 21 1215 ± 186 
119 ± 10 (0.41±0.06) 138 ± 3 (0.35±0.02) 260 ± 3 (0.44±0.01) 128 ± 5 (0.25±0.03) 131 ± I (0. 15±0.0) 
0.6: I 78± 7 108 ± 6 574 ± 9 993 ± 23 146 ± 26 
102 ± 17 (0.75 ±0.44) 162±5 (0.42±0.03) 192 ± 6 (0.41±0.04) 151 ± 4 (0.36±0.05) 148 ± 5 (0.17±0.08) 
0.7: I 186 ± 9 155 ± 9 651 ± 15 1336 ± 7 1654 ± 169 
157 ± 9 (0.51 + 0.03) 149±2 (0.34±0.01) 152±2 (0.28±0.01) 150 ± 9 (030±0.09) 181 ± 19 (0.26±0.03) 
0.8: I 349 ± 17 153 ± 14 632 ±4 1666 ± 60 1527 ± 59 
149 ± 7 (0.52 ± 0.03) 155 ± 2 (0.37±0.01) 158 ± 2 (0.33±0.0 I) 152 ± 3 (0.25±0.04) 120±0 (O.12±O.O3) 
0.9 : I 371 ± 15 173 ± 3 338 ± 5 1555 ± 6 1122 ± 195 
294 ± 88 (0.88 ± 0.19) 141 ± 2 (0.22±0.01) 130± I (0.22±0.01) 154 ± 2 (O.21±0.02) 130± 10 (O.17±0.03) 
1.0 : I 509 ± 72 288 ± 5 416 ± 6 1341 ±4 1599 ± 659 
202 ± 60 (0.70 ± 0.25) 127 ± I (0.30 ± 0.0 I) 136 ± 1 (0.32±0.0 I) 113 ± 3 (0.35±0.03) 141 ± 4 (0.21 ±().03) 
2.0: I 418 ± 54 416± 3 587 ± 10 927 ± 27 1468 ± 62 
.ll/5 ± 159 (0.69±0.24) 123 ± 0 (0.31±0.0 1) 151±1 (0.37±0.01) 137 ± 13 (0.49±0.1) 125 ± 9 (0.21 ±O.O I) 
S.O : I .lX6 ± 46 359±4 591 ± 20 987 ± 58 1052 ± 104 
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Table 3.2 Particle size, scattering intensity and polydispersity of DNA complexes with DMA homopolymer and DMA40MPCy measured by PCS 
Monomer: nucleotide 
Particle size ± SD (nm) (Polydipersity ± SD) 
molar ratio Scattering intensity (KCps) ± SD 
DMA homopoll':mer DMA40MPCI0 DMA40MPC20 DMA40MPC40 DMA40MPC50 
0.2:1 226 ± 2 (0.40±0.0 1) 152 ± 2 (0.22±0.02) 251 ±42 (O.78±0.08) 143 ± 9 (0.33±0.ll) 364 ± 68 (O.89±0.I) 
292 ±2 342 ± 13 346 ± 10 203 ± 3 64± 7 
0.3:1 178 ± 8 (O.39±0.06) 146 ± 1 (O.21±0.02) 202 ± 14 (O.55±0.05) 118 ± 4 (0.33±0.1O) 147 ± 3 (O.3±0.05) 
453 ± 11 479±6 655 ± 19 244± 9 528 ± 167 
0.5:1 168 ± 3 (O.38±0.04) 144 ± 2 (O.21±0.0I) 206 ± 27 (O.49±0.07) 138 ± 10 (O.31±0.01) 157 ± 2 (O.26±0.04) 
527 ±7 635 ± 8 1038 ± 75 361 ± 8 603 ±5 
0.6:1 154 ± 2 (0.32±0.02) 186 ± 2 (O.20±0.01) 192 ± 11 (O.53±0.06) 160 ± 27 (O.26±0.09) 173 ± 16 (O.26±0.04) 
739 ± 11 1194 ± 18 1434±71 463 ± 17 612 ± 20 
0.7:1 196 ± 5 (O.30±0.01) 198 ±8 (O.23±0.09) 219 ± 8 (O.59±0.03) 154 ± 20 (O.43±0.20) 187 ± 32 (O.48±0.05) 
1911 ± 23 1045 ± 17 1339 ± 38 565 ± 36 589 ± 20 
0.8:1 540 ± 140 (O.46±0.07) 201 ±12 (O.24±0.IO) 242 ± 21 (O.63±0.05) 139 ± 1 (O.24±0.03) 182 ± 32 (O.48±0.05) 
2659 ± 25 853 ± 38 1320 ± 80 694± 9 564 ± 25 
Il. 9: I 1704 ± 99 (O.69±0.1 0) 309 ± 62 (0.53±0.41) 214 ± 12 (O.49±0.06) 145 ± 4 (O.29±0.05) 286 ± 31 (0.4R±0.05) 
2226 ± 69 925 ± 39 1671 ± 52 786 ± 33 564 ± 39 
I .Il: I 1412± 172 (0.5±0.04) 356 ± 10 (OJ6±0.04) 208 ± 6 (0.45±0.04) 143 ± 2 (0.21±0.01) 242± 34 (O.4I±O.19) 
2687 ± 69 1656 ± 27 1964±33 733 ± 12 514±39 
2.1l: I 1105 ± 138 (0.54±0.06) 375 ± 7 (0.43±0.04) 186 ± 5 (0.33±0.03) 146 ± 2 (0.3±0.02) 357 ± 35 (O.49±0.25) 
2714±53 1563 ± 22 1792 ± 34 545 ± 10 476 ± 20 
5.0: I 1437 ± 179 (0.57±0.05) 377 ± 9 (0.43±0.06) 204 ± 9.7 (0.42 ± 0.06) 165 ± 15 (OJI±O.OI) 380 ± 41 (O.49±O.25) 
2687 ± 40 1600 ± 36 1510±74 518 ± 27 456 ± SO 
~ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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In companson to other copolymers, the DNA complexes with the 
DMA IOMPC30 copolymer were initially (at ratio 0.2: 1) large ( ~ ~ 500 nm). 
polydisperse (1.0) and producing weak scattering intensity. As the ratio 
increased, the particle size decreased to approximately 120 to 150 nm, 
whereas the scattering intensity increased gradually. When the ratio reached 
above 1.0: 1, the particle size increased to around 300 nm with the scattering 
intensity continuing to increase. A similar trend was observed for the DNA 
complexes formed by the D M ~ o M P C 5 0 0 copolymer, another copolymer with 
high proportion of MPC content. 
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3.3.5 Long term stability of polymer - DNA complexes 
The DMA6oMPC3o copolymer was chosen for the long term stability study of 
DNA complexes due to its promising DNA condensation and steric 
stabilising properties as shown in the previous studies. The DNA complexes 
(at 2:1 monomeric unit: nucleotide ratio) were prepared with a varying 
concentration of sucrose or glucose (lyoprotectant) and the size of complexes 
were measured before and after freeze-drying. DNA complexes in the 
absence of sugar were prepared as control. The results are shown in tables 
3.3 -3.6. 
The presence of sugar affects the particle size in the freshly prepared samples 
(before freeze-drying). When sugar was first added into the buffer before the 
formation of DNA complexes, particle size increased gradually with sugar 
concentration. The particle size of complexes was around 120 nm without 
sugar, and complexes size increased gradually with sugar concentration. 
With 25% w/v sugar (glucose or sucrose), the particle size increased to above 
200 nm, which was significantly larger compared to the sample without sugar. 
A similar effect was observed when sugar was added after the formation of 
complexes, but to a lesser extent. 
After freeze-drying and subsequent rehydration, DNA complexes in the 
absence of sugar formed large aggregates ( ~ 2 2 Jlm) with high polydispersity, 
indicating that freeze-drying promoted aggregation of complexes. In the 
presence of sugar, there was a marked decrease in particle size of freeze-dried 
complexes following rehydration, confirming the importance of sugar in 
preservmg particle size. The particle size was comparable to the 
corresponding unfrozen control at around 2% -10% w/v sugar. There was no 
substantial change in particle size and polydispersity as the sugar 
concentration further increased. 
In comparmg the two method of lyoprotectant containing complexes 
preparation, when sugar was added first into the buffer (before formation of 
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DNA complexes), a higher sugar concentration was necessary to preserve 
particle size compared to those with sugar added after the formation of DNA 
complexes. When sucrose or glucose was first added, a sugar concentration 
of 5% or 10% w/v respectively was required to preserve particle size during 
freeze drying. However, when the sugar was added after formation of 
complexes, 20/0 w/v sugar concentration (for both sucrose and glucose) was 
sufficient to preserve particle size. 
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Table 3.3 The effect of sucrose as Iyoprotectant on particle size, with sucrose 
added before complexes formation. The particle size, scattering intensity and 
polydispersity of DMA6oMPC3o -DNA complexes were measured by PCS before and 
after freeze-drying. 
Sucrose Particle size (nm) Scattering Intensity Polydispersity 
0/0 w/v (KCps) Before After Before After Before After 
0 123 ± 7 1922 ± 647 312±15 29 ± I 0.37±0.1 0.84 ± 0.2 
1 121 ± 5 1699 ± 640 311 ± 7 87± 7 0.33 ± 0.1 0.96 ± 0.1 
2 125 ± 2 729 ± 161 375 ± 8 59±2 0.24 ± 0.0 0.95 ± 0.2 
5 183 ± 2 211 ± 10 282±4 304± 7 0.37 ± 0.0 0.44 ± 0.1 
10 181 ± 3 220± 9 325 ± 10 351 ± 8 0.21±0.1 0.37±0.1 
15 188 ± 2 231 ± 17 256 ± 5 271 ± 15 0.20 ± 0.0 0.45 ± 0.1 
20 176 ± 16 362 ± 26 224 ±4 217 ± 7 0.4±0.1 0.32 ± 0.1 
25 241 ± 13 289 ± 32 263 ± 7 315±14 0.29 ± 0.1 0.37±0.1 
Table 3.4 The effect of sucrose as Iyoprotectant on particle size, with sucrose 
added after complexes formation. The particle size, scattering intensity and 
polydispersity of DMA6oMPC3o -DNA complexes were measured by PCS before and 
after freeze-drying. 
Sucrose Particle size (nm) 
Scattering Intensity Polydispersity (KCps) 
%w/v Before After Before After Before After 
0 123 ±7 1922 ± 647 313±15 29 ± I 0.37±0.1 0.84 ± 0.2 
1 109 ± 0 473 ± 30 278 ± 23 56 ±2 0.22 ± 0.1 0.61 ± 0.1 
2 97 ± I 254 ± 7 320± 5 735 ± 20 0.22 ± 0.1 0.47 ± 0.0 
5 155 ± 15 214 ± 26 242 ± 28 379 ± 24 0.49 ± 0.1 0.53 ± 0.1 
10 205 ± 2 248 ± 5 592 ± 5 777 ± 26 0.18±0.0 0.31 ± 0.0 
15 181 ± 13 220 ± 23 381 ± 15 494 ± 34 0.31±0.1 0.38 ± 0.1 
20 190 ± 13 192 ± 6 305 ± 23 451 ± 5 0.33 ± 0.1 0.33 ± 0.0 
25 256 ± 5 297± 8 241 ± 7 418 ± 25 0.27 ± 0.0 0.44 ± 0.1 
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Table 3.5 The effect of glucose as Iyoprotectant, with glucose added before 
complexes formation. The particle size, scattering intensity and polydispersity of 
DMA6oMPC3o -DNA complexes were measured by PCS before and after freeze-
drying. 
Glucose Particle size (nm) Scattering Intensity Polydispersity 
% w/v (KCps) Before After Before After Before After 
0 123 ±7 1922 ± 312 ± 15 29 ± 1 647 0.37±0.1 0.84 ± 0.2 
1 193 ± 15 1514 ± 262± 6 62 ± 12 0.46 ± 0.1 619 1.0 ± 0.0 
2 187 ± 9 445 ± 36 286 ± 8 73 ± 6 0.40 ± 0.1 0.79 ± 0.1 
5 197 ± 1 I 368 ± 25 265 ± 20 516 ± 13 0.58 ± 0.1 0.57 ± 0.0 
10 194 ± 6 21 I ± 7 300 ± 10 617 ± 39 0.28± 0.1 0.27 ± 0.0 
15 191 ± 15 285 ± 27 137±6 218 ± 8 0.44 ± 0.1 0.48 ± 0.1 
20 238 ± 1 I 237±4 144 ± 0 217 ± 7 0.10 ± 0.0 0.36 ± 0.0 
25 22 I ± 15 312 ± 20 155 ± 7 533 ± 18 0.36 ± 0.1 0.52±0.1 
Table 3.6 The effect of glucose as lyoprotectant, with glucose added after 
complexes formation. The particle size, scattering intensity and polydispersity of 
DMA6oMPC3o -DNA complexes were measured by PCS before and after freeze-
drying. 
Glucose Particle size (nm) 
Scattering Intensity Polydispersity (KCps) 
%w/v Before After Before After Before After 
0 123 ± 7 1922 ± 647 312±15 29 ± 1 0.37±0.1 0.84 ± 0.2 
1 98 ± 1 616 ± 75 182 ± 17 93 ± 2 0.35 ± 0.0 0.86 ± 0.1 
2 131 ± 17 251 ± 59 182 ± 9 94±6 0.40 ± 0.1 0.77 ± 0.2 
5 101 ± 3 150 ± 2 205 ±4 337 ± 4 0.20 ± 0.0 0.35 ± 0.0 
10 134 ± 1.0 150 ±4 229± 5 267± 3 0.29 ± 0.0 0.33 ± 0.0 
15 160 ± 13 174 ± 5 264 ± 10 273 ± 6 0.37±0.1 0.33 ± 0.1 
20 180 ± 7 196 ±4 312 ± 2 340 ± 10 0.30 ± 0.0 0.3 ± 0.0 
25 191 ± 2 242 ± 17 247 ±2 272 ± 1 0.29 ± 0.0 0.21± 0.1 
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3.4 DISCUSSION 
3.4.1 Characterisation of polymer - DNA complexes 
DMA based copolymers have been extensively studied for gene delivery in 
recent years. The DMA - PEG diblock copolymers with various 
architectures have also been investigated in order to address the poor 
colloidal stabilities of DNA complexes produced by DMA homopolymers 
and improve their biological properties (van de Wetering et aI., 1998, 
Rungsardthong et aI., 2001). The DMA-MPC diblock copolymers described 
herein offer a potential alternative chemical structure for conferring the 
necessary steric stabilization. 
The DMAxMPC30 copolymer senes was used to explore the effect of 
systematically varying the DMA block size on the DNA binding and 
condensation efficiency. DMA lOMPC30 interacted with DNA, but with 
reduced affinity compared to other copolymers and DMA homopolymer, as 
shown in both EtBr displacement assay and gel retardation assay. In a 
previous study, it was reported that a DMA homopolymer with a mean 
degree of polymerisation of 32 was able to condense DNA at the 
experimental pH of 8.0, at which the polymer was approximately 24 % 
protonated. This corresponded to only eight cationic residues per DMA 
chain (Rungsardthong et al., 2003). Thus it appears that the presence of the 
MPC block, rather than the relatively short DMA block, is the reason for the 
relatively weak DNA binding affinity shown by DMA10MPC30. However. 
the charge distribution along the chain should also be considered. At pH 8. 
DMA with a degree of polymerisation of 32 (24% protonation) has charge 
distributed widely along the chain of DMA polymer (figure 3.7), which is 
different from DMA1oMPC30 at pH 7.4 (>55 % protonation) (figure 3.8). 
Thus. a minimum length of DMA may still be required to condense DNA. 
Therefore, it is still possible that the length of DMA in DMAIOMPC30 is 
simply not long enough to achieve efficient DNA condensation. 
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+ 
Figure 3.7 Schematic diagram to show the charge distribution along the chain 
ofDMA32 at pH 8. 
+ + nlp c 
Figure 3.8 Schematic diagram to show the charge distribution along the chain 
ofDMA IOMPC30 at pH 7.4. 
Increasing the size of DMA moiety resulted in higher condensation ability, as 
indicated by gel retardation assays. In addition, copolymers with relatively 
high DMA content associated with the complexes at ratios above 1: 1 and , 
consequently, the complexes would be expected to possess positive surface 
charge, as confirmed by the zeta potential measurements, even though the 
charge was partially screened by the MPC layer. With the exception of 
DMA 10MPC30, all the copolymers investigated in the DMA,MPC30 serie 
formed DNA complexes in sub-200 nm particle size range. Hovve\'er. li ght 
scattering data indicated that longer DMA block lengths lead to the formation 
of less 'soluble ' complexes. DNA complexes formed \\'ith 0 lAoo 'IPC3il 
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and DMA lOOMPC30 have relatively high scattering intensities, which suggests 
formation of fairly compact DNA condensates. 
In the DMA40MPCy copolymer senes, the cationic moiety possessed a 
corresponding size comparable to DMA-PEG diblock copolymers which 
have previously demonstrated to condense DNA (van de Wetering et al.. 
1998). The effects that varying the MPC size may have on the copolymers' 
binding and condensing ability, and the effectiveness of MPC to provide 
steric stabilization were studied. The data demonstrate that as the size of 
MPC moiety increased, the DNA binding ability of the copolymers was 
reduced. The EtBr displacement and gel retardation assays clearly showed 
that copolymers with shorter MPC blocks ( D M ~ o M P C J O O and D M ~ o M P C 2 0 ) )
had higher DNA binding affinities, comparable to the DMA homopolymer. 
Full complexation was achieved (as indicated by the disappearance of 
fluorescence within the well) and 'excess' of polymer associated with the 
complexes at ratios above 1: 1. 
Copolymers with longer MPC blocks ( D M ~ o M P C 3 0 , , D M ~ o M P C 4 0 0 and 
D M ~ o M P C 5 0 ) ) exhibited decreased affinity for DNA complexation, 
suggesting that the size of zwitterionic MPC residues was deleterious to 
complexation. Also, 'excess' of polymer immediately above 1: 1 ratio is seen 
as free in the retardation gels, contrary to the homopolymer and copolymers 
with low MPC content. Similar behaviour was observed with DMA-PEG 
diblock copolymers in a separate study (Rungsardthong et aI., 2001). Both 
phenomena suggest that the presence of a steric stabilising moiety in the 
copolymer reduces the association of 'excess' polymer with the complexes. 
MPC molecule is strongly hydrated, with approximately 12 water molecules 
per MPC residue (Ishihara et aI., 1998, Konno et aI., 2001). Thus the space 
that MPC occupies, together with associated water surrounding MPC chains, 
may produce steric hindrance during DNA complexation. Furthennore, 
complexes with longer MPC chains had lower (less positive) zeta potentiaL 
suggesting the charge shielding effect offered by the MPC molecules. 
87 
Chapter 3: Physicochemical Analysis 
Although the MPC moiety appeared to hinder DNA complexation and 
condensation, it nevertheless prevents aggregation by imparting steric 
stabilization of the complexes. DNA complexes with the DMAtoMPC 10 
copolymer formed aggregates, as indicated by particle size data. However, 
the DMAtoMPC20 complexes were somewhat less aggregated compare to 
DMA4oMPClO complexes. Both DMAtoMPC30 and DMAtoMPC40 formed 
complexes with hydrodynamic diameters of approximately 150 nm diameter 
and aggregation was no longer observed. Although the zeta potential of 
DMA40MPC lO - DNA complexes was more positive than that of 
DMA4oMPC3o, the hydrophobic interactions between the former complexes 
were sufficiently strong that they overcome the electrostatic repulsion, 
resulting in self-aggregation. On the other hand, DMAtoMPC3o - DNA 
complexes with lower zeta potentials were able to remain discrete due to the 
presence of steric stabilizer formed by the hydrophilic MPC. It appeared that 
30 to 40 monomeric units of MPC are sufficient to prevent complex 
aggregation and provide effective steric stabilization. Further increase in the 
size of the MPC block in DMAtoMPCso copolymer resulted in larger 
complexes with a higher polydispersity. Together with the results from the 
gel retardation assay and EtBr displacement assay, it is suggested that the 
complexes formed with DMAtoMPCso were less well condensed than the 
other complexes in the same series. This is probably due to the presence of 
large the MPC block which hinders the interaction between cationic DMA 
block and the negatively charged DNA. 
Interestingly, the addition of MPC homopolymer at high molar ratios led to 
reduced fluorescence from DNA-EtBr complexes, suggesting some. albeit 
relatively weak, ability to interact with DNA when present in significant 
excess. The MPC repeat unit comprises a zwitterionic PC group, so it is 
tempting to suggest that the cationic quaternary amine group might be 
responsible for the DNA interaction. However, the formation of MPC-DNA 
complexes is not supported by the gel retardation assay data. It may be 
possible that if these relatively weak MPC-DNA 'complexes' \\:ere formed. 
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they could dissociate relatively easily due to the electric current applied 
during electrophoresis. 
The above observations demonstrate that the balance in the block 
composition plays a primary role in influencing DNA condensation by the 
DMA-MPC copolymers. Comparing copolymers with the same DMA:MPC 
block ratio but different overall size is instructive. A higher degree of DNA 
condensation (the respective gel retardation assays) and effective steric 
stabilization was observed for DMA6oMPC3o, relative to D M ~ o M P C 2 o . .
Similarly, the DMA2oMPC3o and D M ~ o M P C 5 o o copolymers have comparable 
(though not precisely the same) DMA:MPC block ratios. Although the latter 
copolymer has a significantly longer condensing cationic block, its DNA 
complexing ability is comparable to that of DMA2oMPC3o. These 
comparisons illustrate that both the overall size of the copolymer molecule 
and the DMA to MPC block ratio are affecting the DNA binding and 
condensing performance of these copolymers. 
3.4.2 Freeze-dried formulations to enhance long term stability of DNA 
complexes 
In order to investigate the prospect of long term stability of the DNA delivery 
system, DNA complexes were subjected to freeze-drying with the use of 
lyoprotectants and the particle sizes of the complexes were assessed using 
PCS. It was noticed that the presence of sugar affected the particle size of the 
DNA complexes before freeze-drying. One of the possible explanations is 
that the presence of sugar and the consequently increased viscosity might 
hinder the formation of complexes between the polymer and DNA (Tajmir-
Riahi et aI., 1994). It was reported that the interaction between DNA and 
sugar results in a conformational change of DNA (Washington 1992), which 
may also affect the affinity of DNA to interact with the polymer. In addition, 
during PCS measurements, the value of the viscosity of the medium was not 
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adjusted, which would result in the viscosity value used in the SIze data 
calculation being inadequate. 
After freeze-drying and rehydration, DNA complexes without sugar as 
lyoprotectant resulted in the formation of large aggregates. It is believed that 
aggregation occurred as particles were concentrated in the unfrozen fraction 
during freeze-drying. The rate of freezing has been reported to have a 
significant impact on the size of freeze-dried complexes (Anchordoquy et aI., 
1998, Li et aI., 2000). During slow freezing, the formation of large ice 
crystals allows complexes to concentrate in the unfrozen solution for a longer 
time, and thus aggregation is facilitated. In contrast, when freezing is rapid, 
smaller ice crystals are formed and less aggregation is observed. In our study, 
all the samples were frozen rapidly in liquid nitrogen first before being 
transferred into a freeze-drier. Aggregation during the freezing stage was 
minimized. Formation of large aggregates might have also occurred during 
dehydration and rehydration. 
From the results, sugars were found to be effective in preserving the size of 
DNA complexes. The exact mechanism is not certain. The most accepted 
hypothesis is the particle isolation hypothesis, which suggested that sugars 
inhibit aggregation by isolating individual particles in the unfrozen fraction 
(Allison et al., 2000). Here, it was found that the concentration of sugar also 
affected the size of particles. At low sugar concentration of 1 % w/v, there 
was a slight reduction in particle size but the amount of sugar was 
insufficient to fully prevent aggregation. As the sugar concentration 
increased, the particle size, as well as the polydispersity, decreased gradually. 
The volume of unfrozen fraction was larger in samples with a greater amount 
of sugar. This effect may contribute to the progressively smaller particle size 
observed at higher sugar concentrations as the particles were less likely to 
concentrate (Allison et aI., 2000). Since it has been reported that a high 
concentration of sugar might affect in vitro transfection (Cherng ef aI., 1997), 
it is important to keep the effective sugar concentration as low as possible. 
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This study clearly demonstrated the ability of both glucose and sucrose to 
preserve particle size on freeze-drying. There are no significant differences 
between the two types of sugar in preserving particle size. The results are 
consistent with other groups (Alison et al., 2000, Kwok et aI., 2000) who 
showed that both sucrose and glucose could effectively prevent aggregation 
of lipid - DNA complexes during freeze-drying. Indeed, it is the method of 
preparing the lyoprotectant containing DNA complexes that appeared to be a 
crucial factor in determining the particle size. From the results, it was found 
that a lower sugar concentration was needed to preserve particle size when 
sugar was added after the formation of DNA complexes. This could possibly 
explain by the observation that a smaller initial particle size was achieved 
when sugar was added after the formation of DNA complexes prior to freeze-
drying. 
As mentioned above, particles are concentrated in the unfrozen fraction 
during freeze-drying. The volume of unfrozen fraction however was 
determined by the initial solute concentration. In other studies, it was found 
that a lower sugar concentration was required for protection of particles in a 
more diluted suspensions, suggests that 'crowding' of particles facilitates 
aggregation (Anchordoquy et aI., 2001). Therefore, the amount of sugar was 
also described in terms of sugar: DNA (w/w) ratio. In our study, 20/0 sugar 
concentration, which is equivalent to 1000: 1 sugar: DNA (w/w) ratio, was 
sufficient to preserve polymer - DNA complexes. Similarly, a ratio of 
1250: 1 was required to protect lipid - DNA complexes (Molina et aI., 2001). 
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3.5 CONCLUSIONS 
This chapter examined different compositions of DMA-MPC diblock 
copolymers as potential non-viral vector for gene delivery, and the prospects 
of long term stability of this system. From the view of physicochemical 
characterisation, a desirable non-viral gene delivery system should be able to 
condense DNA efficiently to form sterically stabilized complexes. It is 
demonstrated in this study that the MPC block is effective in providing steric 
stabilization for the DNA complexes. However, a long MPC block also 
hinders the interaction between the cationic DMA and DNA. Therefore, the 
balance in the block composition of DMA-MPC copolymers plays an 
important role in designing an optimal gene delivery system. 
The DMA6oMPC3o system appears to be a suitable candidate with desirable 
characteristics as mentioned above. Thus, it was chosen for the long term 
stability study of polymer - DNA complexes. The data shows that both 
glucose and sucrose demonstrate the ability to preserve particle size of 
polymer - DNA complexes during freeze-drying. The amount of sugar and 
the sequence at which sugar was added are important factors affecting the 
particle size. The DNA complexes were better preserved during freeze-
drying when sugar was added after formation of complexes, and the size of 
complexes that were comparable to the unfrozen control could be achieved at 
1000: 1 sugar: DNA (w/w) ratio. 
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CHAPTER 4 
MORPHOLOGICAL STUDY OF DMA-MPC DIBLOCK 
COPOLYMER - DNA COMPLEXES 
4.1 INTRODUCTION 
One of the essential characteristics of non-viral gene delivery systems is the 
ability to condense DNA into small compact structures. DNA are large polar 
macromolecules that are not readily taken up by cells. A wormlike chain 
(WLC) model is often used to describe the conformation of DNA molecules 
in solution (Lu et aI., 2002). In the uncondensed state, DNA are easily 
degraded by enzymes. The condensed conformations of DNA can provide 
protection from nucleases (K woh et aI., 1999, Richardson et aI., 1999). In 
addition, the reduced dimension of the DNA in condensed conformation 
facilitates its transport in the extracellular matrix and enhance cellular uptake. 
Cationic polymers have been widely used for DNA condensation through 
electrostatic interaction. Their effectiveness at condensing DNA depends on 
the chemical structure, polymer architecture, charge density and molecular 
weight. To assist the design of an efficient non-viral gene delivery system, it 
is necessary to understand the condensation of DNA by examining the 
morphology of the polymer - DNA complexes. 
4.1.1 Theoretical aspects of DNA condensation 
DNA condensation is defined as the collapse of extended DNA chains into 
compact orderly particles containing only one or a fe',,\ molecules of DNA 
(Bloomfield 1997). DNA is a very long negatiyely charged macromolecule 
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which is orders of magnitude longer than any dimensions of a cell can fit in. 
The dimensions and morphology of DNA condensates are largely 
independent of the size of the DNA when the length of DNA is above 400 
base pairs (Bloomfield, 1991). This striking phenomenon has attracted much 
attention and has been investigated by many researchers in different areas of 
SCIence. 
DNA condensation anses from very complex intermolecular and 
intramolecular interactions (Marquet and Houssier, 1991, Bloomfield, 1996). 
For condensation to occur, the DNA needs to overcome a number of 
energetic barriers, including Coulombic barriers due to the repulsion of 
negatively charged phosphate groups of DNA, entropy loss when organising 
the extended DNA molecule into well-defined structures, and bending of the 
stiff double helix. Polycations are among the most well-studied in vitro 
condensing agents. They act by decreasing repulsions between DNA 
segments. Thermodynamic studies show that condensation of DNA occurs 
spontaneously when approximately 90% of the phosphate backbone is 
neutralized by polycations (Wilson and Bloomfield, 1979, Bloomfield, 1998). 
A number of simulation models have been developed in attempt to explain 
the electrostatic interactions occurring during the DNA condensation process. 
Traditional approximations such as Poisson-Boltzmann and Debye-Huckel 
theories are only valid for weakly charged objects and low-valent counterions 
and cannot fully explain the complicated DNA condensation process (Neu, 
1999, Sader and Chan, 1999). Monte Carlo simulation is a widely accepted 
model used to investigate the transition from coil and globule state in 
alternate ionic strengths (Crothers et aI., 1990, Lyubartsev and Nordenskiold, 
1995, Ivanov et aI., 2000). There are many other simulation models 
described in the literature (Klenin et aI., 1998, Sottas et aI., 1999. Stevens, 
2001, Sarragw;a and Pais, 2004). However, the debates of the relative 
significance of all these models in the process of DNA condensation are 
beyond the scope of this thesis. 
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Experimental methods to investigate DNA condensation include visualisation 
of DNA condensates using technique such as electron microscopy and atomic 
force microscopy. A range of different structures of DNA condensates have 
been observed. Toroids and rods are the most commonly reported 
morphology for DNA condensates (Bloomfield, 1998). A toroid typically 
has an outer diameter of 50 nm and an inner diameter of 15 nm. It is believed 
that a toroid is formed from circumferentially wound DNA, with local 
hexagonal packing of the parallel double strands (Marx and Ruben, 1983). 
The rod structure is less commonly reported than the toroidal structure. The 
relationship between toroids and rods is not clearly understood. It has been 
suggested that a rod is formed when the solvent is non-polar, as the non-polar 
environment may lower the free energy of exposed heterocyclic bases, 
favouring sharp local kinking over gradual bending (Bloomfield 1998). 
More recently, it is suggested that rod formation is related to the stiffness of 
the molecules (Maurstad et a!., 2003). 
4.1.2 Aims 
Transmission electron mIcroscopy (TEM) IS a traditional tool used to 
visualise DNA condensates (Bloomfield, 1996), whereas atomic force 
microscopy (AFM) has become popular in recent years for such 
investigations (Hansma et a!., 1998, Pope et al., 1999, Liu et al., 2001, 
Danielsen et a!., 2004). The aim of this study was to examine the 
morphology of DNA complexes produced with DMA homopolymer and a 
series of DMA-MPC diblock copolymer, using TEM and AFM. The basic 
principles of these two techniques are described in section 2.3.5 and 2.3.6 
respectively. The images of DNA complexes obtained from both techniques 
are compared. The morphology of the complexes in relation to the process of 
DNA condensation and the development of gene delivery system are also 
discussed. 
95 
Chapter 4: Morphology Study 
4.2 MATERIALS AND METHODS 
4.2.1 Materials 
Materials used were as described in chapter 2, section 2.1 unless stated 
otherwise in the following sections. 
4.2.2 Morphology study using TEM 
DNA solution (2.5 Ilg) was added to 10% PBS solution, followed by addition 
of polymer solution. All the complexes were prepared in a 2: 1 monomeric 
unit: nucleotide ratio and the total volume of each solution was 250 Ill. The 
samples were incubated at room temperature for 30 min. Drops (20 Ill) of 
sample were placed onto a copper grid coated with pioloform resin (T AAB 
Laboratory Equipment, Reading, UK) for 30 s. Excess buffer was removed 
using filter paper. The sample was stained with uranyl acetate (40/0 w/v 
solution of uranyl acetate in 50% ethanol) for 2 min. The grid was then 
washed in 50% ethanol once and distilled water twice prior to air-drying. 
The samples were analyzed under the TEM (leol JEM-I010 TEM, Jeol Ltd., 
Welwyn Garden City, UK) at a voltage of 80 kY. Micrographs were taken at 
25K to lOOK magnification using Kodak Megaplus digital camera 1.6i. 
Control grids containing DNA only, polymer only and buffer medium were 
prepared and stained in the same way. Image analysis was carried out using 
analySIS Pro 3.1, Soft Imaging System. 
4.2.3 Morphology study using AFM 
All the AFM experiments described in this chapter were performed by Anne 
Chim of the Laboratory of Biophysics and Surface Analysis. University of 
------------------------ ~ - ~ - - -
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Nottingham, in collaboration with the author and the Advanced Drug 
Delivery Group. 
The samples of DNA controls contained 1 ~ g / m l l plasmid DNA 10% PBS 
solution and 2 mM NiCh. After 30 min incubation at room temperature, 15 
~ l l of the sample was deposited onto freshly cleaved muscovite mica (Agar 
Scientific, Essex, UK) of approximately 1 cm2 and allowed to stand one 
minute before washing twice with 50 ~ l l of distilled water, drying under 
nitrogen gas and imaging in air. DMA-MPC copolymer - DNA complexes 
at a 2: 1 monomeric unit: nucleotide ratio in 30 ~ l l of 10% PBS solution were 
incubated at room temperature for 30 min prior to immobilization onto 
freshly cleaved muscovite mica and imaged directly in liquid. 
All AFM imaging was carried out using a Tapping Mode (TM) Atomic Force 
Microscopy on a Veeco™ Nanoscope (IlIa) MultiMode system (Veeco 
Instruments, Santa Barbara, CA, USA). Topographical images were taken at 
512 x 512 pixel resolution, plane-flattened and analyzed either by the 
computer program accompanying the Nanoscope IlIa Multimode AFM or by 
an offline-processing package, SPIP (version 2.2.2) (Image Metrology, 
Lyngby, Denmark). For imaging in air, NP tips on 160 ~ m m silicon 
cantilevers (Olympus OMCL-AC160Ts-W2) with a resonant frequency 
between 300-400 kHz were used. For imaging in liquid, an AFM liquid cell 
and oxidation-sharpened NP-S tips on a V -shaped, silicon nitride cantilever, 
with a spring constant of around 0.1 N/m (Nanoprobe, Veeco Instruments) 
and resonant frequency between 8-10 kHz were used. 
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4.3 RESULTS 
4.3.1 Morphology of DNA complexes under TEM 
Representative Images of DNA complexes produced with DMA 
homopolymer at monomeric unit: nucleotide ratios 2: 1 are displayed in 
figures 4.1. 
TEM images show that DNA complexes formed with DMA homopolymer 
were highly condensed and aggregated. The complexes, stained with uranyl 
acetate, are visualized as clumps of electron-dense aggregates. This 
observation is consistent with PCS results (chapter 3), which also suggest that 
the DMA homopolymer - DNA complexes are highly aggregating. In order 
to increase colloidal stability of the complexes, hydrophilic MPC moiety was 
introduced into the system. The morphology of DNA complexes formed 
with DMA-MPC diblock copolymers are shown in figures 4.2 - 4.11. 
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a 
Figure 4.1 TEM images of DMA homopolymer - DNA complexes at 2:1 
monomeric unit: nucleotide ratio . Complexes were prepared in 10% (\ /\) PBS 
and stai ned with uranyl acetate. The bars represent (a) 1000 nm and (b) 200 11m . 
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For the DMA40MPCy series, it is clearly shown that as the length of MPC 
increased, the level of aggregation decreased. For D M ~ o M P C l O , , which has 
a relatively short MPC chain, the DNA complexes were aggregating (figure 
4.2) and the TEM images are similar to that observed with DMA 
homopolymer. For D M ~ o M P C 2 0 , , the complexes were only partially 
aggregating (figure 4.3). The majority of the non-aggregating complexes 
appeared as rod-like structures, with a small proportion of complexes 
appeared as toroidal structures. For D M ~ o M P C 3 0 0 and D M ~ o M P C 4 0 0 (figure 
4.4 and 4.5 respectively), aggregation of complexes was no longer observed. 
Complexes formed by these two copolymers comprised a mixture of well 
condensed toroidal and rod-like structures, or 'intermediate' structures. The 
measurement of the toroids and rod structures are shown in table 4.1. The 
average outer diameter of the toroids are 52 ± 12 run and 51 ± 7 run for 
D M ~ o M P C 3 0 0 and D M ~ o M P C 4 0 0 respectively. These dimensions are 
consistent with typical toroidal structures reported by other groups using 
different cationic polymers (Tang and Szoka et al., 1997). When the length 
of MPC is further increased, the complexes appeared to be less well 
condensed. For DNA complexes formed with D M ~ o M P C 5 0 , , plectonemic-
like and loose rings structures are observed instead of well-defined rods and 
toroids (figure 4.6). 
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a 
Figure 4.2 TEM images of D M A A o M P C C o o - DNA complexes at 2:1 monomeric 
unit: nucleotide ratio . Complexes were prepared in 10% (v i \') PBS and stained 
with uranyl acetate . The bars represent (a) 1000 11m and (b) 200 nm . 
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Figure 4.3 TEM images of DMA-toMPC2o - DNA complexes at 2:1 monomeric 
unit: nucleotide ratio . Complexes were prepared ill 10% (v/\') PBS and taill ed 
with uranyl acetate. The bars represent (a) 1000 11m and (b) 200 11111. 
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Figure 4.4 TEM images of D M A ~ o M P C C o o - DNA complexes at 2:1 monomeric 
unit: nucleotide ratio . Complexes were prepared in 10% (v/v) PB S and stain ed 
with uranyl acetate. The bars represent (a) 1000 nm and (b) 200 nm . 
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Figure 4.5 TEM images of DMA.toMPC.to - DNA complexes at 2: 1 monomeric 
unit: nucleotide ratio. Complexes were prepared in 10% (vi \') PBS and tained 
with uranyl acetate. The bars represent (a) 1000 nm and (b) 200 nm . 
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Figure 4.6 TEM im ages of DMA-toMPCso - DNA complexes at 2: 1 monomeric 
unit: nucleotide ratio. Comp lexes were prepared in 10% (v/\ ) PBS and -tained 
with uranyl acetate. The bars represent (a) 1000 nlll and (b) 200 111ll . 
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Table 4.1 Measurements of rods aDd toroids structures formed with 
DMA40MPC30 and DMA40MPC40 uDder TEM. The outer diameter of toroids, 
length of rods, and the thickness of DNA condensates were measured (n = 20). 
Copolymer 
system 
DMA4oMPC3o 
DMA4oMPC4o 
Outer diameter of 
toroid (om) ± sd 
52± 12 
51 ± 7 
Length of rods 
(om) ± sd 
71 ± 19 
62 ± 17 
Thickness (om) 
± sd 
17 ± 3 
15 ± 3 
A range of morphologies is obtained for the DNA complexes prepared using 
the DMAxMPC30 copolymers. TEM images show that as the length of DMA 
increased, the level of condensation increased accordingly. For the 
DMAlOMPC30 copolymer, loosely condensed, 'spaghetti-like' structures were 
observed (figure 4.7). For the DMA20MPC30 copolymer, the complexes 
appeared as loose ring and long linear structures, with a significant fraction 
of well-defined toroids and rods (figure 4.8). Both ring-like and linear 
structures had similar widths. For DMAwMPC30 copolymer, the complexes 
appeared as shorter rods, tight toroids, or intermediate between the two, with 
rods as the dominant species (figure 4.4). As the length of DMA further 
increased, toroids were no longer observed. DNA complexes formed by 
DMA60MPC30 and DMAlOOMPC30 copolymers appeared as highly condensed 
compact globular particles (figure 4.9 and 4.10 respectively). These particles 
appeared as either short, thick rods or oval-shaped structure. Measurements 
including the thickness, contour lengths and diameter of the condensates are 
shown in table 4.2 and 4.3. 
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Figure 4.7 TEM images of DMA IOMPC30 - DNA complexes at 2: 1 monomeric 
unit: nucleotide ra tio . Comp lexes were prepared in 10% (v/v) PBS and tained 
with uranyl acetate. The bars represent (a) 1000 11m and (b) 200 nm 
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Figure 4.8 TEM images of DMAzoMPC3o - DNA complexes at 2:1 monomeric 
unit: nucleotide ratio. Complexes were prepared in 10% (v/v) PB S and stain ed 
with uranyl acetate . The bars represent (a) 1000 nm and (b) 200 nm 
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Figure 4.9 TEM images of DMA6oMPC3o - DNA complexes at 2:1 monomeric 
unit: nucleotide ratio. Complexes were prepared in 10% (v/\') PBS and stain ed 
with uranyl acetate. The bars represent (a) 1000 11m and (b) 200 11111 
109 
Chapter 4: Morphology Study b. • 
" 
~ ~ ~ ~
• 
• 
• 
• • • 
• 
• 
.. 
• •
~ ~
• 
.' 
• 
, 
. ~ ~ • 
.. , 
,. 
., 
• " I .. ~ ~ ;I • 
" 
. 
.. • " 
• • .. #: 1 & • 
• 
, .. • II 
• • , I . , 
• 
.., .. 
• 
J 
" • 
• 
, 
• 
.. l • 
• '. • t . • • ~ . . .. 
.. 
, 
~ ~.. .. .. 
... 
~ ~ . . 
.. • ... ' . 
• .. " I I ' ' • . 
• 
.. 
.. 
.. 
• 
.. , • • • 
• . 
• • 
... 
., 
• 
# 
'0 
'" • 
. * 
.-
• • 
• • . , . 
• • • f .. -. .. 
'\ .,. 
, 
• • ; . " .. # • 
Figure 4.10 TEM images of DMA lOoMPC3o DNA complexes at 2: 1 
monomeric unit: nucleotide ratio. Compl exes were prepared in 100 0 ( \ \ ) PB 
and stained with uranyl acetate. The bars represent (a) 1000 11m and (b ) 200 nlll 
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Table 4.2 Measurements of rodsllinear and toroids structures formed with 
DMA IOMPC30, DMA20MPC30, and DMA40MPC30 under TEM. The thickness and 
contour lengths of rods and toroids of DNA condensates were measured (n = 20). 
Copolymer Thickness Contour length of Contour length of 
System (nm) ± sd linear structure toroid (nm) ± sd 
DMA lOMPC30 
DMA20MPC30 
DMA40MPC30 
7 ± 1 
11 ± 2 
17 ± 3 
(nm) ± sd 
537 ± 342 
142 ± 117 
71 ± 19 
n/a 
155±37 
137 ± 30 
Table 4.3 Measurements of toroids or globular structures formed with 
DMA20MPC30, DMA4oMPC3o,DMA6oMPC3o and DMA lOOMPC30 under TEM. 
The diameter of toroids for DMA20MPC30 and D ~ o M P C 3 0 0 (n = 20) and the 
average size of globular particles for DMA60MPC30 and DMA lOOMPC30 (n = 100) 
were measured. 
Copolymer system 
DMA20MPC30 
DMA40MPC30 
DMA60MPC30 
DMA)ooMPC30 
Outer diameter of toroids / Size of 
globular particles (nm) ± sd 
54 ± 13 (toroids) 
52± 12 (toroids) 
48 ± 9 (particles) 
42 ± 9 (particles) 
4.3.2 Morphology of DNA complexes under AFM 
According to the TEM images, it is found that the extent of DNA 
condensation is largely dependent on the length of DMA within the 
copolymer. Therefore, it is interesting to further investigate the behaviour of 
DNA complexes of this copolymer series (DMAxMPC30) in a liquid 
environment using AFM. 
Figure 4.11 shows an AFM image of luciferase plasmid (a) in a liquid 
environment and (b) dried in air. Both images show a typical relaxed circular 
plasmid with structure consistent with other published images of 
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uncondensed DNA (Hansma et aI. , 1998, Golan et aI. , 1999. Maurstad el al.. 
2003 ). The average contour length of the plasmid in liquid measured under 
the AFM was 1802 run ± 102 run (n =3). 
Figure 4.11 AFM images of unco ndensed luciferase plasmid (a) in liquid 
. ell t wl·tll a - ra ll oe of 10 11m (b) dried in air. with a z range of 5 11m . The enVlronm , - b • 
bars represent 200 nm. 
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The morphology of DNA complexes (in liquid) formed with DMAIOMPC30, 
DMA20MPC30, DMAtoMPC30 and DMA6oMPC30 are shown in figures 
4.12 - 4.15. 
From the AFM images, it is clearly seen that DNA was only barely 
condensed with DMA lOMPC30 copolymer. Some of the condensates were 
simple flower-like structures composed of a central focus and loops of DNA 
that form 'petals' (figure 4.12b). Others simply consisted of plectonomic 
loops without a focus point. There were also structures that appeared as open 
loops which was similar to the uncondensed DNA (figure 4.12c). For 
DMA20MPC30 copolymer, the majority of the complexes formed were 
flower-like structures. Compared to DMA IOMPC3o, these structures were 
highly looped and the central focus appeared to be larger and more intense 
(figure 4.13b). Oblong looped structures with multiple focal points can also 
be seen (figure 4.13c). These structures have been previously reported by 
other groups using spermidine and silanes as DNA condensing agents (Fang 
and Hoh, 1999). For DMA40MPC30, the complexes appeared as blobs of 
condensates with folded loops of DNA surrounding the central cores (figure 
4.14). These structures were similar to those reported for PEl-DNA 
condensates (Dunlap et al., 1997). For DMA6oMPC3o, the complexes were 
very similar to those observed with DMAtOMPC30, although the centre core 
appeared larger and the complexes were more tightly packed (figure 4.15). 
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Figure 4.12 AFM images of DMA IOMPC3o - DNA complexes at 2:1 monomeric 
unit: nucleotide ratio . Complexes were prepared in 10% (v/v) PBS . The bars 
represent 200 11m. (a) scan size 2 ~ l l 2 2 with a:: range of 5 11111 . (b and c) call Ize 
0.5 ~ ~ 2 2 with a z range of 10 n111 . 
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Figure 4.13 AFM images of DMA20MPC30 - DNA complexes at 2:1 monomeric 
unit: nucleotide ratio . Complexes were prepared in 10% (v/v) PBS. The bars 
represent 200 nm . (a) scan size 2 ).lm 2 with a:: range of 5 nm. (b and c) scan size 
0.5 ).lm 2 with a z range of 10 nm . 
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Figure 4.14 AFM images of DMA.toMJ>C3o - DNA complexes at 2: 1 monomeric 
unit: nucleotide ratio. Complexes were prepared in 10% (vi \') PBS. The bar 
represent 200nm . (a) scan size 2 11m2 with a ~ ~ ran ge of 18 nl11 . (b and c) can sIze 
0.5 pm 2 with a ~ ~ range of 1011111. 
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Figure 4.15 AFM images of DMA6oMPC3o - DNA complexes at 2: 1 monomeric 
unit: nucleotide ra tio. Complexes were prepared in 10% (v/v) PBS. The bars 
represent 200 11 m. (a) scan size 2 pm 2 with a:: range of 8 nm. (b and c) scan size 
0.5 pm 2 with a z range of 10 nm . 
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Table 4.4 shows the contour length measurement of flower-like structures of 
DMA lOMPC30 and DMA20MPC30, and the dimensions of flower-like or blob 
structures of DMA20MPC30, DMA40MPC30 and DMA60MPC under the AFM. 
Since the central cores of the complexes o f D ~ o M P C 3 o o and DMA60MPC30 
are tightly packed with dense material, it is not possible to measure the 
contour length of these condensates. 
Table 4.4 Measurements of contour length and dimensions of DNA condensates 
formed with DMAxMPC30 under AFM. DMA lOMPC30 (n = 10), DMA20MPC30 (n 
= 20), DMA40MPC30 (n = 20), and DMA60MPC30 (n = 20). 
Copolymer System 
DMA lOMPC30 
DMA20MPC30 
DMA40MPC30 
DMA60MPC30 
Contour length of 
condensate (nm) ± 
sd 
1014 ± 454 
1795±278 
n/a 
n/a 
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Dimensions of flower-like / 
blob structures (nm) ± sd 
n/a 
156 ± 56 
151 ± 59 
146 ± 56 
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4.4 DISCUSSION 
4.4.1 Comparison ofTEM and AFM data 
In general, both imaging techniques indicate that more efficient DNA 
condensation occurs as the DMA block length increases. TEM studies 
revealed striking morphological differences for DNA complexes prepared 
with different compositions of the copolymers. On the other hand, the 
morphological differences of the complexes under the AFM were somewhat 
less dramatic. When comparing the dehydrated (TEM) and hydrated (AFM) 
complexes images, only structures of DMAlOMPC30 - DNA complexes were 
fairly similar. With this system, the DNA is barely condensed. Therefore the 
structures were perhaps less affected by the differing sample preparation 
protocols and environments applied by these two imaging techniques. 
However, there are certainly significant structural differences between TEM 
and AFM data for other DMA-MPC copolymers - DNA complexes. Under 
the TEM, DNA complexes formed with DMA2oMPC3o appeared as either 
linear or ring-like structure, whereas under AFM, the majority of the 
complexes appeared as flower-like structures. For D M ~ o M P C 3 o o and 
DMA60MPC30, the DNA complexes under TEM appeared as a mixture of rod 
and toroids structures, and highly dense oval-shaped particles respectively, 
whereas under the AFM, the complexes appeared as block-like structures 
with loops of DNA protruding out in both system. Generally, the structures 
observed under the TEM appeared to be better condensed compared to AFM. 
The discrepancy between the techniques may be simply because dried 
samples were studied under TEM and hydrated / liquid samples under AFM. 
The MPC chains are extremely hydrophilic. Each MPC unit binds 
approximately 10-12 water molecules (Ishihara et af., 1998; Konno el af.. 
2001). Hence dehydration of the DNA complexes would be expected to haye 
a dramatic impact on the morphology of MPC chain and consequently the 
DNA complexes morphology. 
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Furthermore, heavy metal staining is necessary to enable visualization of the 
complexes under the TEM. In this study, a 500/0 ethanolic solution of uranyl 
acetate was used as a stain for the DNA and the image produced was actually 
the shadow of the stain. It has been shown that the presence of ethanol can 
affect the extent of DNA condensation. Thus the TEM images need to be 
interpreted with caution. In addition, an extraordinary behaviour of MPC 
polymers in water : ethanol mixtures has been previously reported (Lewis et 
aI., 2000). It has been found that in 50 : 50 water: ethanol (v/v) solution, the 
MPC polymer chains collapse and interact with each another, leading to the 
formation of precipitate. The reason of this observation is not fully 
understood. However, the compact structures observed under TEM after 
staining could be a consequence of this behaviour. 
In contrast, neither drying nor staining is necessary for AFM studies, so one 
can assume that this less invasive sample preparation significantly decreases 
the probability of artefacts. However, the complexes still require adsorption 
onto a substrate for AFM imaging. For this reason, DNA complexes that do 
not adhere onto the substrate cannot be imaged. Thus, repeated AFM 
experiments under the same conditions may reveal different structures 
adsorbed onto the mica surface. This was particularly true for condensates 
formed in the presence of the DMA2oMPC3o and D M ~ o M P C 3 o o copolymers, 
for which a range of variably condensed DNA complexes apparently co-exist 
in solution. It is not yet clear whether the complexes observed by AFM are 
truly representative of the entire population present in the bulk solution. 
4.4.2 DNA condensation 
A range of different structures of DNA condensates have been reported by 
many researchers. A few questions have been raised regarding the 
condensation of DNA: 
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1. How are these different structures formed? 
2. Which is the most stable form of condensates? 
3. How are these structures related to the development of gene delivery 
systems? 
One of the aims of the present study is to gain the insight of how the DNA is 
condensed by examining the morphology of the condensates with different 
compositions of copolymer. Due to the different environmental condition of 
the sample and the remarkable difference of morphology between TEM and 
AFM images, it is hard to propose a pathway of DNA condensation by 
putting the two sets of images together. 
On studying the TEM images alone, it was found that the morphology of 
DMA-MPC copolymer - DNA complexes varies markedly with different 
compositions of the copolymer. By increasing the length of MPC, the 
morphology of the complexes changed from highly aggregating condensates 
to discrete rod and toroid structures. This suggests that the hydrophilic MPC 
is able to provide efficient steric stabilization to the complexes. However, as 
the MPC further increased, the complexes became less condensed, indicating 
that high levels of MPC would indeed affect the condensation of DNA. On 
the other hand, by increasing the length of DMA, DNA progressively became 
more effectively condensed, as the morphology of the complexes changed 
from loosely condensed 'spaghetti-like' structures, to well condensed rods 
and toroids. The average contour length of the condensates decreased and 
the thickness increased, probably due to the successive folding and coiling of 
DNA molecules. 
The relationship between toroids and rods is not fully understood. These 
two types of structures were frequently found to co-exist (Martin et al.. 2000, 
Liu et aI., Maurstad et al.. 2003). though toroids were reported to be the 
dominant species in most cases. It has been suggested that toroids and rods 
are formed by different condensation pathways (Bloomfield 1997). yet there 
is also evidence suggesting that rods and toroids are actually interchangeable 
121 
Chapter 4: Morphology Study 
via real time observation (Martin et al., 2000). Martin et al. were able to 
capture a series of AFM images which showed that toroids and rods existed 
dynamically, having the ability to reversibly equilibrate between each other. 
It has been postulated that DNA rods may bend around (Dunlap et ai., 1997) 
or open up to form toroids (Golan et al., 1999), or that toroids collapse to 
give rods (Erbacher et al., 1998). 
Although it is not possible to confirm in our systems whether rods and 
toroids are indeed interchangeable using TEM, a series of 'snapshots' of 
DNA condensates formed with DMA2oMPC3o and D M ~ o M P C 3 o o copolymers 
has suggested that linear and ring structures are very likely to be in the 
process of interchanging. Figure 4.16 and 4.l7 show a number of 
'intermediate' DNA condensates. It appeared that some rods may open up or 
bend around to form toroids, or toroids collapse to give rods. Based on these 
'snapshots', it is impossible to judge which are the precursors of the others. 
Nevertheless, these structures may provide clues to the way in which DNA 
may condense into toroids and rods. 
It is not clear which morphology, rod or toroid, is the more stable form of 
condensates. Although toroids have been reported to be the most common 
morphology for DNA condensates (Bloomfield 1996), rods clearly 
predominate for complexes formed with DMA2oMPC3o, D M ~ o M P C 3 o o and 
DMA4oMPC4o copolymers. Table 4.5 shows the estimated relative 
proportions of toroids and rods for the three systems under TEM. Other 
polymeric vectors such as chitosan also produced a high proportion of rods 
(Danielsen et al., 2004). The preference between rod or toroid structure 
seems to be dependent on the properties of the condensing agent. Theoretical 
studies indicate that the chain stiffness of macromolecules plays an important 
role in coil-globule transitions. This can be applied to the structural 
behaviour of DNA condensates (Noguchi and Yoshikawa, 1998, Stevens 
2001, Maurstad and Stokke, 2005). A toroidal morphology is more likely for 
a stiff chain, whereas a rod is favoured when the polymer chain is flexible 
(Ivanov et al.. 2000). Our results therefore suggest that the chains of DNA 
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condensates are relatively flexible due to DNA complexation with the DMA-
MPC copolymers, allowing coexistence of toroids and rods to occur. 
As the DNA was further condensed, toroids are no longer observed. Short 
thicker rods or highly dense compact particles are seen for DMA6oMPC3o and 
DMA lOOMPC3o copolymer. In contrast to toroidal structures, these 
condensates were stained in the centre. These condensates may be formed by 
further coiling and folding of rod structures, or indeed forms of densely 
packed toroidal condensates. 
Table 4.5 Comparison of the relative populations (%) of toroids and rods 
under TEM. DNA condensates were formed with DMA20MPC30 DMA40MPC30 
and DMA40MPC40 at monomeric unit: nucleotide ratio 2: 1 (n=300). 
Copolymer % oftoroids 0/0 of rods 0/0 of 'intermediate' 
system 
DMA20MPC30 22.7 49.3 28 
DMA40MPC30 16.7 74 9.3 
DMA40MPC40 4.3 89.5 6.2 
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Figure 4.16 TEM images of intermediate DNA structures (between rods and 
toroids) formed with DMA2oMPC3o copolymer. The DNA complexes were 
prepared at monomeric unit: nucleotide ratio 2: 1 in 10% (v/v) PBS and stained with 
uranyl acetate. The bar represents 100 nm. 
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Figure 4.17 TEM images of intermediate DNA structures (between rods and 
toroids) formed with DMA4oMPC3o copolymer. The DNA complexes were 
prepared at monomeric unit: nucleotide ratio 2: 1 in 10% (v/v) PBS and sta ined w ith 
urany l acetate. The bar represents 100 nm. 
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From the AFM images, it IS also suggested that the level of DNA 
condensation increases with increased the length of DMA within the 
copolymer. It is clear that the DNA is only barely condensed with 
DMAlOMPC30. Initially, the partially condensed DNA consists of a single 
focal point where the condensation of DNA is believed to initiate. This is the 
site where strands of DNA meet. Loops of uncondensed DNA can be 
observed surrounding the focal point. As the length of DMA increases, the 
size of the focal point becomes larger as strands of DNA are packed together 
and condensed. The number of focal points also increased in some of the 
condensates. Interestingly, it was found that the contour length of the 
uncondensed plasmid (1.8 ~ m ) ) was longer than that of DMA)oMPC30 
condensates, but similar to that of DMA2oMPC3o condensates (table 4.4). At 
2: 1 monomeric: nucleotide ratio, DMAlOMPC30 was able to condense DNA 
to a slight extent, as suggested in the gel retardation assay (chapter 3). The 
copolymer may cause coiling of DNA around its circumference, which leads 
to a shorter contour length of the DNA. The contour length ofDMA2oMPC3o 
complexes is longer than that of DMAlOMPC30, suggesting that more than 
one plasmid may be present in each DMA2oMPC3o condensate. Eventually, 
compact condensates were formed, as seen with D M ~ o M P C 3 0 0 and 
DMA6oMPC3o complexes. 
It is obvious that the DNA complexes formed with copolymer with longer 
DMA are more condensed and compacted. However, the condensation 
appears to be incomplete even with DMA6oMPC3o, as loops of folded DNA 
can easily be seen around the centre core of the condensates. Since the centre 
core of the complex is tightly packed with dense material, it is not possible to 
measure the contour length of each condensate. However, it is speculated 
that each of these condensates may consist of more than one plasmid. 
So how do the DNA structures relate to the development of a gene deliyery 
system? It is believed that the condensed state of the DNA protects if from 
nucleases activity and allows it the pass more easily through small openings 
in the biological barriers. It is known that certain compositions of DMA-
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MPC copolymer are able to condense DNA efficiently to form complexes 
with a small particle size. Based on the AFM images, loops of DNA are seen 
to be exposed to the environment for all complexes studied, suggesting that 
the complexes may be susceptible to enzymatic activity. However, further 
experiments are needed before conclusions can be made. The ability of these 
copolymers to protect DNA from enzymatic degradation was investigated 
and described in Chapter 5. 
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4.5 CONCLUSIONS 
This study demonstrates that the structure and morphology of DNA 
complexes formed by the DMA-MPC diblock copolymer is highly dependent 
on the composition of the copolymer. In general, copolymers with longer 
DMA blocks produced more condensed structures. The hydrophilic MPC is 
able to provide steric stabilization to the DNA complexes. However, long 
MPC chains appeared to hinder electrostatic interaction between the DNA 
and the copolymer, resulting in the formation of partial or loosely condensed 
structure. 
The morphology of the dehydrated DNA complexes observed by TEM was 
significantly different to the in situ AFM images obtained in the liquid 
environment. These differences are most likely attributed to the highly 
hydrophilic nature of the MPC block. Dehydration of the steric stabilizing 
component may have a significant impact on the resulting morphology, thus 
explaining the discrepancy between liquid AFM and dried TEM images. The 
different sample preparation procedures and environments may also affect 
the resulting morphology observed in TEM and AFM. The TEM images 
show that as the condensation of DNA progress, the morphology of DNA 
complexes changed from loosely condensed 'spaghetti-like' structures to rods, 
toroids, or 'intermediate' structures of the two, and finally into well 
condensed compact oval-shape particles. On the other hand, the AFM 
images show that the condensation of DNA is likely to be initiated from a 
single focal point, which subsequently increased in number and size to give 
structures with a compact, dense core, with loops of uncondensed / partially 
condensed DNA protruding from the centre of the condensates. Nevertheless, 
both imaging techniques have provided useful insights into the process of 
DNA condensation. 
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CHAPTER 5 
BIOLOGICAL STUDY OF DMA-MPC DIBLOCK 
COPOLYMER - DNA COMPLEXES 
5.1 INTRODUCTION 
An important part of the development of non-viral gene delivery systems is 
the evaluation of their biological properties. The major disadvantage of non-
viral delivery systems is their low efficiency compared to viral vectors. 
Biological characteristics such as transfection efficiency have become the 
prime interest in determining the potential of a non-viral delivery system. In 
the previous chapters, the physicochemical properties of DMA-MPC diblock 
copolymer were assessed and the initial results suggest that certain 
compositions of this copolymer system appear to be promising candidates for 
further investigation. Before moving on to an in vivo study, relatively 
straight forward and low cost in vitro screening of a system is often carried 
out. Although the in vitro study may not always truly reflect the performance 
of a system in vivo, it is still valuable in indicating candidate systems that are 
eligible for further development. 
5.1.1 Aims 
The aims of this chapter were to examine the biological properties of DMA-
MPC diblock copolymers for gene delivery, including its capability to protect 
DNA from enzymatic degradation and membrane interaction of polymer -
DNA complexes using liposomes as model membranes. In addition. the 
cellular association of the copolymer - DNA complexes using flow 
cytometry, and transfection efficiency of the DNA complexes in vitro were 
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also investigated. How the different composition of the copolymers and their 
physicochemical properties relate to the biological performance were 
discussed. 
5.1.2 Principle of enzymatic degradation study 
Once the polymer - DNA complexes are present inside the blood circulation, 
they are intermediately exposed to enzymatic activities (Wickstrom 1986, 
Eder et aI., 1991). This leads to the rapid degradation of any unprotected 
DNA before transfection takes place. In order to achieve successful 
transfection, the DNA must survive the Journey from the site of 
administration to the nucleus of the target cells. In other words, the 
therapeutic DNA must be efficiently protected from enzymatic degradation. 
In the enzymatic degradation study, the ability of different structures of 
DMA-MPC copolymers to resist DNase I enzyme degradation of DNA was 
determined by a fluorescence study (Dash et aI., 1997) and gel 
electrophoresis (Arigita et ai., 1999, Hill et aI., 2001, Tiyaboonchai et aI., 
2003). DNase I is a pancreatic endonuclease which catalyses the hydrolysis 
of double-stranded DNA (Pan et aI., 1998). In the presence of Mg2+, DNase I 
hydrolyses each strand of a duplex independently leading to random single 
strand breaks. The purine-pyrimidine bonds are subsequently preferentially 
cleaved resulting in double strand breaks, leading to a final product of di- and 
higher oligonucleotides (Fojta et aI., 1999). 
In order to examine if there is any protection of DNA in the polymer - DNA 
complexes, DNA must be released from the complexes after they were 
subjected to enzymatic activity. One of the approaches to release the DNA is 
through the 'polyelectrolyte displacement' of the complexes with a polyanion. 
such as poly( aspartic acid) (pAsp) (Kayatose and Kataoka 1997) (equation 5). 
Other approaches include the use of sodium dodecyl sulphate (SDS) 
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(Bielinska et al., 1997, Murphy et al., 1998) or heparin (Ruponen et al.. 1999, 
Moret et al., 2001) as displacement agents. 
polycation - DNA + p(Asp) ~ ~ polycation - p(Asp) + DNA (5) 
A fluorescent probe intercalation study is a simple technique to estimate the 
amount of DNA in a sample. The polymer - DNA complexes were first 
incubated with the enzymes, followed by the dissociation of the complexes. 
Any free DNA released from the complexes would interact with a fluorescent 
probe such as EtBr to induce fluorescence. By measuring the fluorescence 
intensity, the amount of DNA preserved can be estimated. Gel 
electrophoresis studies follow a similar principle. Any protected DNA 
released from the complexes after the displacement reaction would 
intercalate with EtBr to give fluorescence, which could be visualized on the 
agarose gel under UV transillumination. In addition, DNA with different size 
or molecular weight is separated during electrophoresis so that any alteration 
of DNA molecular weight caused by enzymes activities could be detected. 
5.1.3 Principle of model membrane interaction study 
In the delivery of DNA into cells, DNA complexes have to initially come in 
contact with cellular membranes. In order to contribute to the rational design 
of an efficient gene delivery system, it is important to understand the 
interaction between the membrane and the DNA complexes. It is known that 
the composition of biological membranes is highly dependent on the cell type 
and function. Nevertheless, they all share the same basic phospholipid 
bilayer structure. The study of interactions between DNA complexes and 
phospholipid bilayers is useful in predicting any non-specific cellular 
interaction. 
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The purpose of model membrane interaction study is to invest igate the 
interaction between DNA complexes with different copolymers composition 
(length of DMA block) and the phospholipids bilayers using liposomes as 
model membranes. 1 ,6-diphenyl-1 ,3,5-hexatriene CDPH) was employed as 
membrane fluorescence probe to study of the effects of DNA complexes on 
the hydrophobic core of bilayers. The non-ionic DPH is essentially non-
fluorescent in water, only inducing fluorescence when bound to lipid 
bilayers (Lentz, 1989). DPH is situated towards the centre of the lipid 
bilayers as shown in figure 5.1. The fluorescence intensity will alter only 
when the complexes have interacted with the hydrophobic core of the 
bilayers. 
Figure 5.1 Location and orientation of DPH in a phospholipid bilayer. DPH is 
generally assumed to be orientated parallel to the lipid acyl chain ax is. but can also 
reside in the centre of the lipid bilayer parallel to the surface (M ulders el o /. . 1986. 
Wang el a /.. 1991). 
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5.2 MATERIALS AND METHODS 
5.2.1 Materials 
Materials used were as described in Chapter 2, Section 2.1 unless otherwise 
specified below. 
Tris acetate EDT A (T AE) buffer consisted of 40 mM Tris acetate, 20 mM 
glacial acetate acid and ImM EDTA in ELGA water, with pH adjusted to 7.4 
using glacial acetic acid. DNA loading buffer contained 0.25% w/v 
bromophenol blue in 40% w/v sucrose solution. 
OptiMEM-I was purchased from Gibco, UK. Lipofectamine TM was 
purchased from Invitrogen, USA. Luciferase assay system was purchased 
from Promega, USA. YOYO-l iodide was purchased from Molecular Probes, 
UK. 
5.2.2 Cell lines and routine subculture 
A549 cells (human lung carcinoma) were used. They were cultured and 
maintained as described in Chapter 2, section 2.2.2. 
5.2.3 Enzymatic degradation assay 
5.2.3.1 Fluorescence Study 
Polymer - DNA complexes (10 Ilg/ml of DNA) were prepared at monomeric 
unit: nucleotide ratios 1:1. 5:1 and 10:1 in 10% PBS (pH 7.4). Free DNA 
was used as a control. MgCb was added in order to activate the enzymes. 
After 30 min, the complexes were incubated with DNase I (1 U/Ilg DNA) for 
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10 min at 37°C. The activity of DNase was then stopped by the addition of 
EDTA. Complexes were dissociated by addition of poly-L-aspartic acid 
(pAsp). EtBr (2 Ilg) was then added to each sample. Any free DNA released 
from the complexes would intercalate with EtBr to give fluorescence. which 
is directly proportional to the amount of DNA in the sample. The 
fluorescence intensity of the solution was measured at an excitation 
wavelength of 560 nm and an emission wavelength of 605 nm using Hitachi 
F -4500 fluorescence spectrophotometer (Hitachi Scientific Instruments, 
Finchampstead, UK). The result was presented as the percentage of 
fluorescence compared to untreated free DNA control. 
5.2.3.2 Gel electrophoresis 
First, the polymer - DNA complexes were tested for complex dissociation 
with the presence of pAsp. Polymer - DNA complexes (2 /J.g of DNA) were 
prepared at different monomeric unit: nucleotide ratios of 0.25:1,0.5:1. 1:1, 
1.5:1,2:1,5:1 and 10:1 in TAE x 1 buffer (pH 7.4) to give a final volume of 
12 /J.l. The complexes were incubated at room temperature for 30 min. 
Dissociation of complexes was achieved by addition of excess of pAsp 
(12.5/1 w/w pAsp/DNA). The mixture was incubated for a further 10 min, 
followed by addition of 3 III DNA loading buffer. pAsp treated complexes 
were analysed by gel electrophoresis (0.8% agarose gel containing 1 /J.g/ml 
EtBr) in TAE x 1 buffer (pH 7.4). The electrophoresis was run at 60V for 45 
min, after which the DNA was visualized and photographed on a UV 
transill uminator. 
In the second part of the experiment, the complexes were tested for their 
ability to resist DNase I degradation. Polymer - DNA complexes were 
prepared as previously described. After 30 min. MgCh was added (to final 
concentration of 10 mM) in order to activate the enzymes. and the compk.\.es 
were incubated with DNase I (1 U//J.g DNA) for 10 min at 3 7°e. The activity 
of DNase was then stopped by addition of 5 /J.I EDT A (O.5M) which chelated 
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with Mg2+. Complexes were dissociated by addition of pAsp as above. 
followed by addition of DNA loading buffer. The samples were then 
analyzed by gel electrophoresis as described above. Free DNA without any 
treatment, DNA incubated with DNase I and DNA marker lambda-Hind III 
were served as control. 
5.2.4 Model membrane interaction study 
5.2.4.1 Preparation of liposomes - model membranes 
Egg-phosphatidylcholin (100 mg) was dissolved in chloroform (1 ml) to give 
a stock solution with concentration 100 mg/ml. Cholesterol (100 mg) was 
dissolved in chloroform (1 ml) to give a stock solution with concentration 
100 mg/ml. Required amount of lipids suspensions (phosphatidylcholin to 
cholesterol 2: 1 molar ratio) in chloroform were mixed by vortexing. To 
prepare 1 ,6-diphenyl-l ,3,5-hexatrien (DPH) - labelled liposomes, the 
fluorescence probe was dissolved in the mixture at 1 :200 DPH: phospholipid 
molar ratio and the mixture was kept in the dark for I h at room temperature. 
The lipid mixture was then evaporated under a stream of nitrogen to prepare 
the lipid film. The lipid film was hydrated with PBS at room temperature. 
The suspension was freeze-thawed for five cycles by immersing into liquid 
nitrogen in order to get the multilamellar vesicles. The resulting vesicles 
were extruded through polycabonate filters (double filters) with a pore size of 
200 nm using a mini extruder fitted with two syringes (1 ml and 0.25 ml) to 
obtain unilamellar vesicles. Both polycarbonate filters and the syringes were 
obtained from LiposoFast System, Avestin Inc., Canada. The samples were 
subjected to 21 passes through the extruder. An odd number of passages 
were performed to avoid contamination of the samples with multi lamellar 
vesicles that might not pass through the filter. Unilamellar vesicles were 
collected and stored it at 4°C before use. 
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5.2.4.2 Fluorescence study 
To prepare polymer - DNA complexes, calf thymus DNA (50 ~ g ) ) was added 
to 10% PBS (200 ~ l ) , , following by the addition of polymer solutions to make 
complexes with 2: 1 and 10: 1 monomeric unit: nucleotide molar ratios. The 
complexes were incubated at room temperature for 30 min. DPH labelled 
liposomes suspensions were added into 10% PBS (1 ml) to give a final 
concentration of 0.09 mM phospholipids. The fluorescence intensity was 
measured using Hitachi F-4500 fluorescence spectrophotometer (Hitachi 
Scientific Instruments, Finchamstead, UK). The excitation and emission 
wavelengths of DPH are 365 to 425 nm respectively. Aliquots of the DNA 
solution (250 ~ g / m l ) ) or polymer - DNA complexes solution were then added 
to the liposomes suspension in a stepwise manner and the sample was mixed 
gently. The fluorescence intensity was measured after each addition. The 
same volume of 50 mM sodium dodecyl sulphate (SDS) and 10% PBS were 
added to the model membranes as positive and negative controls respectively. 
5.2.5 Flow cytometry study 
DNA was labelled with YOYO-I iodide (1 molecule of the dye per 300 base 
pairs of the nucleotide) (Ogris et aI., 2000) according to the manufacturer's 
protocol. The excitation and emission wavelengths for YOYO-l are 491 and 
509 nm, respectively. Six well plates were seeded with 2 x 105 cells per well 
and the cells were incubated at 37°C and 5% CO2 for 24 h. After 24 h, the 
medium was aspirated off from the wells and gently replaced with DNA-
copolymer complexes. The complexes were prepared in OptiMEM-I (2 ml) 
by addition of copolymer solution to luciferase plasmid (8 ~ g ) , , followed by 
incubation for 30 min at room temperature prior to addition to cells. All 
complexes were prepared using a 2: 1 monomeric unit: nucleotide ratio. 
Lipofectamine™ was complexed with DNA according to the manufacturer's 
protocol at a lipofectamine: DNA ratio of 2: 1 (w/w). The cells were then 
incubated at 37°C and 5% CO2 for 3 h. After 3 h, the complexes were 
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aspirated off from the wells. The cells were trypsinized using trypsin _ 
EDT A and centrifuged at 800 rpm for 5 min. They were then washed twice 
with ice-cold PBS. Finally, they were suspended in 1 ml of PBS. The cell 
samples collected were stored in ice until analysis was performed. The 
percentage of fluorescent cells in the popUlation and the fluorescence level of 
the cells were measured by flow cytometry (Beckman Coulter Epics XL). 
The measurements were performed using an Argon-Krypton Ion laser with an 
emission wavelength of 488 nm. Data were analyzed using EXP032 version 
1.0, Applied Cytometry system. 
5.2.6 Transfection study 
Six well plates were seeded with 1 x 105 cells per well and the cells were 
incubated at 37°C and 5% CO2 for 24 h. After 24 h, the medium was 
aspirated off from the wells and gently replaced with DNA-copolymer 
complexes. Complexes containing 4 Ilg of DNA were prepared as described 
above. The cells were incubated for 4 h at 37°C and 5% CO2. Following 
incubation, the complexes were removed and replaced with RMPI-1640 
medium and the cells were incubated for a further 24 h before analysis. 
5.2.6.1 Detection of luciferase 
The medium was removed from the cells, which were then washed with PBS 
twice. Luciferase detection was performed with a luciferase detection kit. 
Cell lysis buffer (300 Ill) was added to each well. A pipette tip was used to 
scrape all cells from the well substrate, after which the lysate was centrifuged 
at 13,500 rpm for 5 min and the supernatants were collected. The luciferase 
activity of each sample was measured by gently mixing reconstituted 
luciferin reagent (100 Ill) with cell lysate (20 Ill) in a scintillation vial insert, 
and inserting into a luminometer (TD 20/20, Progema). 
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5.2.6.2 Determination of cellular proteins 
Recoverable cellular protein in each sample was determined via the Bradford 
assay (Bradford, 1976). A calibration curve was plotted using bovine serum 
albumin standard prepared over a concentration range of 1 - 1400 J.lg/J.ll. 
Aliquots of each standard (100 J.lI) were added to polystyrene cuvettes, to 
which Bradford reagent (3 ml) was added. They were allowed to stand at 
room temperature for at least 5 min before AS9S was measured using a UV-
visible spectrophotometer. A linear standard curve was used to give an 
equation that related AS9S to protein concentration, which could be used to 
determine the unknown protein concentration of cell lysates. Aliquots of 
lysate samples (20 J.lI) were first diluted with water (80 J.lI) before adding 
Bradford reagent and measuring AS9S as described above. Results in terms of 
light units / ml obtained from luminescence measurements were divided by 
J.lg protein per ml to give a final value of light units / J.lg cellular protein. 
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5.3 RESULTS 
5.3.1 Enzymatic degradation study 
In the fluorescence enzymatic degradation study, the relative amount of DNA 
released from the complexes is shown in figure 5.2. The fluorescent intensity 
was expressed as percentage compared to untreated DNA control. After 
incubation with DNase I for 30 min, the fluorescence intensity of the control 
DNA decreased to only 20%, indicating that the majority of the DNA was 
degraded by nuclease. When DNA was complexed with DMA 
homopolymers, over 800/0 of the fluorescence was retained at 1: 1 monomeric 
unit: nucleotide ratio. At ratio 5:1 and 10:1, the extent of protection was 
further increased as over 95% of fluorescence could be detected. 
Different degrees of protection were observed with different compositions of 
the copolymers. Similar results were observed for DMA4oMPCIO, 
DMA4oMPC3o, DMA6oMPC3o and DMAlOoMPC30 copolymer systems 
compared to DMA homopolymers. Over 80% of fluorescence was detected 
after the complexes were subjected to DNase I activity compared to untreated 
DNA controls. For DMA lOMPC3o and DMA2oMPC3o copolymers, there were 
significantly reductions of fluorescence intensity compared to the control 
(p<0.05). Only about 30 % of fluorescence could be detected in these cases. 
For DMA4oMPCso copolymers, a slightly higher amount of fluorescence, with 
approximately 60% of fluorescence remained. 
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Figure 5.2 Enzymatic degradation study using fluorescent probe intercalation 
method. The diagram shows the relative fluore scence following the add iti on of 
EtBr to polymer - DNA complexes, which were incubated with DNase I (3 r e, 10 
min) and displaced by pAsp. DNA complexes were prepared at monomeri c un it: 
nucleotide ratios 1:1 , 5:1 and 10:1 and the resu lts were expressed in % of 
fluorescence intensity produced compared to the untreated DNA (n=3). Naked DNA 
was used as control. 
In the gel electrophoresis study, the ability of polymers to protect DNA from 
enzyme degradation was assessed by comparing the topology of released 
DNA from the complexes with the naked DNA control. Figure 5.3 shows the 
gel of naked DNA without treatment and after subj ecting to DNase I 
degradation. No fluorescence could be detected after the naked D A was 
incubated with DNase I (lane 3), indicating a high level of enzymatic 
degradation. Displacement of DNA fro m polymer - D A compl exes at 
different monomeric unit: nucleotide ratios was carried out using pAsp 
(fi gure 5.4). The results show that DMA homopolymers and OM -M PC 
copolymers were ab le to dissociate to release free 0 A as the r lea ed ON 
had the same molecular weight as the untreated D A contro l. 
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Figure 5.3 Gel electrophoresis of naked DNA in enzymatic degradation study. 
Lane 1 contained lambda Hind III DNA marker. Lane 2 contained untreated DNA 
control. Lane 3 contained naked DNA after DNase I incubation at 37°C for 10 min. 
Figure 5.5 shows the results of polymer - DNA complexes after incubation 
with DNase I followed by displacement of DNA from the complexes using 
pAsp. Presence of DNA bands on the gel indicate the ability of polymer to 
protect DNA from enzymatic degradation. Both low and high molecular 
weight DMA homopolymers offered some degree of protection of DNA 
against DNase I degradation at ratios as low as 0.25: l. As the ratio increased, 
the degree of protection appeared to increase accordingly judged by the 
fluorescence intensity on the gel. For both homopolymers, a low molecular 
weight DNA fragment was also seen in the gel. 
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Figure 5.4 Gel electrophoresis of polymer - DNA complexes dissociated with 
pAsp. Lane 1-7 contained polymer - DNA complexes ratios at 0.25: I, 0.5: 1. 1: 1. 
1. 5: 1, 2: I, 5: 1 and 10: 1 respecti ve ly after pAsp induced dissociation . (a) DMA 
homopolymer ( low molec ul ar weight), (b) DMA homopo lymer (high molecular 
we ight), (c) DMAIOM PC 10, (d) DMAIO MPC 30, (e) DMAIO MPC 50. (f) DMAooMPC ,n 
and (g) DMA1 ooMPC,o. 
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For the DMA-MPC diblock copolymers, only D M ~ o M P C I O O and 
DMAIOoMPC3o were able to provide preservation of DNA structure from 
DNase I degradation, as similar molecular weight of released DNA compared 
to the control was seen at high ratios. However, the fluorescence intensity of 
the DNA bands appeared to be dimmer compared to DMA homopolymers, 
suggesting that less protection was offered by these copolymers. F or other 
DMA-MPC copolymers studied, the original DNA topology could not be 
seen. Only low molecular weight DNA fragments were observed at the top 
of the gel. 
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Figure 5.5 Gel electrophoresis of polymer - DNA complexes in an enzymatic 
degradation study. DNA comp lexes were incubated \vith DNase I at 37°C fo r 10 
min fo ll owed by dissociation with pAsp. Lane 1-7 contained polymer - D 
complexes ratios at 0.2 5: 1. 0.5 : 1. I : 1. 1. 5: 1. 2: 1. 5: I and 10: I (a) DM 
homopo lymer (low M\\') , (b) DM A homopolymer (hi gh M\\ ). (c) DM .WMPC IO. (d) 
DMAIO MPC .1o. (e) DM A..lO MPCso. (f) DM A60 MPC ;0 and (g) DMA 1LlO MPC ;Ll · 
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5.3.2 Model membranes interaction study 
DPH labelled liposomes were used as model membranes to investigate the 
effect of polymer - DNA complexes on the hydrophobic core of lipid 
bilayers. Sodium dodecyl sulphate (SDS) is an anionic surfactant which is 
known to be able to permeate and solubilise biological membranes (Kragh-
Hansen et al., 1998). It has been frequently used as a model substance to 
study structural changes in cell membranes. In this study, SDS was 
employed as a positive control and the results are shown in figure 5.6. The 
solubilisation of phospholipid by SDS induced a significant reduction of 
fluorescence intensity of DPH-Iabelled liposomes as the DPH was displaced. 
The fluorescence intensity continued to decrease as the amount of SDS 
increased until a plateau was reached. However, a total displacement of DPH 
was not achieved. On the other hand, 10% PBS which does not interact lipid 
membranes was used as a negative control. The slight reduction in 
fluorescence intensity caused by 10% PBS was solely due to dilution effect. 
The DNA solution was added to the DPH labelled liposomes to examine 
whether DNA alone could interact with the membrane model. No significant 
change in fluorescence intensity was observed as compared to the control 
(10% PBS). 
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Figure 5.6 The effect of DNA (250 Ilg Iml) on model membra nes. DPH labelled 
liposomes were used as mode l membranes . Fluorescence intensity was measured 
after the addi t ion of DNA so lution on liposomes and the results were expressed as 
re lati ve fluorescence (%). Equivo lume of SDS (50 mM) and 10% PBS were used as 
contro ls (n=3). 
The effect of polymer - DNA complexes on phospholipid bilayers was 
studied by add ing the complexes to the DPH labelled liposomes (fi gure 5.7 
and 5.8). Since DPH is situated at the hydrophobic interi or of the lipid 
bi layers (Mulders e/ aI. , 1986. Wang el al.. 1991 ). it is as umed that the 
fluo rescence intensity will only be affected when the interi or of the bil aye r 
is perturbed . Any interaction with the surface of the Ii posomes may not be 
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able to induce any noticeable change of fluorescence intensity as the DPH 
situated at the hydrophobic core of the liposomes is not disturbed. A similar 
trend was observed for all polymer - DNA complexes. A sharp decrease in 
relative fluorescence intensity was detected when small amount of DNA 
complex was added to the model membranes. As the amount of DNA 
complex increased, the relative fluorescence intensity decreased gradually. 
However, a plateau was not reached as the dilution effect caused the 
fluorescence level to decrease. 
For DNA complexes prepared at 2: 1 monomeric unit: nucleotide ratio (figure 
5.7), all complexes induced a greater reduction of relative fluorescence 
intensity compared to the control (100/0 PBS) at the beginning. Among all the 
MPC containing copolymer - DNA complexes, DMA lOOMPC30 - DNA 
complexes caused the largest reduction of fluorescence intensity. 
Interestingly, as the amount of DNA complex increased, the loss of 
fluorescence intensity appeared to be retarded. When a large amount of 
DNA complex was added (50llg DNA) to the liposomes, the relative 
fluorescence intensity of DMA2oMPC3o - DNA complex treated liposomes 
was similar to the control. For other copolymer - DNA complexes, the 
relative fluorescence intensity was only approximately 5% lower than the 
control. For DMA homopolymer - DNA complexes, the relative 
fluorescence intensity was about 100/0 lower than the control. At 10: 1 
monomeric unit: nucleotide ratio (figure 5.8), the copolymer - DNA 
complexes behaved similarly as those prepared at a 2:1 ratio. However, it 
was noticeable that the DMA homopolymer - DNA complexes at 10: 1 
monomeric unit: nucleotide ratio induced a greater reduction in fluorescence 
intensity than at the 2: 1 ratio. When a large amount of DMA homopolymer-
DNA complex was added (50llg DNA) to the liposomes, the relative 
fluorescence intensity was approximately 15% lower than the control. 
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as mode l membranes. Fluorescence intensity was measured after the addition of 
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5.3.3 Flow cytometry study 
In this study, flow cytometry was used to investigate the cellular association 
of the copolymer - DNA complexes. DNA was labelled with YOYO-l 
fluorescent probe and the cellular association of the complexes was evaluated 
by measuring the fluorescence intensity associated with the cells. The results 
were expressed as the percentage of cells that showed a significant increase 
in fluorescence compared to the untreated control cells (figure 5.9), and the 
level of cell-associated fluorescence (figure 5.1 0). 
From figure 5.9, it can be seen that when the cells were incubated with naked 
DNA, the percentage of fluorescing cells was low, approximately 10% of 
total cell populations. In contrast, when DNA was complexed with DMA 
homopolymer, the percentage of fluorescing cells markedly increased. Over 
95% of cells showed associated fluorescence, which was comparable to that 
achieved with lipoplexes formed with lipofectamine™. For the copolymer 
complexes, as MPC content in the DMAtoMPCy increased, the percentage of 
fluorescing cells decreased accordingly. When the cells were treated with 
DMA40MPClO - DNA complexes, approximately 60% of cells showed 
associated fluorescence. When the cells were treated with DMAtoMPCso -
DNA, the percentage of fluorescing cells was only about 100/0, which was 
similar to those obtained with naked DNA. On the other hand, when the 
DMA content of the DMAxMPC30 series increased, the percentage of 
fluorescing cells increased. Approximately 200/0 of cells showed associated 
fluorescence for DMAlOMPC30 and DMA2oMPC3o complexes. In contrast, 
more than 95% of cells showed associated fluorescence for the 
DMA)ooMPC3o complexes, which was comparable to that achieved with the 
DMA homopolymer and lipofectamine TM. 
Although the percentage of fluorescing cells for DMA lOOMPC3o complexes 
was similar to that of DMA homopolymer and lipofectamine™, the 
fluorescence intensity differed significantly. From figure 5.10, it is obyious 
that all the MPC- based copolymer complexes displayed much lower cellular 
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association as the fluorescence level were significantly lower than that of 
DMA homopolymer (p<0.05 in all cases). Only complexes formed with 
DMA homopolymer and lipofectamine™ displayed a significant increase in 
fluorescence level compared to naked DNA (p < 0.05). The fluorescence 
intensity of the cells incubated with MPC copolymer complexes was 
comparable to that obtained with naked DNA. Complexes with higher DMA 
contents had somewhat higher cellular association, with the highest value 
obtained for the DMA IOOMPC3o copolymer. However, the fluorescence 
intensity was still relatively low and was only about 25% of those obtained 
for DMA homopolymer, and 10% oflipofectamine™. 
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Figure 5.9 Percentage of A549 cells exhibiting associated fluorescence at 180 
min in flow cytometry study. DNA was labelled with YOYO-l flu ore cent probe. 
All copolymer complexes were prepared at a 2: 1 monomer unit: nucleotide rati o. 
Naked DNA and Lipofectamine™ were used as negati ve and po iti\ e control 
respectively (n=3). * P < 0.05 when compared with naked DNA . 
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Figure 5.10 The average fluorescence intensity associated with AS49 cells at 180 
min in flow cytometry study. DNA was labelled with YOYO-J fluorescent probe . 
All complexes were prepared at a 2: J monomeric unit: nucleotide ratio. Naked 
DNA and Lipofectamine ™ were used as negative and positive control respect ive ly 
(n=3). * P < 0.05 when compared with naked DNA. 
5.3.4 Transfection study 
Transfection studies were carried out on A549 cells usmg the luciferase 
plasmid. This particular cell line was chosen for the study because earlier 
experiments in our group showed that DMA homopolymer - DNA 
complexes displayed reasonable transfection efficiency on thi s cell line 
(Rungsardthong et aI. , 2001). The aim of the study was to compare the leve l 
of gene expression in vitro with different compositions of DMA-MPC 
copolymer. Naked DNA and Lipofectamine™ were used as control . 
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The transfection results are displayed in figure 5.11. Each of the DMA-MPC 
copolymer - DNA complexes showed significantly lower transfection 
efficiencies than that of the DMA homopolymer. The transfection data in 
general displayed a similar trend to the flow cytometry study: the higher the 
cellular association, the higher the transfection efficiency. For the 
D M ~ o M P C y y series, D M ~ o M P C l O O had the highest transfection efficiency. 
The transfection level decreased as the length of MPC increased, whereby 
D M ~ o M P C 5 0 0 had the lowest transfection level. On the other hand, for the 
DMAxMPC30 series, the transfection efficiency increased as the DMA length 
increased. Complexes formed using the DMAlOOMPC30 copolymer showed 
the highest level of transfection, but even this was 10 times lower than that of 
DMA homopolymer complexes. The transfection efficiencies of most of the 
copolymer - DNA complexes were not significantly different from naked 
DNA (p > 0.05 for all copolymer - DNA complexes except DMA40MPClO 
and DMA lOOMPC30). Neither DMA homopolymer nor DMA lOOMPC30 
copolymer had transfection efficiency that was comparable to the commercial 
transfection agent lipofectamine™. The low transfection efficiencies of 
MPC containing copolymers correlate with cellular association, as suggested 
by flow cytometry study. 
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Figure 5.11 Transfection efficiency of polymer - DNA com plexes (2: 1 
monomeric unit: nucleotide ratio) on A549 cells. Data were presented in terms of 
relative light units (RLU) per mg protein . Naked DNA and Lipofectamine were 
used as controls (n=3). * P < 0.05 when compared with naked DNA . 
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5.4 DISCUSSION 
A number of biological properties such as protection of DNA from enzymatic 
degradation, membrane interaction, cellular association and the transfection 
efficiency ofDMA-MPC copolymer system were investigated in this chapter. 
In order to assess the polymers' ability to protect DNA from degradation, 
DNA was released from the complexes after subjection to enzymatic activity. 
Poly(L )aspartic acid (pAsp) was used to release DNA from the polymer _ 
DNA complexes through a displacement reaction (Kayatose and Kataoka 
1997). The gel electrophoresis study shows that the copolymer - DNA 
complexes were dissociated by pAsp and that the released DNA has a 
molecular weight the same as the DNA control. Although this is an artificial 
way to dissociate the DNA complexes, the use of polyanions may mimic the 
situation that the complexes encounter inside cells. The presence of 
negatively charged biopolymers, such as proteins, may act on the complexes 
to release the therapeutic DNA. Dissociation of the complexes and the 
release of DNA is a critical step in the transfection process (van de Wetering 
et aI., 1999) as only unbound and intact DNA can be transcribed into RNA. 
The results here show that dissociation of copolymer - DNA and the release 
of DNA can be achieved with the presence of anionic polymers. 
pAsp was also used to dissociate the DNA - complexes following their 
exposure to enzymatic activity so that any protected DNA can be released 
and evaluated. Following DNase I incubation and dissociation of complexes, 
the released DNA was allowed to interact with EtBr to give fluorescence. 
The percentage of DNA remaining in the complexes was expressed as a 
percentage of the fluorescence intensity of EtBr induced by untreated DNA 
controls. The gel electrophoresis study was able to provide an even clearer 
picture as the released DNA was separated according to the molecular weight 
so that any alteration in the structure of DNA could be seen. The results 
from the fluorescence study showed that only 20% of the fluorescence could 
be detected after naked DNA was incubated with DNase I. As for the O\IA 
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homopolymer - DNA complexes, over 80% of fluorescence could be 
detected. Similar results were observed for D ~ O M P C I O , , D M ~ o M P C 3 o , ,
DMA6oMPC3o and DNAIOOMPC3o. For the copolymers with relatively long 
MPC components, a reduced amount DNA was protected as the fluorescence 
level was considerably lower. This suggests that a long MPC chain had a 
negative effect on DNA protection efficiency. A previous study 
demonstrated that a high MPC content hindered the interaction between the 
cationic DMA and the negatively charged DNA as discussed in Chapter 3. 
As a result, loosely condensed structures were formed and the DNA could be 
more susceptible to enzymatic attack. 
In the gel electrophoresis study, it was demonstrated that the DMA 
homopolymer was able to protect the DNA structure and that this protection 
could be achieved at a monomeric unit: nucleotide ratio of as low as 0.25: 1. 
The level of protection appeared to increase with the ratio. However a small 
amount of low molecular weight DNA fragments still appeared on the gel, 
indicating that protection was not entirely complete. Amongst the DMA-
MPC copolymers studied here, it appeared that only D M ~ o M P C C IO and 
DMA lOOMPC30 could preserve the structure of DNA, though to a lesser extent 
compared to the homopolymers, judged by the intensity of fluorescent DNA 
bands. Other copolymers with a relatively high proportion of MPC failed to 
preserve DNA structure as only low molecular weight DNA fragments were 
observed. Although the fluorescence studies suggested that copolymers such 
as DMA4oMPC3o and D M ~ o M P C 5 o o could provide some degree of protection. 
none of them could successfully retain the original DNA structure. This is 
not desirable as the breakdown of DNA leads to the loss of therapeutic 
information of the gene, subsequently preventing gene expression (Adami el 
at., 1998). 
As mentioned before, the presence of MPC has an adverse effect on DNA 
condensation, resulting in the formation of loosely condensed structures in 
which the DNA was more susceptible to enzymatic attack. As shown in 
Chapter 4, the structures of DMA2oMPC3o and DMA.+ot\.IPC3o -- D1\A 
--- -- - --
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complexes (in liquid under AFM) are 'flower-like' with loops of DNA 
around the perimeter in the form of petals. These uncondensed regions are 
probably the sites where enzymatic attack of DNA is initiated (Abdelhady et 
al., 2003). The incomplete condensation of DNA by those copolymers may 
explain the unsuccessful DNA protection. 
The results from the fluorescence study indicated that the measurement of 
fluorescence intensity after DNA interaction with EtBr is not an ideal 
approach for studying the state of released DNA after DNase I incubation, as 
EtBr yields fluorescence with intact plasmid as well as small molecular 
weight DNA fragments. Gel electrophoresis on the other hands revealed the 
molecular weight of the released DNA, hence it gave a better indication of 
the level of DNA degradation. Nevertheless, the fluorescence study gave a 
good indication of how the compositions of the copolymers might affect their 
ability to protect DNA from degradation. 
In the model membranes interaction study, DNA alone was not able to induce 
any changes of fluorescence intensity of DPH labelled liposomes, indicating 
that there was no significant interaction between DNA and the phospholipid 
membranes. All the homopolymer polymer - DNA complexes investigated 
were able to induce a reduction in fluorescence level to various extents. 
Since the reduction of fluorescence intensity was greater than that caused by 
10% PBS control, the loss of fluorescence was not only due to dilution effect, 
but also the perturbation of the hydrophobic core of the model membranes. 
However, it is difficult to determine the nature of the interaction between the 
DNA complexes and the phospholipid bilayers with this technique. The 
change in fluorescence intensity of DPH only provides an estimation of the 
relative extent of interaction between the phospholipid bilayers and the DNA 
complexes, but is not able to distinguish the exact mechanism of interaction. 
Both electrostatic and hydrophobic interactions could be involved. To gain 
an insight into any membrane structure alteration caused by the complexes. 
such as the fluidity and the stability of the model membranes. the orientation 
and polarization of DPH probes could be measured (Nagy ef al.. 2003). 
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In general, all the DMA-MPC copolymer - DNA complexes investigated in 
this study appeared to be less membrane active compared to the DMA 
homopolymer - DNA complexes. This was particularly obvious when DNA 
complexes were prepared at high monomeric unit: nucleotide ratio (l 0: 1). It 
is possible that the hydrophilic MPC formed a steric barrier that effecthely 
reduced the interaction between phospholipid membranes and the DNA 
complexes. 
In the flow cytometry and transfection study, all the copolymer systems 
investigated had a significantly lower cellular association and transfection 
efficiency compared to the homopolymer system. When DNA complexes 
with DMA homopolymer at 2: 1 monomeric unit: nucleotide ratio, it is 
expected the complexes would have cationic character due the association of 
excess DMA homopolymer molecules with the complexes above the 1: 1 (as 
shown in gel retardation assay in chapter 3). Hence, their cellular association 
is most likely a consequence of the charge interaction with the cell surface. 
In contrast, all the DMA-MPC copolymer - DNA complexes showed poor 
cellular association with low transfection efficiency, which were comparable 
to that obtained with naked DNA. This is supported by the model 
membranes interaction study, as copolymer - DNA complexes were less able 
to displace or disturb the fluorescent probe DPH from the membrane model 
compared to the DMA homopolymer - DNA complexes. Among all the 
copolymer systems studied, DMA lOOMPC30 - DNA complexes had the 
highest cellular association and transfection ability. Again, this is consistent 
with the model membranes interaction study as DMA lOOMPC30 - DNA 
complexes demonstrated the greatest interaction with model membranes 
within all copolymers studied. This system also has the highest ability to 
protect DNA from enzymatic degradation. However. the cellular association 
and transfection efficiency were still only about 25% and 10% of those 
obtained for DMA homopolymer - DNA complexes. respectiyely. The 
results hence demonstrate that MPC-rich copolymers haye 10\\ non-specific 
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cellular association and transfection efficiency. This can be attributed to the 
steric barrier around the complexes, created by the hydrophilic MPC blocks. 
which prevents adhesion to the cellular surface, as suggested in the model 
membranes interaction study. Additionally, the MPC surface layer shields 
possible positive charges arising from the polycation groups, as suggested by 
the zeta potential study presented in chapter 4. 
The effect of the hydrophilic component on the transfection efficiency in 
vitro has been a matter of a debate. It is not clear how exactly the 
hydrophilic polymer, such as the frequently used PEG, affects the cellular 
association and transfection efficiency of the DNA complexes. It has been 
suggested that PEG is membrane active, thus increasing the cellular 
association and subsequently the transfection efficiency of PEG containing 
DNA complexes such as PLL-PEG (Toncheva et at., 1998) and PEl-PEG 
(Ahn et at., 2002). The authors suggested that PEG may act locally to 
dehydrate the membrane, thereby promoting entry of the complexes into the 
cells. In contrast, there is also evidence showing that PEO or PEG modified 
PEl or PLL - DNA complexes had much lower transfection efficiency 
compared to the unmodified controls (Choi et at., 1998, Nguyen et at., 2000). 
Nevertheless, it has also been pointed that the transfection efficiency of PEG 
containing systems might be dependent on cell lines and the molecular 
weight of PEG (Park et al., 2005), therefore the effect of hydrophilic PEG is 
not certain at this stage. For DMA based delivery systems, the incorporation 
of PEG polymer was shown to reduce cellular interaction and transfection 
efficiency (Zuidam et at., 2000, Rungsardthong et at., 2001), possibly due to 
the charge shielding effect or steric barrier around the complexes that inhibits 
interaction with the cells. It appears that the effect of MPC is very similar to 
PEG as both of these molecules are extremely hydrophilic. and the MPC and , 
PEG modified DMA - DNA complexes shared similar biological properties. 
The relatively poor cellular association and low transfection efficiency 
achieved using the DMA-MPC diblock copolymers is indeed essentially 
beneficial for the design of an effective gene deliyery system. prO\ided that 
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adequate DNA condensation is achieved. The ultimate goal of gene delivery 
is to deliver therapeutic DNA to specific target cells with minimal 
promiscuous non-specific cellular interaction and transfection. It is therefore 
important that the delivery vector does not disturb the balance of the cell 
membrane. Thus, provided that specific cells can be targeted by conjugation 
of an appropriate ligand, these DMA-MPC copolymers will be promising 
candidates as synthetic v e ~ t o r s s for gene therapy applications. In fact, a novel 
folate conjugated DMA-MPC copolymer system has been developed recently 
and the evaluation of this functionalised copolymer system is described in the 
following chapter. 
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5.5 CONCLUSIONS 
This chapter examined the biological properties ofDMA-MPC copolymer for 
gene delivery. With the addition of polyanions, DNA - complexes formed 
by the homopolymer and copolymer can be dissociated to release the DNA, 
which is an essential process for successful transfection. The enzymatic 
degradation study shows that the DMA homopolymer can effectively protect 
and preserve the DNA from DNase I activity. However, the presence of a 
high proportion of MPC in the copolymers reduced their ability to protect 
DNA from enzymatic degradation, probably due to the formation of less well 
condensed structures. In addition, high proportions of MPC also reduce 
cellular association and consequently the transfection efficiency. It is 
possible that the steric barrier formed by the hydrophilic MPC prevents the 
interaction between the DNA complexes and the phospholipid bilayer of the 
cell membrane, as suggested by the model membranes interaction study. The 
goal of gene delivery is to transfer the DNA into target cells only, with 
minimal interaction with non-specific cells. The low cellular association and 
transfection efficiency of the DMA-MPC copolymer system is in fact 
desirable in the design of such gene delivery systems as any non-specific 
interaction is minimized, whereas specific targeting could possibly be 
achieved by conjugation of appropriate ligands. 
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CHAPTER 6 
CELLULAR UPTAKE OF DMA HOMOPOLYMER - DNA 
COMPLEXES 
6.1 INTRODUCTION 
A number of different endocytic pathways have been identified in eukaryotic 
cells that may be involved in the cellular uptake of DNA complexes. The 
two main pathways that are believed to be involved in polycation delivery are 
the cIathrin coated pits mediated pathway and the caveolae mediated pathway 
(Zuidam et aI., 2000, Jones et aI., 2003). The subsequent intracellular routes 
and eventual fate of substances internalized by these two different pathways 
are very distinct. Therefore, the mode of internalisation of DNA complexes 
might affect the kinetics of their intracellular processing, and thus the 
transfection efficiency. In order to improve our understanding and to assist 
the rational design of a non-viral gene delivery system, it is essential to 
elucidate the mechanism of uptake of DNA - complexes. 
6.1.1 Endocytosis 
The plasma membrane is the interface between cells and their external 
environment. Uptake of nutrients and communication between cells and their 
environment occurs through this dynamic interface. Endocytosis is the 
process by which cells ingest extracellular materials by trapping them in 
invaginations of the plasma membrane, which then pinch off to form 
intracellular transport vesicles. A number of endocytic pathways are 
distinguished and they fall into two broad categories, namely phagocytosis 
(the uptake of large particles) and pinocytosis (the uptake of fluid and 
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solutes). The latter includes four distinct mechanisms, including clathrin-
mediated endocytosis, caveolae-mediated endocytosis, macropinocytosis. and 
clathrin- and caveolin-independent endocytosis. Each of these mechanisms 
are utilised by the cells to accomplish different tasks (Kirkham and Parton. 
2005). Certain cell treatments can inhibit cellular internalization via 
endocytosis, which is useful in determining the uptake pathways of different 
system. Commonly used cell treatments are summarised in table 6.1. 
It has been demonstrated that some polymeric gene delivery vectors are able 
to transfect cells. However, the uptake mechanisms that these systems 
employ to gain entry into the cells are not clearly understood. Two 
mechanisms are generally believed to be involved in the uptake of polymer 
based delivery system, the clathrin-mediated endocytosis and caveolae-
mediated endocytosis (Rejman et aI., 2005). Each of these mechanisms is 
described in more detail below. 
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Table 6.2 Effect of different cell treatments on cellular uptake mechanism. 
Treatment Effect Mechanism Reference Low General inhibitor of Energy depletion Lamaze and temperature endocytosis Schmid (1995) Potassium Specific inhibitor of Dissociation of Hansen et af. depletion clathrin-mediated cIathrin coats (1993) 
endocytosis 
Hypertonic Specific inhibitor of Dissociation of Hansen et af. 
medium (e.g. clathrin-mediated cIathrin coats (1993) 
sucrose) endocytosis 
Low pH Specific inhibitor of Dissociation of Hansen et af. 
treatment clathrin-mediated cIathrin coats (1993 ) 
endocytosis 
Chlorpromazine Specific inhibitor of Causes cIathrin to Wang et af. 
cIathrin-mediated localize and (1993) 
endocytosis accumulate in late 
endosomes 
Concanavalin A Specific inhibitor of Prevents coated pits Smith et af. 
cIathrin-mediated assembly (2001) 
endocytosis 
Brefeldin A Specific inhibitor of Interfere with the Brodsky et af. 
cIathrin-mediated assembly of cIathrin (2001) 
endocytosis coats 
Nystatin Specific inhibitor of Sequester cholesterol Lamaze and 
caveolae-mediated Schmid (1995) 
endocytosis 
Filipin Specific inhibitor of Cholesterol binding Schnitzer et al. 
caveolae-mediated (1994) 
endocytosis 
M e t h y l - ~ ~ Specific inhibitor of Deplete cholesterol Lamaze and 
cyclodextrin caveolae-mediated Schmid (1995) 
endocytosis 
Genestein Inhibitor of caveolae- Tyrosine kinase Orlandi and 
mediated endocytosis inhibitor Fishman (1999) 
Colchicine Inhibitor endocytosis Microtubule Margolis et af. 
depolymerisation (1980) 
Vinblastine Inhibitor of endocytosis Microtubule Wang and 
depolymerisation MacDonald 
(2004) 
Nicodazole Inhibitor of endocytosis Microtubule Wang and 
depolymerisation MacDonald 
(2004) 
Cytochalasin D Inhibitor of endocytosis Actin Parton et al. 
and macropinocytosis depolymerisation (1994 ) 
Latruncubin B Inhibitor of endocytosis Inhibits actin Spector et af. 
and macropinocytosis polymerisation and ( 1983) 
disrupts microfilament 
organisation 
Chloroquine Disruption of endosomes Prevents endosomes Wattiaux et af. 
and Iysosomes acidification and (2000) 
causes swelling to 
endosomes and 
Iysosomes i 
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6.1.2 Clathrin-mediated endocytosis 
Clathrin-mediated endocytosis is a process by which virtually all eukaryotic 
cells internalise nutrients, antigens, growth factors, pathogens and recycling 
receptors (Mellman, 1996, Hirst and Robinson, 1998, Lakadamyali et al.. 
2004). It usually occurs at specialized sites on the plasma membrane. The 
most prominent feature of clathrin-mediated endocytosis is the formation of 
coated pits, which cover 0.5 - 2% of the cell surface (Brown and Petersen, 
1999). The most abundant proteins found in coated pits are clathrin and 
adaptor protein 2 (AP-2). Internalization occurs either constitutively or in 
response to certain stimuli. The constitutive pathway is mainly involved in 
the uptake of receptors that undergo continuous internalization and recycling. 
It is also responsible for ligand-independent internalisation of signalling 
receptors (Parent et aI., 2001, Waterman and Yarden, 2001). The uptake of 
macromolecules and certain viruses, and the regulation of a number of 
proteins in the circulation rely on the constitutive pathway. The signal 
induced pathway is responsible for the control of signalling potency of the 
receptor by regulating events that occur at the level of internalisation, which 
in tum determine the post-endocytic fate, i.e. recycling or degradation of the 
receptor (Mousavi et aI., 2004). 
The process of clathrin-mediated endocytosis is summarized in figure 6.1. 
Three main stages are identified during the formation of clathrin coated 
vesicles: (1) Assembly of clathrin into a polygonal lattice and formation of 
coated pits, (2) invagination of coated pits, and (3) pinching-off the coated 
vesicles. During the process, clathrin is assembled on the cytoplasmic face of 
the plasma membrane by the recruitment of AP-2 to form a characteristic 
invagination or coated pits, which are typically 100-150 nm (Takei and 
Haucke, 2001, Mousavi et aI., 2004). Following the release of clathrin 
coated vesicles from the plasma membrane, the internalised molecules are 
delivered to early endosomes where clathrin is subsequently released. 
Molecules such as recycling receptors are rapidly recycled back to the plasma 
membrane for reutilization. The rest are transported to the increasingly 
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acidic milieu of the late endosomes and lysosomes for degradati on 
(Gruenberg 2001 ). 
There are number of ways to inhibit clathrin-mediated endocytosis. 
Approaches such as hypertonic challenge (using sucrose) , intracellul ar 
potassium depletion and low pH shock treatment have been traditionall y used 
to disrupt clathrin-mediated endocytosis by dissociation of clathrin coats 
from the plasma membrane (Hansen et aI. , 1993, Brodsky ef al .. 200 1). 
Chemical agents such as concanavalin A (conA), chlorpromazine and 
brefeldin A (BFA) are also frequentl y employed as alternati ves to inhibit 
clathrin-mediated endocytosis (Wang et aI. , 1993 , Brodsky e/ aI. , 200 1, 
Smith et aI. , 2001). 
clathrin coated pit 
( ) invagination coat assembly 100-150 n ~ m r r __ " ' 7 j ; ; o " " ' l ~ ~_________ ~ ~
~ - ~ ~ "U ---1 ( O ~ ~ ----"".--- "i ,_/ '_,.,,1 ~ ~
- O - ~ ~ clathrin-coated vesicle I \ I J 
' J- / \ 
uncoating L( -\; 
....... f J <:) endosome 
\ 
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c:> 
Figure 6.1 Schematic diagram of c1athrin-mediated endocytosis. Clath rin is first 
assembled at the intracellular surface of the plasma membrane. Clathrin coated pit 
is formed and the invagination of the coated pi t occurs. The deeply in vagin ated 
coated pits pinch off from the plasma membrane to fo rm clathrin coated ve icle . 
The ves icle loses its clathrin coat and progress to endosornes whi ch are ac idified . 
The end osomes are then transpor1ed to Iysosomes \\"h ere the intern ali sed material i-
degraded . 
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6.1.3 Caveolae-mediated endocytosis 
Caveolae are flask-shaped, cholesterol and sphinogolipid rich invaginations 
of the plasma membrane on the surface of endothelial cells. They belong to a 
sub domain of the biochemically defined glycolipid raft (Anderson, 1998, 
Nabi and Le, 2003). Not all cell types have caveolae. Caveolae are smaller 
than clathrin coated vesicles, with a diameter of 50-100 nm. Up to 30% of 
the cell surface can be occupied by caveolae (Parton and Richards, 2003). 
The most characterized protein component of caveolae is the caveolin-l 
(Rothberg et al., 1992), which are widely used as markers for caveolae. 
Caveolin-l is essential for the formation and stability of caveolae. Caveolae 
cannot be detected in cells that lack caveolin-l. However, introduction of 
caveolin-l to these cells induces the formation of caveolae at the plasma 
membrane (Fra et al., 1995). A number of substances are known to 
internalise into the cells through this pathway, including membrane 
components (e.g. glycosphinogolipids and glycosylphosphatidylinositol-
anchored proteins), extracellular ligands (e.g. folic acid), bacterial toxin (e.g. 
cholera toxin), and non-enveloped viruses (e.g. simian virus 40) (Rothberg et 
al., 1990, Parton et al., 1994, Anderson et al., 1996, Nichols et al., 2001, 
Duncan et al., 2002). 
The process of caveolae-mediated endocytosis is summarized in figure 6.2. 
In contrast to clathrin-mediated endocytosis, internalization via caveolae is 
not a constitutive process and only occurs upon cell stimulation (Thomsen et 
al., 2002, Pelkmans and Helenius 2003). In addition, internalisation via 
caveolae occurs at a much slower rate compared to the clathrin-mediated 
pathway (Tran et al., 1987, Anderson et al., 1996, Pelkmans and Helenius 
2003). It is also a more tightly regulated process. One interesting aspect of 
caveolae-mediated endocytosis is that the internalized caveolae bypass the 
acidic endosomes and lysosomes. Instead, they are transported to a specific 
endosomal compartment with neutral internal pH, which is often referred as 
caveosomes (Pelkmans et al., 2001). The internalised material could reside. 
be sorted to the Golgi complex or to the endoplasmic reticulum. For this 
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reason, the caveolar internalisation pathway has potential advantages for 
targeted drug or gene delivery (Bathori et aI., 2004). 
Several drugs have been reported to selectively inhibit caveolae-mediated 
endocytosis. Cholesterol is a very important component of caveolae and is 
required to maintain the structural integrity of these vesicles. Caveolae 
disappear in cells that are depleted of cholesterol. Therefore, the most 
effective way to disrupt caveolar function is to use sterol-binding drugs 
which remove cholesterol from the plasma membrane and cause disassembly 
of caveolae. Such drugs include m e t h y l - ~ - c y c l o d e x t r i n , , filipin and nystatin 
(Rothberg et aI., 1992, Schnitzer et aI., 1994, Orlandi and Fishman, 1998), 
none of which typically affect clathrin-mediated endocytosis. These drugs 
have been frequently used in the study of uptake of simian virus (SV 40), 
which is well known to be internalised through caveolae dependent pathway 
(Anderson et aI., 1996, Sieczkarski and Whittaker, 2002, Pelkmans and 
Helenius, 2003). 
caveolae (50-100 ~ n ~ m : : . . ) ) _ ~ i _ n V " j a r " g , i n _ a _ t i o _ n n_________ __ 
------<S ~ ~ 0 ----~ ~
o caveolar vesicle 
\ 
C ::, caveosome 
golgi ER 
e 5 ~ ~
Figure 6.2 Schematic diagram of caveolae-mediated endocytosis. Caveolae 
appear as flask-shaped vesicles at plasma membrane, which subsequently invaginate 
and bud into the cytoplasm. The internalised caveolar vesicles fuse to form 
caveosomes which have neutral pH. Without being transported into the Iysosomes. 
the internalised materials are sorted to golgi complex or endoplasmic reticulum. 
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6.1.4 Involvement of microtubules and actin filaments in endocytosis 
Both microtubules and actin filaments are known to be involved in the 
endocytosis process (Cole and Lippincott-Schwartz et aI., 1995, Qualmann et 
aI., 2000, Murray and Wolkoff, 2003). However, they are involved in 
different stages of the process. Microtubules, a component of the 
cytoskeleton, consist of tubulin and several associated proteins. The protein 
filaments stretch across cells and provide a mechanical basis for chromosome 
sorting, cell polarity and organelle localization among other functions. The 
transport of endocytic contents from early to the late endosomes is dependent 
on microtubules which also promote fusion and fission of endocytic vesicles 
(Aniento et aI., 1993, Elkjaer et aI., 1995, Harada et aI., 1995). Colchicine, 
vinblastine and nocodazole are well known microtubules depolymerising 
agents that bind specifically to tubulin and inhibit its polymerization 
(Margolis et aI., 1980, Wang and MacDonald 2004). 
Filamentous actin is also a major component of cytoskeleton. However, its 
involvement in endocytosis is less well defined. It is believed that the actin 
filaments are important for events that take place during the invagination of 
the vesicles, but not the trafficking of vesicles within the cells (Salas et aI., 
1986, Lamaze et aI., 1997, Zegers et aI., 1998, Mundy et aI., 2002). 
Commonly used actin filament disrupting drugs include cytochalasin D and 
latrunculin B (Spector et aI., 1983, Cooper, 1987, Coue et aI., 1987, Sampath 
and Pollard, 1991, Morton et aI., 2000). Cytochalasin D is a fungal alkaloid 
that binds to the positive end of the actin filaments and prevents elongation. 
Latrunculin B is a marine toxin which inhibits actin polymerization and 
disrupts microfilament organization as well as microfilament-mediated 
processes. Both agents are frequently used to investigate the internalization 
pathway of bacteria (Murai et aI., 1993, Wells et aI., 1998, van de Walle et 
aI., 2001, Biswas et aI., 2003), but are less commonly used in the study of 
gene delivery system. 
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6.1.5 Aims 
The purpose of this work was to establish the mechanism of internalisation 
and intracellular trafficking of DNA complexes formed with DMA 
homopolymer, which has been previously demonstrated to be able to 
transfect several different cell lines (Desphande et al., 2004). The luciferase 
assay was performed on A549 cells at different time point post transfection in 
order to create a time profile of gene expression of the DMA homopolymer -
DNA complexes as a control. Various endocytic inhibitors with effects on 
different routes and stages of endocytosis were also employed in the 
transfection study in order to examine the mechanism of cellular uptake of 
the DNA complexes. In addition, a confocal microscopy study was 
performed to assist the understanding of the route of uptake as well as 
intracellular trafficking of the DNA complexes. 
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6.2 MATERIALS AND METHODS 
6.2.1 Materials 
Materials used were as described in Chapter 2, Section 2.1 unless otherwise 
specified below. 
OptiMEM-I was purchased from Gibco, UK. Lipofectamine TM was 
purchased from Invitrogen, USA. Luciferase assay system was purchased 
from Promega, USA. YOYO-1 iodide and CellTracker Orange were 
purchased from Molecular Probes, Oregon, USA. 
6.2.2 Cell lines and subculture 
A549 cells (human lung carcinoma) were used. They were cultured and 
maintained as described in Chapter 2, section 2.2.2. 
6.2.3 Transfection study at different time point 
A transfection study was carried out as described in Chapter 5, section 5.2.5 
with minor modifications. After the cells were incubated with DNA 
complexes for 4 h, the complexes were removed, replaced with RMPI-1640 
medium and incubated at 37°C and 5% C02. The cells were analysed at 4, 8, 
12, 24, 36, 48 and 72 h post transfection. The detection of luciferase and 
determination of cellular proteins were carried out as described in Chapter 5. 
sections 5.2.6.1 and 5.2.6.2 respectively. 
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6.2.4 Transfection with inhibitors 
The transfection study was carried out as described in Chapter 5, section 
5.2.6 with minor modifications. Prior to the transfection study, six well 
plates were seeded with 1 x 105 cells per well and the cells were incubated at 
37°C and 5% CO2 for 24 h. The cells were pre-treated with colchicine (1-25 
J.lg/ml), cytochalasin D (1-25 J.lg/ml), chlorpromazine (1-25 J.lg/ml), conA (1-
250 J.lg/ml), nystatin (1-25 J.lg/ml) or filipin (1-10 J.lg/ml) for 1 h at 37°C. 
Subsequently the cells were washed and incubated with polymer - DNA 
complexes (4 J.lg DNA / well) at 37°C and 5% C02 for 4 h (with or without 
inhibitors). Following incubation, the complexes were removed and replaced 
with serum supplemented RPMI-1640 medium (with or without inhibitors). 
The cells were incubated with 5% CO2 at 37°C for the required time before 
analysis. The detection of luciferase and determination of cellular proteins 
were carried out as described in Chapter 5, section 5.2.6.1 and 5.2.6.2 
respectively. 
6.2.5 Confocal microscopy study 
In the intracellular trafficking study, 1 x 105 A549 cells were seeded on a 
Mattek dish (Mattek Corp. Ashland MA, USA). The cells were incubated at 
37°C and 5% C02 for 24 h. After 24 h, the medium was removed and 
replaced with DMA homopolymer - DNA complexes. The complexes were 
prepared at 2: 1 monomeric unit: nucleotide ratio in OptiMEM-I and the 
plasmid DNA was labelled with YOYO-l iodide (1 molecule of the dye per 
300 base pairs of the nucleotide) according to the manufacturer's protocol. 
The excitation and emission wavelengths for YOYO-l are 491 and 509 nm. 
respectively. The cells were incubated at 37°C and 50/0 C02 in a heated 
Perspex box throughout the experiment. Confocal imaging was performed 
on the same sample at 5, 30, 60, 90 and 150 min after the addition of DNA 
complexes. 
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F or other confocal studies, A549 cells were seeded and incubated in the 
Mattek dish as described above. After 24 h of incubation, the medium was 
removed from the cells and the cytoplasm of the cells were labelled with 
CellTracker Orange according to the manufacturer's protocol. The excitation 
and emission wavelengths for CellTracker Orange probe are 541 and 565 nm 
respectively. The cells were then treated with inhibitors if needed for 1 h. 
The cells were then washed with PBS before the addition of DMA 
homopolymer - DNA complexes (with the presence of inhibitors if needed). 
The complexes were prepared at 2: 1 monomeric unit: nucleotide ratio in 
OptiMEM-I and the plasmid DNA was labelled with YOYO-l iodide. DNA 
complexes were incubated with the cells at 37°C and 5% CO2 in the 
incubator for 240 min. Confocal imaging was then performed. The cells 
were incubated at 37°C and 5% CO2 in a heated Perspex box during imaging. 
Confocal laser scannmg mIcroscopy (Zeiss Axiovert 100 with a Zeiss 
LSM51 Ouv META Combi confocal system, Germany) was used for optical 
sectioning of cells to visualize the cellular uptake and intracellular trafficking 
of DNA complexes. 63X Zeiss Plan Apochromat objective lens was used. 
An argon laser at 488 nm with a BP505-530 filter and a helium-neon laser at 
543 nm with a LP560 filter were used to induce fluorescence of YOYO-I 
probe and CellTracker Orange probe respectively. Image analysis was 
performed on all the images to determine their relative position from the cell 
surface using Zeiss LSM Image Browser Version 3.5.0.376 (Carl Zeiss 
GmbH, lena, 1997-2005). 
173 
Chapter 6: Uptake mechanism 
6.3 RESULTS 
6.3.1 Transfection study at different time points 
The first part of the study was to investigate the expression of the reporter 
gene luciferase at various times post-transfection. DMA homopolymer -
DNA complexes (2: 1 monomeric unit: nucleotide ratio) were incubated wi th 
A549 cells and the luciferase assay was carried out at various time, starti ng 
from 4 to 72 hours post-transfection. The results are shown in fi gure 6.3. It 
was found that expression of the luciferase plasmid was observed as earl y as 
4 h post-transfection, and the level of gene expression increased considerably 
over time, with the peak level of transfection efficiency seen at 16 hours post-
transfection. The transfection efficiency remained steady at the maximum 
level for next 20 hours. From 48 hours post-transfection and onwards, the 
transfection efficiency was reduced gradually . 
-+- Lipofectamine - DMA 
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Time (hours post transfection) 
Figure 6.3 Transfection efficiency of DMA homopolymer - DNA complexes on 
A549 cells measured at different time post-transfection. 0 A compl exes \\ ere 
prepared at 2: I monomeri c uni t: nucleotide rat io. The luciferase assay \\ as carri ed 
at 4, 8. 12. 24. 36, 48 and 72 h post-transfection. LipofectamineTI\\ \\ as u ed as 
contro l (n=3). 
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6.3.2. Transfection with tubulin / actin inhibitors 
In order to investigate the contribution of microtubules and actin filaments to 
the transport of DMA homopolymer - DNA complexes, the effects of two 
different inhibitors, colchicine, a microtubule inhibitor (Margolis et at., 1980), 
and cytochalasin D, a microfilament inhibitor (Cooper, 1987, Sampath and 
Pollard, 1991), on transfection efficiency in A549 cells were examined by 
luciferase assay. 
When the cells were pre-treated with colchicine (figure 6.4), the transfection 
efficiency was significantly inhibited by almost 80% relative to the untreated 
control at 16 hours post-transfection for all concentrations. At 24 hours post-
transfection, the gene expression was restored and there was no significant 
difference in transfection efficiency compared to the control (p>0.05). As the 
time increased, the transfection efficiency continued to increase. At 36 hours 
post-transfection, the inhibitor caused a 10-fold increase in transfection and 
at 48 hours post-transfection, the gene expression was enhanced dramatically 
by 20- to 40-fold in a dose dependent manner. A similar pattern was 
observed in both situations when the cells were pre-treated and incubated 
with colchicine throughout the experiment (figure 6.6). A much higher 
transfection level was observed at 48 hours pos-transfection, with 40- to 50-
fold increase observed in a dose dependent manner. Recovery protein level 
of the cells was used as an indicator of the health status of colchicine treated 
cells. The protein level of the cells decreased gradually as the time of 
exposure and the concentration of inhibitor increased (figure 6.5 and 6.7). 
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Figure 6.4 Transfection efficiency of DMA homopolymer - DNA complexes on 
colchicine pre-treated A549 cells. The complexes were prepared at 2: 1 monomeric 
unit: nucleotide ratio . The transfection activ ities were measured at d ifferent time 
post-transfection and the results were expressed as fold difference compared to 
control (without inhibitor) which is equal to 1 at all time (n=3). 
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Figure 6.5 Protein level of colchicine pre-treated A549 cells in the luciferase 
assay . T he ce ll s were incubated w ith co lchi c ine at vari ous concentrati ons 1 h prio r 
to complexes addition. The prote in leve l was determined usin g Bradfo rd assay. The 
results were expressed as % co mpare to th e contro l (without inhibito r) (n=3). 
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Figure 6.6 Transfection efficiency of DMA homopolymer - DNA complexes on 
colchicine pre-treated A549 cells, with colchicine present during the experiment. 
The complexes were prepared at 2: 1 monomeric unit: nucleotide ratio . Transfection 
activities were measured at different time post-transfection . The results were 
expressed as fold-difference compare to control (without inhibitor) whi ch is equal to 
1 at all time (n=3). 
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Figure 6.7 Protein level of colchicine treated A549 cells in the luciferase assay . 
The ce ll s were incubated with co lchicine at va ri ous concentrations 1 h pr ior to 
complexes addition and during the exper iment . The protein leve l was determ ined 
using Bradford assay. The results were expressed as % compare to the control 
(without inhibitor) (n=3). 
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Cytochalasin D was incubated with the cells one hour prior to the addition of 
the DNA complexes and was then removed. It was clearly shown that the 
transfection efficiency of DMA homopolymer - DNA complexes was 
effectively inhibited by cytochalasin D (figure 6.8). At 24 hours post-
transfection, the transfection efficiency was decreased significantly compared 
to the untreated control (p<O.05) in a dose dependent manner. At 48 hours 
post-transfection, the level of gene expression was inhibited to approximately 
35% of the control. However, there was no significant difference of 
transfection efficiency between different concentrations of the inhibitor 
(p>O.05). Again, the recovery protein level of the cells was used as an 
indicator of the health status of cytochalasin D treated cells. It was found 
that the protein level reduced with increasing concentration of inhibitor 
(figure 6.9). 
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Figure 6.8 Transfection efficiency of DMA homopolymer - DNA complexes on 
cytochalasin D pre-treated A549 cells. The complexes were prepared at 2: 1 
monomeric unit: nucleotide ratio. The transfection activities were measured at 
different time post transfection and the results were expressed as percentage 
compare to the control (without inhibitor) (n=3). 
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Figure 6.9 Protein level of cytochalasin D pre-treated A549 cells in the 
luciferase assay . The ce ll s were incubated with cytochal as in 0 at va ri ou 
concentrations I h prior to complexes addition. The protein leve l was determined 
lI sin g Bradford assay and th e results were expressed as % compared to the control 
(\ ithout inhibitor) (11 =3). 
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6.3.3 Transfection with clathrin / caveolae inhibitors 
In order to explore the role of the two types of cellular uptake mechanism 
(clathrin-mediated and caveolae-mediated endocytosis) in transfection, both 
mechanisms were investigated using respective inhibitors. ConA and 
chlorpromazine are inhibitors of clathrin-mediated endocytosis (Smith et al., 
2001, Brodsky et al., 2001), whereas filipin and nystatin are inhibitors of 
caveolae-mediated endocytosis (Rothberg, et al., 1992, Orlandi and Fishman, 
1998). Transfection experiments were carried out on A549 cells. When the 
cells were treated with conA or chlorpromazine, the transfection efficiency 
was markedly reduced with increasing concentration of the inhibitors (figure 
6.10 and 6.11). The transfection efficiency was reduced to approximately 
20% and 30% of the untreated control when 250 ~ g / m l l of conA and 25 ~ g / m l l
of chlorpromazine were used respectively. When the cells were treated with 
filipin or nystatin, the transfection of the cells were also inhibited, but to a 
lesser extent when compared to those treated with conA or chlorpromazine 
(figure 6.12 and 6.13). The transfection efficiency was decreased to 
approximately 40% of the untreated control when 1 0 ~ g / m l l of filipin or 25 
~ g / m l l of nystatin was incubated with the A549 cells. 
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Figure 6.10 Transfection efficiency of DMA homopolymer - DNA complexes on 
conA pre-treated A549 cells, with conA present during the entire experiment. 
The complexes were prepared at 2: 1 monomeric unit: nuc leotide rat io. The 
transfect ion acti v ities were measured 24 h post transfection and the resul ts were 
expressed as percentage compare to the contro l (without inhibitor) (n=3). 
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Figure 6.11 Transfection effi ciency of DMA homopolymer - DNA complexes on 
chlorpromazine pre-treated A549 cells, with chlorpromazine present d uring the 
experiment. The comp lexes were prepared at 2: 1 monomeri c unit: nuc leotide rati o. 
T he transfectio n acti v iti es \-ve re measured 24 h post transfec ti on and th e res ults were 
expressed as percentage compare to contro l (with out inhibitor) (11 =3). 
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Figure 6.12 Transfection efficiency of DMA homopolymer - DNA complexes on 
filipin pre-treated A549 cells, with filipin present during the experiment. T he 
complexes were prepared at 2: 1 monomeric unit: nucleotide ratio. The transfection 
activities were measured 24 h post transfection and the results were expressed as 
percentage compare to control (without inhibitor) (n=3) . 
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Figure 6.13 Transfection efficiency of DMA homopolymer - DNA complexes on 
nys tatin pre-treated A549 cells, with nystatin present during the experiment. 
The complexes were prepared at 2: 1 monomeric unit: nuc leotide rati o . The 
transfecti on acti v ities were measured 24 h post transfecti on and the res ult were 
expressed as percentage compare to control (with o ut inhibitor) (n=3). 
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6.3.4 Confocal microscopy study 
In the first part of this study, the confocal microscopy was used to investigate 
the intracellular trafficking of DMA homopolymer - DNA complexes in 
A549 cells over a period of time. The confocal images were captured on the 
same living cells at T=5, 30, 60, 90 and 150 min. All the images were taken 
at the same xy position and same z height throughout the experiment. The 
confocal images are shown in figure 6.14. At t=5 min, a speck of dim 
fluorescence was observed at the periphery of the cell. As the time 
progressed, the fluorescence appeared to move towards the centre of the cells. 
In addition, more fluorescent spots could be detected inside the cell. At 
t=150 min, several fluorescent spots were observed surrounding the nucleus 
of the cell. The fluorescence was not uniform throughout the cell, but rather 
present at distinct points inside the cell. 
These first set of confocal images demonstrated the movement of DNA 
complexes into the cell over time. In order to confirm whether the DNA 
complexes were indeed located inside of the cells, the cytoplasm of the cells 
were fluorescently labelled in the second study. Since the DNA was also 
fluorescently labelled, one is able to tell whether the DNA complexes were 
taken up into the interior of the cells by comparing the relative position of the 
fluorescently labelled DNA to the cytoplasm of the cell through analysing the 
image in xz and yz planes. In this set of experiments, the A549 cells were 
labelled with the CellTracker Orange (red) and the plasmid DNA was 
labelled with YOYO-l iodide (green). The cells were imaged 240 min after 
the addition of DNA complexes. The trans-section confocal image is shown 
in figure 6.15. Figure a and b show the same cells with the fluorescence 
located at different position in the cell (as indicated by the arrow). The 
images clearly show that the DNA complexes were situated inside the celL as 
revealed by the analysis of the image in the xz (right panel) and yz (top panel) 
planes. 
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Figure 6.14 Confocal images showing intracellular trafficking of DMA 
homopolymer - DNA complexes on A549 cells at various time intervals. DNA 
complexes were prepared at 2: I monomeric unit: nucleotide ratio. Plasmid DNA 
was labe ll ed with YOYO-l fluorescence probe (green) . The arrows indicate the 
position of DNA complexes in the cell. All the images were taken at the same ~ ~
height . The ce ll s were kept at 37°C with 5% C C ~ ~ throughout the entire experiment. 
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Figure 6.15 Trans-sectional confocal images of A549 cells at 240 min following 
the addition of DMA homopolymer - DNA complexes . D A complexes \\'ere 
prepared at 2:1 monomeric unit : nucleot ide ratio . Plasmid DNA \\'as labe ll ed \\ith 
YOYO-l fluorescent probe (green) and the cel l \\"as labelled \\ ith Ce ll Trad.e r 
Orange (red). The arrows indicate the position of D A complexes. 
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In order to explore the routes of cellular uptake of the DNA complexes in 
A549 cells, conA and nystatin were employed to inhibit clathrin-mediated 
endocytosis and caveolae-mediated endocytosis respectively in the confocal 
study. The cells were incubated with the inhibitors one hour before the 
addition of DNA complexes and throughout the entire experiments. The 
confocal images were taken 240 min after the complexes were added to the 
cells. 
When the cells were treated with conA (figure 6.16 and 6.17), the DNA 
complexes were found to be located outside the cells. In figure a, the image 
was captured at a z height which was at the top surface of the cells. Green 
fluorescence (YOYO-I labelled DNA) was seen to be located at the surface 
of the cells. When the image was captured at a different z height which was 
across the mid section of the same cells (figure b), green fluorescence could 
not be observed, suggesting the DNA complexes did not enter into the cells. 
Figure c shows the tran-sectional view of the cells. It was clearly 
demonstrated that the green fluorescence (indicated by the arrows) was 
located at the outer surface of the cells, as shown by the analysis of the image 
in the xz (right panel) and yz (top panel) planes. When the cells were treated 
with nystatin, the green fluorescence (indicated by arrows) could be seen 
inside of the cells as illustrated in the xz (right panel) and yz (top panel) 
planes in figure 6.18. 
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Figure 6.16 Confocal images of conA treated A549 cells at 240 min foll owin g 
the addition of DMA homopolymer - DNA complexes (1). DNA complexes were 
prepared at 2: 1 monomeric unit: nuc leotide ratio . The ce ll s with incubated with 
conA (250 /-lg/ml) one hour pri or the additi on of DNA comp lexes and durin g the 
experiment. Plasmid DNA was labe lled w ith YOYO-I fluorescent probe (green) 
and the ce ll was labe lled w ith Ce ll Tracker Orange (red). The arro\\ indi cates the 
pos iti on of DN A compl exes . (a) Image captured at the surface of th e ce ll. (b) im age 
captured at th e centre of the ce ll and (c) Trans-sec ti onal \i e\\ of the ce ll . 
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Figure 6.17 Confocal images of conA treated A549 cells at 240 min following 
the addition ofDMA homopolymer - DNA complexes (2) . DN A complexes were 
prepared at 2: 1 monomeric unit: nucleotide ratio. The ce ll s with incubated with 
conA (250 Ilg/ml ) one hour prior the addition of DNA complexes and during the 
experiment. Plasmid DNA was labelled with YOYO-I fluorescent probe (green) 
and the ce ll was labe lled with Cel lTracker Orange (red). The arro\\" indicates the 
positi on of DNA comp lexes. (a) Image captured at the surface of the ce ll. (b) image 
ca ptured at th e centre of the ce ll and (c) Trans-sect iona l vie\\" of the ce ll. 
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Figure 6.18 Trans-sectional confocal images of nystatin treated A549 cells at 
240 min following the addition of DMA homopolymer - DNA complexes. D A 
complexes were prepared at 2: I monomeric unit: nucleotide ratio. The ce ll s were 
incubated with nystatin ( 10 Ilg/ml) one hour prior to the additi on of D A complexes 
and during the experiment. Plasmid DNA was labelled \\'ith YOYO- I flu orescent 
probe (green) and the ce ll was labell ed with Ce ll Tracker Orange (red). The alTO \\ s 
indicate the pos ition of DN A complexes . 
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6.4 DISCUSSION 
To investigate the cellular uptake pathway of DMA homopolymer - DNA 
complexes, inhibitors were used in cell culture to evaluate their effects on the 
uptake and the level of gene expression. The profile of time course effect on 
transfection efficiency of the DNA complexes was performed as a control. It 
was noticed that in the absence of inhibitors, the expression of the luciferase 
reporter gene was detected within a few hours after the addition of the DNA 
complexes to the cells, and a peak level of transfection was observed after 16 
to 36 hours. Between the cellular uptake of the DNA and the synthesis of 
protein, the DNA has to travel from the site of intemalisation at the cell 
membrane, into the nucleus where the transcription takes place. Indeed, the 
intracellular trafficking of the DNA complexes is recognised as one of the 
major barriers to efficient gene delivery. However, the mechanism by which 
the DMA homopolymer - DNA complexes are taken up into the cells are not 
clearly understood. 
The importance of microtubules and actin filaments in the uptake of DMA 
homopolymer - DNA complexes was investigated. These two types of 
protein filaments are involved in the different stages of endocytosis. The 
former is important in transport of vesicles within the cells whereas the latter 
is believed to be involved in the formation and invagination of vesicles 
(Harada et aI., 1995, Mundy et al., 2002, Murray and Wolkoff, 2003). It has 
recently been reported that microtubule inhibitor such as nocodazole and 
colchicine enhanced the expression of genes using cationic lipid or liposome 
based gene delivery system (Hasegawa et al., 2001, Lindberg et aI., 2001, 
Nair et aI., 2002, Wang and MacDonald, 2004). In their studies, the 
magnitude of enhancement varied from 2- to 30-fold compared to the 
untreated control, depending on the cell types, the choice and the 
concentration of inhibitors. The gene expression assay was carried out 24 
hours post-transfection in the majority of these studies. Since the 
microtubule is the major contributor to the trafficking in the endosomal / 
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lysosomal pathway, it was logical to expect that these inhibitors might block 
the transfer of DNA from the endosomes to the lysosomes, thus preventing 
degradation of DNA, resulting in an increase of transfection efficiency 
(Chowdhury et ai., 1996). 
Our results showed that the transfection efficiency of DMA homopolymer -
DNA complexes was inhibited by the microtubule inhibitor, colchicine, to 
approximately 20% when the luciferase assay was carried out 16 hours post-
transfection. However, the level of gene expression increased as the time 
increased. A dramatic increase in transfection efficiency compared to the 
untreated control was observed from 36 hours and onwards. Interestingly, 
van der Aa et ai. have demonstrated that when cells were treated with another 
microtubule inhibitor, nocodazole, gene expression of DMA homopolymer -
DNA complexes was reduced to 20% after 24 hours post transfection. 
However, other time points were not investigated in their study (van der Aa 
et ai., 2005). 
Based on the results of our studies, it appears that the course of time was an 
important factor in determining the level of gene expression. This time 
course effect has not been reported in the literature before. One of the 
possible explanations of our results is that, initially, the intracellular transport 
of the internalised vesicles containing the DNA complexes was impeded due 
to the destruction of microtubules by the colchicine. This could possibly lead 
to the accumulation of vesicles at the periphery of the cells, which slowly 
diffused towards the nucleus of the cells. The DNA complexes might 
therefore require a longer time to travel into the nucleus, resulting in a delay 
of the transcription and hence the translation process. Thus, a reduction of 
transfection level was observed at early stage. Since the internalised DNA 
complexes were not transported to the endosomes / lysosomes for destruction, 
the transfection efficiency was significantly improved at a later stage. 
Techniques such as fluorescence microscopic study at real time will be 
helpful to explore this hypothesis. 
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Another possible hypothesis is that the time course effect of colchicine may 
affect the intracellular transport of the DNA complexes. Colchicine is a 
reversible microtubule inhibitor. It has been reported that when colchicine 
was injected into rats, disruption of microtubular structures was noticed in the 
hepatocytes within an hour, with maximum disruption was observed after 
two hours. The microtubular network were partially regenerated at 24 hours 
and fully regenerated after 48 hours of administration (Chowdhury et at., 
1996). 
In our case, it is possible that the disruption of microtubules in the early stage 
impaired the movement of DNA complexes within the cells, resulting in an 
inhibition of transfection efficiency initially. As time progressed, the 
microtubules started to regenerate, assisting the movement of the DNA 
complexes towards the nucleus, restoring the transfection efficiency. 
However, as the recovery of the microtubules was not fully complete, some 
of the vesicles failed to be transported along the endosomes / lysosomes 
pathway for degradation, resulting in an increase in the level of gene 
expreSSIOn. 
It must be noted that for both hypotheses, an assumption has been made in 
the very first place that the escape from endosomes / lysosomes was a 
limiting factor for the efficient delivery of DMA homopolymer - DNA 
complexes. In fact this is an important barrier to most non-viral gene 
delivery systems (Lechardeur et at., 2005). Although some polymeric 
delivery systems such as PEl (Boussif et at., 1996) and polyamidoamine 
(Tang et at., 1996) have the ability to escape from the acidic endosomes 
(proton sponge property), recent study has indicated that DMA homopolymer 
does not possess this desirable property (Jones et at., 2004) (further 
discussion later in this section). 
Whether the cells were only pre-treated with colchicine or incubated with it 
throughout the experiment, there was no significant difference in the terms of 
the trend of transfection level over time. although the enhancement of gene 
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expression appeared to be augmented. In fact, it has been suggested that 
multi-drug resistance (MDR) could be developed over time when the cells 
were treated with a variety of hydrophobic drugs, including colchicine (Ford 
and Hait, 1990). This may be developed as a result of overexpression of 
membrane P- glycoprotein (PGP), which acts as a defence mechanism 
against potentially harmful substances by exporting these substances from the 
cell (Ford and Hait, 1990, Nair et aI., 2002). It has been demonstrated that 
treatment of cells with colchicine together with glucocorticoid, which is a 
known substrate for PGP (Rao et aI., 1994), resulted in efficient blockage of 
colchicine efflux, and the gene expression of liposomes - DNA was further 
enhanced compared to treatment with colchicine alone. This could explain 
why prolonged incubation of the cells with colchicine might not have further 
effects on the structure of microtubule, but might continue to contribute to 
the toxicity towards the cells. 
The studies conducted up to this point confirmed that microtubules play a 
role in the uptake of DMA homopolymer - DNA complexes. The effect of 
actin filaments on the uptake of the DNA complexes was also explored. 
With the treatment of a microfilament depolymerising agent, cytochalasin D, 
transfection efficiency of DMA homopolymer - DNA complexes was 
effectively inhibited, indicating the involvement of actin filaments in the 
uptake of the DNA complexes. Since actin filaments are known to be 
involved in endocytosis, the results confirmed that the DNA complexes were 
taken up into the cells through endocytotic process. This agrees with an 
earlier study by another group, who showed that DMA homopolymer - DNA 
complexes entered cells through endocytosis as the uptake process was 
inhibited at 4°C (Zuidam et aI., 2000). However, since both clathrin -
dependent and clathrin - independent endocytosis are both inhibited by 
cytochalasin D in different cell types (Gottlieb et aI., 1993, Jackman et aI., 
1994, Durrbach et al.. 1996), more specific inhibitors are hence required to 
differentiate between the two pathways. 
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Inhibitors of clathrin-mediated endocytosis and caveolae-mediated 
endocytosis were used to examine the relative importance of clathrin coated 
pits and caveolae in mediating the uptake of the DNA complexes on A549 
cells. From the transfection data, it was found that conA, a well-
characterised clathrin-mediated endocytosis inhibitor, significantly inhibited 
transfection efficiency by almost 80%. ConA binds to cell surface 
glycoproteins and impairs their mobility within the membrane bilayer, 
thereby blocking the movement of proteins into coated pits and coated pits 
assembly (Smith et aI., 2001). Chlorpromazine is another frequently used 
inhibitor of clathrin-mediated endocytosis. It causes coated pits to disappear 
from the cell surface and reappear on endosomal membranes, probably due to 
the reverse of an on/off switch that controls AP-2 binding to membrane 
(Brodsky et al., 2001). Transfection efficiency was effectively reduced by 
70% when the cells were treated with 25 ~ g / m l l of chlorpromazine. These 
results hence clearly demonstrate that DMA homopolymer - DNA 
complexes recruited the coated pits for the entry into the cell. The confocal 
images also show that incubation of the cells with conA blocked the entry of 
the DNA complexes into the cells, supporting the transfection data. 
Nystatin and filipin are sterol-binding agents that effectively disrupt caveolar 
structure, hence inhibiting caveolae mediated uptake (Rothberg et aI., 1992, 
Orlandi and Fishman, 1998, Stuart et aI., 2003). It was found that both 
agents were also able to inhibit transfection efficiency, though to a lesser 
extent compared to clathrin inhibitors. With 5 ~ g / m l l of filipin or 1 0 ~ g / m l l of 
nystatin, the commonly used concentrations to inhibit caveolar function, the 
transfection efficiency was reduced by about 20% relative to the control. In 
the confocal study, it was found that 1 0 ~ g / m l l nystatin did not appear to 
affect the cellular uptake of DMA homopolymer - DNA complexes. Since 
the transfection efficiency was only slightly inhibited by nystatin, it was not 
surprising that DNA complexes were found to be taken up into the cells. 
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It is apparent that the DMA homopolymer - DNA complexes were 
internalized primarily through a clathrin-mediated pathway, with a minor 
fraction possibly entered cells via caveolae. This can be concluded as 
transfection efficiency and the uptake of the DNA complexes was more 
effectively inhibited by the clathrin inhibitors than by the caveolae inhibitors. 
However, it cannot be ignored that other combinations of pathways, such as 
phagocytosis and pinocytosis, might also be involved as none of the 
inhibitors could completely abolish the uptake of the DNA complexes. 
Although a number of pathways are believed to be involved in the uptake of 
DNA complexes, the determination of the route of uptake is indeed poorly 
understood. It is reported that the size of the particles play an important role 
in the choice of entry pathway (Rejman et aI., 2004). With the use of 
liposomes as delivery vector on non-phagocytotic mammalian cells in the 
study, it was suggested that particles that were less than 200 nm were 
predominantly internalised through the clathrin-mediated pathway. With 
increasing particle size, a shift to a mechanism that relied on the caveolae-
mediated pathway became apparent, and became the major route of entry for 
particles of 500 nm in size. This finding is interesting as current general 
understanding considers that the typical size of caveolae (50-100 nm) is far 
too small to accommodate particles as large as 500 nm. Certain bacteria, 
such as Fim-H expressing E coli. and Mycobacterium bovis, utilize caveolae 
for entry into the host cells (Shin and Abraham, 2001) although their size 
exceeds 1 ~ m . . However, a clear explanation of this phenomenon is lacking. 
In contrast, a conflicting result was observed by another research group 
(Grosse et aI., 2005) using polycations to deliver genes. It was reported 
polyplexes with size ranged from 100 - 200 nm were taken up primarily 
through clathrin coated pits. However, caveolae were involved in the uptake 
of polyplexes only when the particle size was less than 100 nm, which in fact 
is consistent with the size of caveolae. When the particle size was over 200 
run, the polyplexes were found to be taken up through macropinocytosis. 
Although from all these results, the effect of particle size on the route of 
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cellular uptake was uncertain, it is apparent that the particle size does play a 
role here. 
For the case of DMA homopolymers, the DNA complexes formed were in 
fact aggregates with particle size of over 1 /-lm, as measured by the photon 
correlation spectroscopy (as shown in chapter 3, table 3.2). However, it is 
not clear how strong the aggregated complexes were associated with each 
other. It is possible that when DNA complexes were added to the cells in 
vitro, some of the loosely aggregated complexes break down into smaller 
fragments to the size around 200 nm and gained entry into the cells through 
clathrin-mediated endocytosis, while smaller or larger complexes entered the 
cells through other pathways, including the caveolae-mediated pathway. 
Indeed, it was noticed from the confocal image that the DNA complexes 
were present inside the cells appeared as small discrete particles (figure 6.19), 
whereas large clumps of complexes remained outside of the cells throughout 
the experiment (figure 6.20). 
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Figure 6.19 Confocal images of DMA homopolymer - DNA complexes that 
entered the cells appeared as discrete particles. DNA complexes were prepared 
at 2: J monomeric unit: nucleotide ratio and the images were taken at 240 min after 
addition of complexes on A549 cells. Plasmid DNA was labelled with YOYO-J 
fluorescent probe (green) and the cell was labelled with CellTracker Orange (red). 
Both (a) and (b) images were taken at different z height on the same cells . The 
arrows indicate the different DNA complexes inside the cells , as revealed by the xz 
(right panel) and yz (top panel) planes. 
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Figure 6.20 Confocal images of DMA homopolymer - DNA complexes that 
remained outside the cells appeared as aggregates. DNA compl exes were 
prepared at 2 : J monomeric unit: nucleotide ratio and the images were taken at 240 
min after addition of complexes on A549 cells. Plasmid DN A was labell ed with 
YOYO-J fluorescent probe (green) and the cell was labelled with Ce llT racker 
Orange (red). Both (a) and (b) images were taken on the same cell s. The arrows 
indicate the different DNA complexes aggregates outside the ce ll s, as revealed by 
the xz (right panel) and yz (top panel) planes . 
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The two different routes of endocytosis lead to different intracellular fate of 
the polymer - DNA complexes. For the clathrin-mediated pathway, the 
internalised materials are normally transported to endosomes where there is a 
reduction of pH and consequently fusion with lysosomes where the 
degradation of the materials takes places. However, there are also exceptions. 
It is well known that the cationic polymer polyethylenimine (PEl) possesses 
substantial buffering capacity below physiological pH. PEl contains 
protonable nitrogen atoms, making it possible to buffer the endosomal 
environment, prompting the osmotic swelling and rupture of the vesicle, 
which leads to the liberation of the polymeric system to the cytoplasm. This 
phenomenon is known as the 'proton sponge' effect (Bohr 1994, Boussif et 
al., 1995). For this reason, the PEl based system is believed to successfully 
escape from endosomal / lysosomal degradation. 
In the case of DMA polymer system, it was at first thought that this polymer 
might act like PEl to have the ability to cause a disruption of the endosomes 
(van de Wetering et al., 1999). This was because DMA has an average pK(a) 
value of 7.5 and is partially protonated at physiological pH, and thus it might 
behave as a proton sponge. It was also found that with the addition of 
endosomolytic agent, chloroquine, the transfection efficiency of DMA 
homopolymer - DNA complexes was not enhanced (van de Wetering et al., 
1997, Deshpande, 2002), suggesting that the endosomal escape might not be 
a limiting step to transfection efficiency of the system, although cytotoxicity 
associated with chloroquine could also be the explanation. Recent work 
indicated that the uncomplexed DMA homopolymer did not physically 
disrupt the endosomes (Jones et al., 2004), though the polymer was found to 
induce changes in the morphology of the late endosomes / lysosomes. 
Although one may argue that the ability of the polymer - DNA complexes to 
disrupt endosomes may be greater than the uncomplexed polymer, a confocal 
study conducted by other groups has shown that the polymer - DNA 
complexes were not present outside the endocytic vesicles up to 48 hours 
after uptake by the cells (Zuidam et al., 2000), suggesting that the 
intracellular trafficking from the endosomes to the nucleus is indeed very 
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inefficient. On the other hand, particles that entered the cells via caveolae-
mediated uptake could avoid the acidic endosomes and lysosomes. They 
were believed to be delivered to vesicles called caveosomes which are , 
neutral compartments (Pelkmans and Helenius, 2002). For this reason, the 
caveolae-dependent pathway is becoming an attractive route for drug and 
gene delivery (Bathori et aI., 2004). However, both transfection and confocal 
studies suggested that caveolae-dependent uptake mechanism was not the 
major route of entry of the DMA homopolymer - DNA complexes. 
Interestingly, it has been reported recently by another group using the same 
polymer system, that DMA homopolymer - DNA complexes were taken up 
by both the clathrin- and caveolae - mediated pathway, but the latter was 
found to be the major route of uptake leading to ultimate expression of the 
delivered gene (van der Aa et aI., 2005). In their work, the transfection 
efficiency of the DNA complexes was almost completely inhibited by the 
caveolae inhibitor, genistein, but not by affected by the clathrin inhibitor, 
chlorpromazine. Their results appeared to conflict with our data. The 
different composition of the polymer - DNA complexes, choice of cell lines 
and inhibitors might contribute to the discrepancy of the results. In fact, 
genistein is a tyrosine kinase inhibitor, which has a different mechanism to 
filipin in blocking caveolae function. It should be noted that many of these 
inhibitors may have a different secondary effect to the cells. For example, it 
is known that chlorpromazine targets other intracellular enzymes, leading to 
multiple effects on cell function. Therefore the specificity of inhibitors 
should be taken in consideration. Nevertheless, the clathrin-mediated 
pathway does not appear to be an effective route of gene delivery, especially 
when the system lacks the ability to escape from the acidic endosomes / 
lysosomes. 
It might be advantageous to target the delivery of the DNA complexes 
through caveolae-mediated pathway. As mentioned earlier, size of particles 
appeared to play a crucial role in determining the route of entry. An 
appropriate tailoring of particle size might be useful to control the route of 
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entry. However, this does not seem to be feasible for DMA homopolymer-
DNA complexes as their size is not easily adjusted. In addition, the effect of 
size on the route of entry is still controversial. Alternatively, the particles can 
be attached to ligands for caveolar receptors, such as folic acid (Rothberg et 
aI., 1990, Rijnboutt et aI., 1996), or antibodies developed against caveolar 
proteins, such as interleukin-2 (IL2) (Lamaze et aI., 2001). However, further 
studies are required to explore the possibility of these strategies. 
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6.5 CONCLUSIONS 
In this chapter, the cellular uptake and intracellular route of DMA 
homopolymer - DNA complexes were investigated. It was found that the 
uptake of the DNA complexes took places within 30 minutes and optimum 
transfection efficiency was observed after 16 to 36 hour post-transfection. 
The uptake pathway of DMA homopolymer - DNA complexes was 
investigated by transfection study using different inhibitors, with the 
assistance of confocal microscopy study. Especially the effect of time course 
in transfection efficiency with the use of inhibitors is first reported here. Our 
results indicated that microtubules and actin filaments were both involved in 
the uptake of DNA complexes, suggesting that the complexes were 
internalised by means of endocytosis. Both the clathrin- and caveolae-
mediated pathways were responsible for the uptake of DMA homopolymer -
DNA complexes, whereby the former appears to be the major route of uptake. 
The escape from the acidic endosomes / lysosomes is one of the major 
limiting factors in the clathrin - mediated endocytosis of non-viral delivery 
system. Since the caveolae - mediated pathway bypasses this potential 
problem, it became an attractive route of targeting gene delivery for future 
investigation. 
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CHAPTER 7 
FOLATE CONJUGATED GENE DELIVERY SYSTEM 
7.1 INTRODUCTION 
The two major problems associated with polycation gene delivery systems 
are low efficiency and lack of specificity. Incorporation of suitable ligand to 
the delivery system to achieve specific targeting has been widely investigated 
in order to tackle the later problem (Varga et aI., 2000, Marcucci and 
Lefoulon, 2004). With this approach, the uptake of the ligand conjugated 
system to the receptor expressing target cells can be enhanced through 
receptor-mediated uptake mechanisms. Among the possible targeting agents, 
folic acid has been employed frequently to target therapeutic agents into a 
wide range of cancer cells (Leamon et aI., 1999, Guo and Lee, 2001, Ward et 
aI., 2002, Zhou et aI., 2002, Saul et at., 2003). 
7.1.1 Folic acid 
Folic acid (figure 7.1) is one of the many ligands being examined for specific 
targeting in gene delivery. It is a low molecular weight vitamin which is 
essential for the biosynthesis of nucleotide bases and a number of amino 
acids (Blakley and Whitehead, 1986). Since mammalian cells lack the key 
enzymes to synthesise this vitamin, efficient routes of uptake have been 
evolved in mammalian cells to capture folate exogenously. There are two 
major pathways responsible for folate internalization. The first one involves 
the use of reduced-folate carrier (RFC), which is the major route of folate 
uptake in normal cells (Sirotnak and Tolner, 1999). RFC is highly specific 
for reduced forms of folic acid such as 5-methyl-tetrahydrofolate. and 
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methotrexate, but has a low affinity for folic acid ( ~ ~ ~ ~ 1-5 IlM) (Antony 
1992). Therefore, folate conjugates will not be taken up by RFC. The 
second route involves the membrane bound folate receptors (FRs), which 
have a high affinity for folic acid (Kd ~ ~ 100 pM) (Kamen and Capdevia 1986). 
FRs are significantly overexpressed in many types of cancer cells, such as 
ovarian, breast, kidney, brain and endometrium tumours (Ross et aI., 1994, 
Weitman et aI., 1994, Toffoli et al., 1997, Bueno et aI., 2001), but are only 
limited in a number of normal tissues. As a result, FRs have become 
attractive sites for specific targeting to tumour tissues. 
It is believed that FRs mediate the uptake of folic acid through endocytosis 
(Kamen and Capdevila, 1986). Simple covalent attachment of folic acid to 
virtually any macromolecule produces conjugates that can be internalised 
into the cells in the same way as free folic acid (Leamon and Low, 1991, 
Reddy and Low, 1998, Sudimack and Lee, 2000). There is evidence 
suggesting that conjugation of molecules to folic acid does not normally 
interfere with the high affinity of folate for its receptors or with its 
endocytosis into the cell (Leamon and Low 1993, Turek et aI., 1993). 
a a 
OH 
Figure 7.1 Chemical structure of folic acid 
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Folic acid has additional advantages over other targeting ligands. First of all, 
folic acid is taken into cells for essential functions. It has been suggested that 
most of the folate conjugates are released into the cytosol, instead of being 
delivered to lysosomes for destruction (Turek et al., 1993). Secondly, 
because of the high affinity of folic acid and its conjugates for FRs, folate 
conjugates can be administered at low concentrations in order to saturate all 
accessible FR. Folic acid is also inexpensive and relatively easily coupled to 
a wide variety of therapeutic agents (Leamon and Reddy, 2004). 
Furthermore, since folic acid is naturally found in the body, it is non-
immunogenic (Low, 2004). 
Folic acid has been employed as targeting moiety in the delivery of a wide 
variety of therapeutic agents, such as imaging agents (Wang et al., 1996, 
Konda et al., 2000), protein toxins (Ward et al., 2000), chemotherapeutic 
agents (Ladino et al., 1997, Lee et al., 2002, Aronov et al., 2003, Reddy et al., 
2006), antisense oligonucleotides (Citro et al., 1994, Li et al., 1998, Jeong et 
al., 2005), liposomal drug carriers (Lee and Low, 1994, Gabizon et al., 1999) 
and gene delivery vectors (Mislick et al., 1995, Leamon et al. 1999, Hofland 
et al., 2002, Benns et al., 2002, Hattori and Maitani, 2004). In addition, the 
folate-targeted therapeutic drug and folate-linked imaging agents are 
currently under evaluation in clinical trials (Paulos et al., 2004). 
7.1.2. Aims 
Folic acid conjugated DMA-MPC diblock copolymer system was developed 
recently (Licciardi et al., 2005), in which the folic acid is covalently attached 
to the terminus of the MPC block. In the previous chapters, it has been 
demonstrated that certain compositions of the DMA-MPC copolymer have 
the ability to condense DNA efficiently to form colloidally stable complexes 
with minimal non-specific cellular association. Here, the DMAsoMPC30 
copolymer, which fulfilled the above characteristics, was employed to 
conjugate with folic acid (DMAsoMPC30 - FA). This copolymer composition 
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was selected based on the results of previous studies (chapter 3 and 4) which 
have suggested that at least 30 units of MPC are required to achieve 
sufficient steric stabilization of the complexes, and no less than 40 units of 
DMA are needed to condense DNA efficiently when 30 units of MPC were 
attached. In addition, a binary polymer system which consisted of 
DMAsoMPC3o - FA / DMA homopolymer (50/50 monomer/monomer) as a 
delivery vector was introduced here. The purpose of blending the two types 
of polymer was in the attempt to produce more condensed structure with 
higher ability to protect DNA from enzymatic degradation compared to the 
diblock copolymer on its own, and also to provide steric stabilization effect 
that was deficient in DMA homopolymer. Both physicochemical and 
biological properties of this novel folate conjugated system are described in 
this chapter. 
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7.2 MATERIALS AND METHODS 
7.2.1 Materials 
Materials used were as described in Chapter 2, Section 2.1 unless otherwise 
specified below. 
DMAso-MPC30-F A functionalised diblock polymers were synthesised by the 
group of Professor S. Armes (Department of Chemistry, The University of 
Sheffield, UK) according to the methods described in the literature (Armes et 
aI., 2001; Licciardi et aI., 2005). The properties and the chemical structures 
ofDMAso-MPC30-FA functionalised diblock polymers are shown in table 7.l 
and figure 7.2 respectively. All polymers were supplied as freeze-dried 
solids which were subsequently dissolved in ELGA water (1-10 mg/ml) and 
subsequently stored at -20°C. 
The binary polymer system consisted of DMAsoMPC30 - FA and DMA 
homopolymer was prepared by mixing the two polymers according to the 
following equation (6): 
Polymer 1 monomer Mw x ratio x Amount of polymer 2 Amount of polymer 1 = - ~ - - - - - - - - - - - - - - - - - ' - - - - - - - = - - - - -
Polymer 2 monomer Mw 
(6) 
Table 7.1. Summary of molecular weight data and folic acid content for DMA-
MPC-F A functionalized diblock copolymers 
Polymer % of conjugated folic acid 
wt ratio % mol ratio % 
100 
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residual free 
folic acid 
(wt %) 
< 0.01 20,300 1.32 
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Figure 7.2 Chemical structures of DMAm-MPCn-FA functionalised diblock 
polymers. 
7.2.2 Preparation of polymer - DNA complexes 
The polymer - DNA complexes were prepared as described in Chapter 2, 
section 2.2.1. For the binary polymer system, DNA complexes were 
produced via a single addition of mixed binary polymer solution to DNA in 
the same fashion as described in section 2.2.1. 
7.2.3 Gel retardation assay 
The DNA binding ability of DMA50-MPC30-FA polymer and the binary 
polymer system was assessed by gel retardation assay as described in Chapter 
3, section 3.2.3. 
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7.2.4 Particle size analysis 
Particle size of DNA complexes formed with DMAso-MPC30-FA polymer 
and the binary polymer system was determined using proton correlation 
spectroscopy (PCS), as described in Chapter 3, section 3.2.5. DNA 
complexes were prepared at monomeric unit: nucleotide ratio 0.5: 1, 1: 1, 2: 1 
and 5:l. 
7.2.5 Morphology study 
The morphology of DNA complexes formed with DMAso-MPC30-FA 
polymer and binary polymer system was examined using transmission 
electron mIcroscope (TEM), as described in Chapter 4, section 4.2.2. 
DMAso-MPC30-F A polymer - DNA complexes were prepared at monomeric 
unit: nucleotide ratio 1:1,2:1 and 5:1, and binary polymer - DNA complexes 
were prepared at nucleotide ratio 2:1 and 5:l. 
7.2.6 Enzymatic degradation assay 
The ability of DMAsoMPC3o - FA and the binary polymer system to protect 
DNA from enzymatic degradation was assessed by gel electrophoresis, as 
described in Chapter 5, section 5.2.3. 
7.2.7 Cell lines and routine subculture 
A549 cells (human lung carcinoma) were provided by the Experimental 
Cancer Chemotherapy Group, University of Nottingham, UK. MCF-7 cells 
(human breast carcinoma) were provided by Tissue Engineering Group. 
School of Pharmacy. University of Nottingham, UK. KB cells (human oral 
carcinoma) were purchased from American Type Culture Collection (A TCC). 
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USA. All cell lines used in this chapter were maintained in folic acid free 
RPMI-1640 medium supplemented with 100 Ulml penicillin, 1 00 ~ g / m l l
streptomycin, and 10% FCS which was the only source of folate for the cells. 
The cells were cultured in humidified atmosphere with 5% CO2 at 37°C. The 
cells were sub-cultured twice a week at a 1: 10 ratio, using Trypsin - EDT A 
as dissociating agent. 
7.2.8 Flow cytometry study 
The flow cytometry was used to investigate the cellular association of the 
folate conjugated system. Three different cell lines, A549, MCF-7 and KB 
cells were used. The experiment was carried out as described in Chapter 5, 
section 5.2.5, with one modification. Instead of using the optiMEM-I, the 
DNA complexes were prepared in folic acid free and serum free RPMI-1640 
medium. Free folic acid (1 mM) was added to the cells together with the 
DNA complexes when required. 
7.2.9 Transfection study 
The transfection study of folate conjugated system was carried out on A549, 
MCF-7 and KB cells, as described in Chapter 5, section 5.2.6, with minor 
modification. Instead of using the optiMEM-I buffer, the DNA complexes 
were prepared in folic acid free and serum free RPMI-1640 medium. After 
the cells were incubated with the DNA complexes for 4 h, the complexes 
were removed and replaced with folic acid free RMPI-1640 medium 
(supplemented with 10% FCS) and the cells were incubated for a further 48 h 
before analysis. Free folic acid (1 mM) was added to the cells together with 
the DNA complexes when required. 
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7.3 RESULTS 
7.3.1 Gel retardation assay 
The gel retardation assay of DMAsoMPC3o - FA - DNA complexes is 
showed in figure 7.3a. Free DNA band could be seen in the upper image at 
low monomeric unit: nucleotide ratio. As the ratio increased, DNA bands 
gradually became fainter. At ratio 1.25: 1, no DNA bands could be observed 
but fluorescence could still be detected in the loading well. As the ratio 
further increased, fluorescence could no longer be seen at all, indicating that 
the binding sites of the plasmid DNA were mostly occupied by the 
copolymer. Polymer band could be seen in the lower image at ratio 2: 1 , 
suggesting the presence of free polymer within the system. The gel 
retardation assay of the binary polymer system, DMAsoMPC3o - FA / DMA 
(50/50), is shown in figure 7.3b. The general pattern of the gel was very 
similar to the DMAsoMPC3o - FA system, with DNA bands disappearing at a 
lower ratio of 0.75:1, suggesting a higher DNA binding efficiency with the 
binary polymer system. Free uncomplexed polymer with the binary system 
also appeared at a lower ratio of 1.5: 1, indicating that less polymer is needed 
to achieve complete binding of the plasmid DNA. 
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8 9 10 11 12 
1 2 3 4 5 6 7 8 9 10 11 12 
Figure 7.3 Agarose gel retardation assay of folate conjugated systems. Lane I is 
the DNA control. Lanes 2-1 1 correspond to 0.25:1 , 0.5:1 , 0.75 :1, 1:1 , 1.25:1 , 1.5:1 , 
1.75: 1, 2: 1, 5:1 and 10:1 monomeric unit: nucleotide ratio. Lane 12 is polymer 
control. (a) DMAsoMPC30-FA (b) The binary polymer system, DMAsoMPC30-F A 
/DMA (50/50). 
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7.3.2 Particle size analysis 
Photon correlation spectroscopy (PCS) was used to measure the particle size 
of DMAsoMPC3o - FA - DNA complexes and the binary polymer - DNA 
complexes. The average diameter, scattering intensity and polydispersity of 
the complexes were measured. The results are shown in tables 7.2 and 7.3 
respectively. For the DMAsoMPC3o - FA system, the complexes formed 
were well below 200 run, with decreasing particle size as the ratio increased. 
At ratio 5: 1, the complexes formed were approximately 100 run. The 
scattering intensity of the complexes increased with the ratios, indicating the 
formation of more condensed and compact particles. The polydispersity of 
the particles was approximately 0.5 at all ratios. For the binary polymer 
system, it was found that the complexes were highly aggregated at ratio 0.5: 1, 
with particle size measured at over 1 /lm. The high scattering intensity also 
indicated the agglomeration of complexes. As the ratio increased, the 
particle size gradually decreased. The particle size of the DNA complexes 
was approximately 200 nm and 120 run at ratio 2: 1 and 5: 1 respectively. The 
scattering intensity decreased as the ratio increased, suggesting the formation 
of colloidally stable complexes which were more 'soluble' and less dense 
than the aggregating complexes at low ratio. The polydispersity of the 
complexes also decreased when the ratio increased. 
Table 7.2 Average particle size, scattering intensity and polydispersity of 
DMAsoMPC3o - FA - DNA complexes measured by PCS. DNA complexes were 
prepared at 0.5:1,1:1,2:1 and 5:1 monomeric unit: nucleotide ratio in 10% (v/v) 
PBS (n=6). 
Monomeric unit: 
nucleotide ratio 
0.5: 1 
1 : 1 
2: 1 
5: 1 
Average diameter 
(nm) ± SD 
165 ± 20 
159 ± 1 
125 + 2 
103±3 
Scattering 
intensity (KCps) ± 
SD 
213 
275 ± 11 
672 ± 7 
719± 17 
796 ± 26 
Polydispersity ± 
SD 
0.63 ± 0.11 
0.44 ± 0.01 
0.49 ± 0.01 
0..+3 ± 0.04 
Chapter 7: Folate Conjugated System 
Table 7.3 Average particle size, scattering intensity and polydispersity of 
DMAsoMPC30-FAIDMA binary polymer - DNA complexes measured by PCS. 
DNA complexes were prepared at 0.5:1,1:1,2:1 and 5:1 monomeric unit: nucleotide 
ratio in 10% (v/v) PBS (n=6). 
Monomeric unit: 
nucleotide ratio 
0.5:1 
1: 1 
2: 1 
5:1 
Average diameter 
(nm) ± SO 
1742 ± 400 
209± 8 
191 ± 8 
119 ± 1 
7.3.3 Morphology study 
Scattering 
intensity (KCps) ± 
SO 
2006 ± 144 
1579.3 ± 27 
1433 ± 63 
871 ± 14 
Polydispersity ± SO 
1.0 ± 0 
0.59 ± 0.03 
0.52 ± .004 
0.34 ± 0.01 
The morphology of the DNA complexes was examined under transmission 
electron microscope (TEM). The TEM images of DMAsoMPC3o - FA -
DNA complexes are shown in figure 7.4-6 and the measurement of the 
complexes are shown in table 7.4. At 1: 1 monomeric unit: nucleotide ratio, it 
appeared that DNA was not well condensed as strands of uncondensed DNA 
could be seen. At ratio 2: 1, particulate DNA complexes were formed; they 
appeared as highly condensed compact particles with either spherical or oval 
shape. At ratio 5: 1, the majority of the complexes appeared as short, thick 
rods or oval shape particles. A small amount of toroids can also be seen. 
The complexes formed at ratio 5: 1 were slightly smaller than those formed at 
2:1 (43± 9 nm and 55 ± 12 nm, respectively, n=50) (table 7.4), which is 
consistent with the size measured using pcs. However, the particle size 
measured under the TEM is considerably smaller than that measured with 
PCS, probably due to the dehydration effect in TEM. 
The TEM images of DMAsoMPC3o - FA / DMA (50/50) - DNA complexes 
are shown in figure 7.7 and 7.8. At 2: 1 monomeric unit: nucleotide ratio, the 
majority of the DNA complexes formed were of spherical or oval shape. The 
complexes were seen aggregating in clumps. This is consistent with the pes 
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results, which also suggests that slight aggregation occurred at this ratio. At 
ratio 5: 1, colloidal DNA complexes were formed, and aggregation was no 
longer observed. The complexes appeared as either rods or oval shaped 
particles, similar to those observed with DMAsoMPC3o - FA - DNA 
complexes at the same ratio. 
Table 7.4 Average particle size of DMAsoMPC30 - FA - DNA complexes and 
DMAsoMPC3o - FA! DMA binary system - DNA complexes measured under 
the TEM. The complexes were prepared in 10% (v/v PBS) and stained with uranyl 
acetate. The bracket indicates the monomer unit: nucleotide ratio of the complexes 
(n=50). 
System 
DMA50MPC30 - FA (2:1) 
DMA50MPC30 - FA (5:1) 
DMA50MPC30 - FA / DMA (5:1) 
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Average article size (nm) ± SD 
55 ± l3 
43 ± 9 
52 ± 11 
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Figure 7.4 TEM images of DMAsoMPC30-FA - DNA complexes at 1:1 
monomeric unit: nucleotide ratio, Complexes were prepared in 10% (v/v) PBS 
and stained with uranyl acetate. The bars represent (a) 1000 nm and (b) 200 11m . 
216 
Chapter 7: Folate Conjugated System 
• 
a, .. • 
.. , . 
• It • 
.. 
, .. .. r • 
.. 
• • • C" • ." .. e-. 
• • t· ~ ~ • • •• 
.. 
• 
' .. • .. 
• • 
... ,. 
• • IT 
,. • .. ,. # .. • .. , .. • . . . 
.. • 
•• 
. ..., • , 
-• , .. , 
• 
-
.. 
•• 
I 
...... • 
.. 
• • 
, 
.. .. 
\ ,. . ~ ~ • • , • • 
• " 
, 
.. 
.,. 
• • • • 
.. ' . 
~ ~ . . . ~ ~
• • .. 
• • ~ . " . .
• • • • .. 
' .. 
.. 
.. 
b 
• 
• 
Figure 7.5 TEM images of DMAsoMPC30-FA - DNA complexes at 2:1 
monomeric unit: nucleotide ratio. Complexes were prepared in 10% (v/v) PBS 
and stained with uranyl acetate. The bars represent (a) 1000 nm and (b) 200 nm . 
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Figure 7.6 TEM images of DMAsoMPC30-FA - DNA complexes at 5:1 
monomeric unit: nucleotide ratio. Complexes were prepared in 10% (v/v) PBS 
and sta ined with uranyl acetate . The bars represent (a) 1000 nm and (b) 20011111. 
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Figure 7.7 TEM images of DMAsoMPC30-FA / DMA binary polymer - DNA 
complexes at 2: 1 monomeric unit : nucleotide ratio . Comp lexes were prepared in 
10% (v/v) PBS and stained with uranyl acetate. The bars represent (a) 1000 11111 and 
(b) 200 nl11 . 
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F igure 7.8 TEM images of DMAsoMPC30-FA / DMA binary polymer - DNA 
complexes at 5: 1 monomeric unit: nucleotide ratio . Complexes were prepared in 
10% (v/v) PB S and sta in ed with uranyl acetate. The bars represent (a) 1000 nm and 
(b) 200 nm . 
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7.3.4 Enzymatic degradation assay 
The ability of the folate conjugated system to protect DNA from enzymatic 
degradation was assessed by gel electrophoresis and the results are shown in 
figure 7.9. For both the DMAsoMPC3o - FA copolymer and the binary 
polymer system, the DNA complexes were dissociated with pAsp, as the 
DNA band with molecular weight similar to the DNA control can be seen on 
the gel after the addition of the polyanion. 
Following the complexes incubation with DNase I, the systems were shown 
to protect DNA from degradation to a different extent. For DMAsoMPC30 -
F A, small molecular weight DNA, instead of the original DNA band, was 
observed at the top side of the gel at low monomeric unit: nucleotide ratios, 
indicating the partial breakdown of the plasmid DNA. As the ratio increased, 
the fluorescence intensity appeared to be brighter, and the DNA band which 
had the same molecular weight with the DNA control could be seen at ratio 
10: 1. The results hence indicate that the protection of DNA from enzymatic 
degradation could be better prevented at high ratio, even though the 
protection was still not complete, as the released DNA band was dimmer than 
the control and fragments of small molecular weight DNA could be seen at 
the top side of the gel. 
For DMAsoMPC3o - FA / DMA binary polymer system, it was found that 
protection of DNA could be achieved at a much lower monomeric unit: 
nucleotide ratio. The DNA bands with molecular weight similar to the 
control could be observed at ratio as low as 1: 1. This was probably due to 
the presence of DMA homopolymer within the binary polymer system and 
hence formation of more condensed complexes. Again, the full protection 
was not achieved as fragments of DNA with small molecular weight can be 
observed on the gel as partial breakdown of plasmid occurred. 
--------------=-:-:---------------
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Figure 7.9 Gel electrophoresis of folate conjugated systems in enzyme 
degradation assay. Lane I = DNA ladder, lane 2 = control DNA, lane 3 = naked 
DNA following DNase I incubation . Lane 4-10 contain DNA complexes at ratios 
0.2 5:1, 0.5:1 , 1:1. 1.5:1,2:1 ,5: 1 and 10:1 respectively, after dissociation with pAsp. 
Lane 11-17 contain DNA complexes at ratios 0.25: I , 0.5: I , I: 1. 1.5 : I , 2: I , 5: I and 
10:1. respectively, after incubation with DNase I at 37°C for 10 min followed by 
dissociation of complexes with pAsp (a) DMA5oMPC30-FA (b) DMA soMPC 30-
FA/DMA binary polymer system. 
7.3.5 Flow cytometry study 
In this study, flow cytometry was employed to investigate the cellular 
association of the folate conjugated systems (DMAsoMPC3o - FA and 
DMAsoMPC30 - FA / DMA binary polymer) . Three different cell lines were 
used : A549, MCF -7 and KB cells. A549 cells have a low leve l of fo late 
receptors (Too and Park, 2004, Cho el al., 2005), whereas MCF -7 and KB 
cells have been reported to have overexpression of fo late receptors (Leamon 
and Low, 199 L Hattori and Maitani, 2004). The aim of thi s study \Vas to 
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investigate whether there was selective uptake of folate conjugated DNA 
delivery system by the folate receptors expressing cells. DMA homopolymer 
and a non-conjugated diblock copolymer with comparable composition to the 
folate conjugated copolymer, DMA60MPC30, were used as controls. 
The average fluorescence intensity measured from flow cytometry of both 
DMAsoMPC30 - FA and the binary polymer system on the three cell lines are 
shown in figure 7.10. The fluorescence intensity for all MPC containing 
copolymer (both folate conjugated and non-conjugated) and binary polymer 
system was lower than DMA homopolymer on all cell lines, suggesting a 
decrease in non-specific cellular association. 
For A549 cells, there were no significant differences in fluorescence intensity 
between the non conjugated DMA60MPC30, the folate conjugated 
DMAsoMPC30 and the binary polymer system. Similar results were observed 
with MCF-7 cells. Although MCF-7 cells were reported to have 
overexpression of folate receptors, there were no significant differences in 
fluorescence intensity between the folate conjugated and non-conjugated 
system (p>O.05). For KB cells, which are the most commonly used cell lines 
in the study of folate conjugated delivery system, there was a significant 
increase in fluorescence intensity for DMAsoMPC30 - FA system at both 
ratios (2:1 and 5:1) compared to the non-conjugated DMA60MPC30 system 
(p<O.05 in each case). However, for the folate conjugated binary polymer 
system, there was no significant difference in fluorescence intensity with the 
non - conjugated system (p>O.05). 
In order to investigate whether the increase of cellular association of the 
folate conjugate copolymer system on the folate receptor expression KB cells 
were due to specific receptor interaction, the DMAsoMPC3o - FA - DNA 
complexes (ratio 5: 1) were incubated with KB cells in the presence of 1 mM 
of free folic acid. The results (figure 7.11) showed that there was a 
significant reduction of fluorescence intensity when the free folic acid was 
present, suggesting that the free folic acid reduced the cellular association of 
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the folate conjugated system by competing with the DNA complexes for the 
folate receptors . 
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Figure 7.10 Average fluorescent intensity associated with A549, MCF-7 and KB 
cells using folate conjugated system in flow cytometry study. DMA 
homopolymer and non-conjugated DMA60-MPC 30 diblock copolymer system were 
used as control (n=6). * P < 0.05 when compared wi th DMA60-MPC 30 system on 
KB ce lls. 
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Figure 7.11 Cellular association of DMAsoMPC30-FA - DNA complexes on KB 
cells, with the presence or absence of free folic acid in flow cytometry study. 
DNA complexes were prepared at 5: 1 monomeric unit: nucleotide ratio . The 
untreated KB cells were used as control. 
7.3.6 Transfection study 
The transfection efficiency of both DMAsoMPC30 - FA and the binary 
polymer system on the three cell lines are shown in figure 7.12. For the 
A549 cells, although the transfection efficiency of the folate conjugated 
systems had been enhanced compared to the non-conjugated DMA60MPC30 
(p<O.05), the overall level of gene expression was still very low. For both 
folate receptor expressing MCF -7 and KB cells, a significant increased in 
transfection efficiency was observed for the folate conjugated system 
compared to the non-conjugated copolymer (p<O.05 in each system). Also . 
for both folate conjugated system (DMA soMPC3o - FA and the binary 
polymer system), DNA complexes formed at 5: 1 ratio had a higher 
transfection efficiency that those formed at 2: 1 rati o. In addi tion. the 
DMA50MPC30 - FA system had a higher transfection effic iency than the 
binary polymer system at respective ratio. Howe\'er. the transfect ion 
effici ency on all the fol ate conjugated systems on the two fo late receptor 
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expressmg cells were still significantly lower than that of the DMA 
homopolymer (p<O.05). 
To decide whether the increase in gene expression of the folate conjugated 
system on MCF-7 and KB cells were due specific receptor interaction, the 
transfection experiments were also carried out in the presence of 1 mM free 
folic acid using the DMA50MPC30 - FA - DNA complexes prepared at both 
ratios 2: 1 and 5: 1 (figure 7.13). For the non-conjugated DMA6oMPC3o 
system, there was no significant difference in transfection efficiency when 
the free folic acid was present or absent in the culture medium (p>O.05). On 
MCF -7 cells, a significant reduction of transfection efficiency was observed 
for the folate conjugated system at ratio 5:1 (p<O.05) when the folic acid was 
present in the medium. However, no significant difference was observed at 
ratio 2: 1 (p>O.05). On KB cells, a significant reduction of transfection 
efficiency was observed for the folate conjugated system at both ratios when 
free folic acid was present (p<O.05 at both ratios). The reduction of 
transfection efficiency could be attributed to the blocking of the folate 
receptor on KB cells by the free folic acid, resulting in reduction of cellular 
uptake of complexes (which is consistent with the flow cytometry results), 
and consequently a lower transfection efficiency. 
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Figure 7.12 Transfection efficiency of folate conjugated systems on A549, MCF-
7 and KB cells. DMA-MPC diblock copolymer and the binary polymer system 
were prepared at monomeric unit: nucleotide ratio 2: I and 5: 1. Data were presented 
in terms of relative li ght unit (RLU) / mg protein . DMA homopolymer and non 
folate conjugated DMA-MPC diblock copolymer were used as contro l (n=6). * P < 
0.05 when compared with DMA6o-MPC3o system on A549 cells. + P < 0.05 when 
compared with DMA6o-MPC3o system on MCF-7 cells. # P < 0.05 when compared 
with DMA60-MPC30 system on KB cells . 
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(a) MCF-7 cells 
DMA60-MPC30 (2: 1) DMA50-MPC30-fa 
(2: 1) 
System 
(b) KB cells 
T 
l. 
+ 
DMA60-MPC30 (2 :1) DMA50-MPC30-fa 
(2: 1) 
System 
o fol ic acid free 
1 mM fol ic ac id 
* 
DMA50-MPC30-fa 
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Figure 7.13 Transfection efficiency of DMAso-MPC30-FA on (a) MCF-7 and (b) 
KB cells, in the presence or absence of free folic acid. Non - conjugated DMA6o-
MPC30 diblock copolymer was used as contro l. (11=6). * P < 0.05 when compared 
with foli c acid free medium at the same ratio on MCF-7 ce ll s. ~ ~ P < 0.05 when 
compared with foli c ac id free med ium at the same ratio on KB ce ll s. " p < 0.05 
when compared with fo li c ac id free medium at the same rati o on KB ce ll s 
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7.4 DISCUSSION 
An ideal gene delivery vector should be able to achieve specific targeting 
with minimal non-specific cellular interaction. The hydrophilic MPC has 
been demonstrated to provide steric stabilization for the DNA complexes, as 
well as reducing non-specific cellular interaction by providing steric 
hindrance, as described previously in chapter 3 and 5. However, the 
transfection efficiency of the DMA-MPC diblock copolymer remains 
relatively low, due to minimal cell surface interaction. In order to improve 
the efficiency of this system, a folic acid ligand is covalently attached to the 
MPC of the copolymer system in order to enhance gene expression via folate 
receptor mediated endocytosis. 
First of all, a series of physicochemical evaluations of the folate conjugated 
system was carried out to investigate whether the attachment of folic acid 
affects the physiochemical property of the DNA complexes. The results 
indicate that DMAsoMPC3o - FA was able to condense DNA effectively to 
produce colloidally stable complexes with small particle size approximately 
120 nm diameter at monomeric unit: nucleotide ratio 2:1 or above. However, 
the enzymatic degradation assay shows that the ability of this system to 
protect DNA from nuclease attack was not entirely satisfactory. A high ratio 
of 10: 1 was required in order to preserve the structure of the plasmid DNA. 
At this ratio, there was an abundance of free folate conjugated copolymer 
available in the solution as shown in gel retardation assay. This is not 
desirable as the uncomplexed folate conjugated copolymer may compete with 
the DMAsoMPC30 - FA - DNA complexes for the folate receptor on the cell 
surface. It has been reported that other folate conjugated delivery system. 
such as PLL - PEG - FA, a high polymer - DNA ratio would in fact lead to 
substantial reduction of transfection efficiency possibly due to competition 
for receptors between uncomplexed polymer and DNA complexes (Cho et al.. 
2005). 
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The binary polymer system, which consists of DMAsoMPC30 - FA / DMA, 
was also investigated. This system formed DNA complexes which were 
aggregating at low monomeric unit: nucleotide ratios, as shown in the PCS 
data and morphology study. This is probably due to insufficient steric 
stabilization provided by the hydrophilic MPC. As the ratio increased. 
colloidally stable complexes were formed, with average particle size 
approximately 200 nm and 120 nm in diameter for ratio 2:1 and 5:1 
respectively. The TEM images also show discrete well condensed particles 
at ratio 5:1. It appeared that the binary polymer system can condense DNA 
more efficiently compared to DMAsoMPC30 - FA, as demonstrated by the gel 
retardation assay. The enzymatic degradation assay also revealed that the 
binary polymer system was superior to DMAsoMPC30 - FAin protecting 
DNA from enzymatic degradation, probably due to the more efficient 
condensing property of the binary polymer system to produce complexes 
with tighter and more compact structure. 
However, it is worth to mention that SInce the two polymers (DMA 
homopolymer and DMAsoMPC30 - FA copolymer) in the binary polymer 
system are not covalently attached to each other, there is a possibility that 
some DMAsoMPC30 - FA polymers are excluded from the DNA complexes 
during condensation of DNA, as DMA homopolymer has a higher affinity to 
DNA compare to DMAsoMPC30 - FA polymer, suggested by EtBr 
displacement and gel retardation assays as shown previously in chapter 3. 
Although the improvement of steric stabilization (as shown in PCS particle 
size and morphology studies) in the binary polymer system has indicated that 
the DMAsoMPC30 - FA polymer was actually present in the binary polymer -
DNA complexes, it is uncertain if the ratio between the two polymers was 
indeed 50 : 50 (monomer: monomer). The observation that the binary 
polymer system is more superior ( in terms of DNA binding/condensation 
and enzymes protection) than the DMAsoMPC30 - FA is \'alid only if 
DMAsoMPC30- FA is present in the binary polymer - DNA complexes at the 
stated ratio. Nevertheless. the initial physicochemical results showed the 
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both folate conjugated system can condense DNA efficiently to fonn 
colloidally stable complexes and provide a certain level of DNA protection 
against enzymatic degradation. Apparently, the conjugation of the folic acid 
ligand does not seem to affect the physicochemical properties of the DMA-
MPC copolymer system. 
In order to find out whether the incorporation of folic acid could improve the 
specificity of the delivery system, it is important to evaluate the biological 
properties of the system in vitro in the first step. In all three cell lines 
investigated, the cellular association and transfection efficiency were 
significantly reduced when hydrophilic MPC was incorporated in the system, 
compared to the DMA homopolymer. The non-specific cellular interaction 
has been successfully reduced due to steric hindrance provided by the MPC. 
Any increase in cellular association and transfection efficiency with the folate 
conjugated system are expected to be the result of folate receptor mediated 
endocytosis. 
On A549 cells, the level of cellular association of folate containing system 
does not seem to be affected by the conjugation of folic acid. However, the 
transfection efficiency seems to be slightly improved. Although the A549 
cells do not have overexpression of folate receptors (Cho et al., 2005), the 
small amount of folate receptors on the cell surface may be responsible for 
the enhancement of gene expression. Even though the transfection efficiency 
has been increased on this cell line, the level of gene expression still 
remained very low, which was about 200- to 500-fold reduction compared to 
DMA homopolymer. 
On MCF -7 and KB cells, it was found that transfection efficiency was 
increased by at least IO-fold when folic acid was conjugated to the copolymer. 
When free folic acid was incubated together with the DNA - complexes, the 
transfection level was inhibited. This suggests that folate conjugated system 
was internalised through folate receptors. On both type of cells, DNA -
complexes prepared at 5: I ratio has higher transfection efficiency than those 
1'1 
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prepared at 2: 1. One of the possible explanations is that at a higher ratio, 
there may be a higher number of ligands present at the surfaces of the DNA 
complexes, increasing the chance of the complexes to be recognised by the 
receptors on the cell surface. In addition, the DMAsoMPC30 - FA system was 
found to have a higher level of transfection compared to the binary polymer 
system at the respective ratio. This may be due to a number of reasons. First, 
the complexes formed by the binary polymer system may have fewer ligands 
per complex compared to DMAsoMPC3o - FA at the same monomeric unit: 
nucleotide ratio, thereby reducing receptor mediated uptake. Secondly, since 
the binary polymer system was more efficient in binding with DNA, less 
polymer was required. to condense DNA at the same ratio. Consequently, 
more free uncomplexed polymer may be present in the solution (as shown by 
the gel retardation assay), leading to their competition for the folate receptors 
with the DNA complexes. Thirdly, with the binary system, the orientation of 
the ligand on the complexes may be less exposed to the surface, compared to 
that of DMAsoMPC3o - FA. The trapped ligands may be more difficult to be 
recognised by the folate receptor on the cell surface, thereby reducing cellular 
association and hence transfection efficiency. Furthermore, the size of DNA 
complexes also appeared to affect the transfection efficiency. 
DMAsoMPC3o - FA system formed smaller complexes with DNA then the 
binary polymer system at respective ratio. For both DMAsoMPC3o - FA 
system and binary polymer system, smaller DNA complexes were formed at 
a high monomeric unit: nucleotide ratio. DNA complexes with smaller size 
in general displayed a better transfection efficiency. 
Although the level of gene expreSSIOn of folate conjugated system was 
enhanced on MCF-7 and KB cells by 10- to 50-fold, the increase of cellular 
association with the DNA complexes did not follow the same trend. One of 
the possible explanations is that a more efficient route of intracellular 
trafficking exists when DNA complexes are taken up through folate receptor 
mediated endocytosis. It has been suggested that once internalised inside the 
celL the folic acid and its conjugates are released into the cytosol before 
being transported into lysosomes for degradation (Leamon and Low. 1992). 
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This could mean that high transfection efficiency of folate conjugated system 
is not necessary accompanied with high cellular association or uptake. Folic 
acid has been used by other groups as a targeting ligand attached to PEG 
which was conjugated to polycation for gene delivery (Leamon et al., 1999, 
Ward et al., 2002, van Steenis et al., 2003). It has been demonstrated by 
Ward et al. that the level of gene expression of folate - PEG - PLL - DNA 
complexes was independent of level of internalised DNA (Ward et al., 2002). 
The folate conjugated systems that showed a lower cellular uptake were 
actually more transfection active. They also showed that the transfection 
efficiency of the systems with low cellular uptake was not increased by the 
presence of the endosomolytic agent chloroquine, suggesting that endosomal 
escape may not be a limiting factor of folate conjugated complexes. In 
contrary, a conflicting result was observed by another group (Mislick et al., 
1995), who demonstrated that following the uptake of folate conjugated 
PLL - DNA complexes, they were eventually delivered into the lysosomes. 
Further investigation, such as confocal microscopy study, maybe useful in 
confirming the uptake mechanism. Nevertheless, it is well understood that an 
efficient intracellular trafficking route is important in improving transfection 
efficiency. 
The initial in vitro data suggests that both DMAsoMPC30 - FA and 
DMAsoMPC30 - FA / DMA binary polymer system improve transfection 
efficiency compare to the non-folate conjugated DMA60-MPC30 copolymer 
on MCF -7 and KB cells, the folate receptor expressing cells. The 
transfection efficiency on A549 cells remained at low level, suggesting that 
these systems show minimal non-specific cellular interaction. However, 
none of the folate conjugated system had transfection efficiency that was 
comparable to DMA homopolymer on both MCF-7 and KB cells. The 
design of this MPC based folate conjugated system is still at its infancy stage. 
The structure and the composition of this system must be further investigated 
and optimized in order to maximize gene transfection efficiency in t a r g ~ t i n g g
cells. 
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First of all, it is highly desirable for the targeting ligand to be exposed on the 
surface of the complexes (figure 7.14a). Proper ligand positioning is 
important for accessibility of the ligand to the receptor since polymers 
carrying bulky moieties may reduce interaction of the complexes with cell 
receptors. MPC is a very flexible hydrophilic molecule (Murphy and Lu. 
2000), and the ligand that is attached at the end of this molecule may be 
trapped or hidden within the hydrophilic chains of the complexes (figure 
7 .14b), reducing its chance be brought in contact and bind to the receptor. 
Further investigations, such as biochemical analysis or surface analysis 
technique, such as surface plasmon resonance (SPR) (Pattnaik, 2005) and 
dual polarization interferometry (DPI) (Swann et a!., 2004) may be helpful in 
examining the surface properties of the complexes, thereby assisting the 
design of a system with ligands that would orient themselves outward 
towards the bulk solution. With other polycation - PEG - FA system 
developed, it was discovered that the chain length of the steric stabilizer PEG 
has played a crucial role in successful delivery of DNA into the target cells 
(Leamon et al., 1999, Ward et a!., 2002, Zhou et a!., 2002). It is believed 
that PEG within the conjugates act not only as steric stabilizer, but also as an 
extended linker arm to allow the ligand to optimally bind to its cell surface 
receptor. The optimal length of MPC in our system should also be 
investigated to optimise its efficiency. 
Secondly, the quantity of ligands attached to each complex must be 
controlled. Polypi exes are formed by spontaneous electrostatic interaction 
and it is uncertain how many polymer molecules interact with one plasmid. 
Consequently, it is difficult to monitor the number of ligands attached to each 
complex. Too few ligands on the complexes lead to decreasing opportunity 
of ligand - receptor interaction. Leamon et a!. (1999) found that in PLL -
PEG - FA system, the number of PEG-FA group per PLL chain is an 
important factor in determining the level of gene expression. When there 
were too few or too many PEG-FA groups per PLL chain. the transfection 
efficiency decreased significantly. For this reason, the optimum number of 
ligands per polymer system must be determined. 
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~ ~ MPC 
folic acid 
Figure 7.14 Schematic diagram of the proposed structure of folate conjugated 
DNA complexes (a) with li gands exposing at the surface of the complexes (b) \\ ith 
li gands being trapped or hiding with in the hydrophilic chains of the complexes. 
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Furthermore, the composition of the functionalised polymer must be carefully 
balanced to maximise its efficiency. The initial data shows that folate 
conjugated DMA-MPC diblock has demonstrated an enhancement of 
transfection efficiency on folate receptor expressing cells, but its capability to 
protect DNA from nuclease attack was less satisfactory. On the contrary, the 
binary polymer system was more effective in protecting DNA from 
enzymatic degradation, but the transfection efficiency was somewhat lower 
than DMAsoMPC3o - FA. Therefore, the composition of system must be 
optimised to create a well balanced effect 
Although the use of folic acid as targeting ligand in the delivery of drug and 
imaging agents to cancer cells has been studied for a long time (Lu and Low, 
2002, Leamon and Reddy, 2004, Ke et a!., 2004, Lu et a!., 2004, Gabizon et 
a!., 2004), the experience with the use of folic acid in polymer based gene 
delivery systems is still very limited and most of the results with these 
systems are restricted to in vitro study only. The majority of the systems are 
formulated with PEG in order to prolong systemic circulation. Interestingly, 
most of the system currently being investigated involve the surface coating of 
the folate-PEG component, by means of covalent or non-covalent coupling, 
to the pre-formed polyplexes (Ward et a!., 2002, van Steenis et a!., 2003, Cho 
et a!., 2005 , Kim et a!., 2005). There is very little literature reporting direct 
incorporation of folic acid molecules to the copolymer system (Leamon et a!., 
1999) like our DMA-MPC-F A system, which allows the targeting ligand to 
be firmly anchored to the backbone of the polymer. The coating of 
hydrophilic component to the pre-formed polyplexes (with or without ligand 
attachment) was claimed to produce more stable complexes that can extend 
circulation times in vivo (Ward et a!., 2002, Verbaan et a!., 2004). However. 
no direct comparison between the two types of preparation methods of folate 
conjugated system was available. In fact, our DMA-MPC-F A system 
requires one step less in the production of complexes compared to the coating 
system, thus potentially better control could be achieved during complexes 
formation with less batch to batch variation. 
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7.5 CONCLUSIONS 
In this chapter, it has been demonstrated that conjugation of folic acid can 
successfully enhance level of gene expression of DMA-MPC-F A copolymer 
- DNA system on folate receptor expressing cancer cells. The transfection 
efficiency of the folate conjugated system was significantly inhibited by the 
presence of free folic acid, indicating that the uptake of the DNA complexes 
was associated with folate receptor function. The increase in transfection 
efficiency of the folate conjugated system was not always accompanied with 
the increase in cellular association, suggesting that the folate receptor 
mediated uptake pathway may possibly provide a more efficient intracellular 
trafficking route with less complexes delivered into endosomes / lysosomes 
for destruction. The concept of blending of two polymer systems 
(DMAsoMPC3o - FA and DMA homopolymer) to form new binary polymer 
system seems to be beneficial as the ability to protect DNA from enzymatic 
degradation was improved. However, parameters such as the optimum length 
of MPC component, number of ligands per DNA complex and the 
composition of the binary polymer system need to be further investigated in 
order to maximize the transfection efficiency. In vivo study will be the next 
stage to evaluate the efficacy and safety of this novel system. Nevertheless, 
this study presents an important step toward the design of non-viral vectors 
with low non-specific transfection and the ability to target therapeutic genes 
to various tumours. 
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CHAPTER 8 
GENERAL CONCLUSIONS AND FUTURE DIRECTIONS 
The development of a safe and efficient gene delivery vector is considered 
to be a bottle-neck and challenge to the success of gene therapy. Although 
viral vector is the most efficient method to deliver gene into human cells, 
the concerns over safety issue and immunological problems has led to the 
development of non-viral vectors as a potentially safer alternative. 
Cationic polymers have been intensively investigated in recent years for 
gene delivery. However the major problem associated with cationic 
polymers is poor efficiency compared to viral vectors. Strategy such as the 
design of a polycation based multifunctional gene delivery system can 
improve the efficiency. 
The overall objective of this thesis was to evaluate the potential of the 
novel DMA-MPC diblock copolymer structure as non-viral gene delivery 
vector, with the phosphorylcholine based hydrophilic MPC polymer being 
proposed for the first time as a new steric stabilizer for the gene delivery 
s y s ~ e m . . Both physicochemical and biological properties of the system 
were examined. In order to achieve specific targeting, folic acid was 
covalently attached to MPC component of the copolymer and the 
properties of this folate conjugated system were evaluated. Furthermore. 
the route of cellular uptake and intracellular trafficking of the DMA 
homopolymer - DNA complexes were also investigated. 
DMA-MPC diblock copolymers with different chain length of DMA and 
MPC were synthesized by the group of Professor S. Armes (Department of 
Chemistry, The University of Sheffield, UK). First, the effect of different 
compositions of these diblock copolymers on the interaction with Oi\ A. 
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and the physicochemical properties of the resulting complexes were 
investigated. It is known that DMA homopolymer is able to condense and 
form complexes with DNA but the highly aggregating complexes are 
considering to be obstacles to the system for in vivo use. In our study. it 
was demonstrated that the hydrophilic MPC block, with a minimum length 
of 30 monomeric units, could effectively prevent self - aggregation of 
DNA complexes by providing a steric barrier to the system. However, the 
presence of this hydrophilic moiety was shown to hinder the electrostatic 
interaction between the cationic DMA and the negatively charged DNA, as 
the copolymer with high proportion of MPC was found to have a lower 
affinity to DNA. Therefore the composition of the diblock copolymer 
must be carefully adjusted so that DNA condensing and steric stabilizing 
effects could be achieved simultaneously. 
For the purpose of improving long term stability of polymer - DNA 
complexes, the complexes were subjected to freeze-drying. However, the 
aggregation of the freeze-dried DNA complexes following rehydration was 
reported to be the major problem associated with freeze-dried formulations. 
Therefore lyoprotectants were frequently employed in order to tackle this 
problem. In our study, DMA6oMPC3o - DNA complexes were freeze-dried 
using sucrose or glucose as lyoprotectant. The results showed that both 
sucrose and glucose were effective in maintaining the size of polymer -
DNA complexes during freeze drying. In addition, the sequence of the 
addition of sugar (sucrose or glucose) was found to be the key factor in 
maintaining the particle size during freeze-drying. The size of the DNA 
complexes were better preserved when sugar was added after the formation 
of complexes, and the size of complexes that were comparable to the 
unfrozen control could be achieved at 1000:1 sugar: DNA (w/w) ratio. 
To enhance our understanding of DNA condensation, the morphology of 
DNA complexes formed with DMA-MPC was investigated using TEM and 
AFM. Surprisingly, the TEM and AFM images of the DNA complexes 
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were drastically different. The structures observed under the IEM 
appeared to be better condensed compared to AFM. One of the reasons is 
that dehydrated sample were studied under TEM whereas hydrated samples 
were studied under AFM. Since MPC is a very hydrophilic polymer, 
dehydration of the DNA complexes during drying would have dramatic 
impact on the morphology of MPC chain and consequently the complexes 
morphology. Moreover, the different sample preparation and environment 
may also affect the resulting morphology observed in IEM and AFM. 
Nevertheless, both imaging techniques have provided useful insights into 
the process of DNA condensation. In general, both imaging techniques 
show that as the length of DMA in the copolymer increased, better 
condensation of DNA was achieved as more condensed structures of DNA 
condensates were observed. In contrast, copolymer with high proportion of 
MPC appeared to hinder interaction between the DNA and the copolymer, 
resulting in the formation of loosely condensed structures. Furthermore, 
the TEM images also demonstrated that MPC can effectively prevent 
aggregation of DNA complexes, leading to the formation of discrete 
complexes. 
One of the important features of a non-viral system is the ability to protect 
DNA from nuclease activity. The enzymatic degradation study has 
revealed that the ability of the copolymer to protect DNA from nuclease 
attack was highly depended on its composition. Only DNA complexes 
formed with DMA homopolymer or copolymer with high proportion of 
DMA block ( D M ~ o M P C l O O and DMA lOOMPC30) was able to preserve the 
structure of DNA following the incubation with DNase I. Other copolymer 
with high proportion of MPC failed to protect DNA from enzymatic 
degradation, probably due to the formation of loosely condensed 
complexes (as shown III the AFM images), and the exposure of 
uncondensed DNA within these complexes may become the site of 
enzymatic attack. 
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The biological study revealed that the presence of MPC has significantly 
reduced cellular association and transfection efficiency of the copolymer _ 
DNA complexes. It is believed that the steric barrier formed by the 
hydrophilic MPC prevents the interaction between the complexes and the 
phospholipid membranes, as suggested by the model membranes study. In 
fact, the reduction of cellular interaction and consequently the low 
transfection efficiency of DMA-MPC copolymer system are desirable 
properties for a gene delivery systems, as an ideal gene delivery vector 
should display minimum non-specific cellular interaction. On the other 
hand, specific targeting and uptake could possibly be achieved via the 
conjugation of appropriate ligands. 
While DMA homopolymer - DNA complexes showed considerable 
cellular association and transfection efficiency, the route of uptake and 
intracellular trafficking of this system were studied. The effects of 
different endocytotic inhibitors on the uptake of the DNA complexes were 
examined. Both actin and microtubulin filaments were indicated to be 
involved in the uptake of DMA homopolymer - DNA complexes, 
suggesting that the complexes were internalised by means of endocytosis. 
Two major endocytosis pathways, the clathrin - mediated endocytosis and 
the caveolae - mediated endocytosis, are generally believed to be 
responsible for the uptake of polymer - DNA complexes. It is important to 
determine the mechanism of entry as the eventual fate of substance 
internalised by these two routes are very different. The clathrin - mediated 
endocytosis often leads to degradation of substances in the endosomes / 
lysosomes unless the substance possess endosomolytic activity. On the 
other hand, substances that enter the cell through caveolae - mediated 
endocytosis are delivered into non-destructive caveosomes and 
subsequently released into the cytosol. Our results from transfection study 
in the presence of appropriate inhibitors and relevant confocal study 
indicated that both pathways are involved in the uptake of DMA 
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homopolymer - DNA complexes, whereby the former appears to be the 
major route of uptake. 
Finally, in order to improve the cell specific uptake of the DMA-MPC 
copolymer system, a targeting ligand was covalently attached to the MPC 
polymer. Folic acid is an attractive ligand for this role due to the 
significant overexpression of folate receptors in a wide variety of cancer 
cells. Moreover, folic acid is inexpensive and non-immunogenic. DMA-
MPC-FA and a binary polymer which consists of DMA-MPC-FA and 
DMA homopolymer were investigated. Physicochemical study showed 
that the attachment of folic acid to the terminal of MPC did not appear to 
affect the DNA binding ability of the folate conjugated systems, and 
colloidally stable DNA complexes were formed at monomeric unit: 
nucleotide ratio 2:1 and 5:1 for DMA-MPC-FA and binary polymer system 
respectively. Moreover, the binary polymer system also demonstrated 
ability to protect DNA from enzymatic degradation. 
In vitro transfection study has shown that conjugation of folic acid could 
successfully enhance the transfection efficiency of the copolymer system in 
folate receptors expressing cells. Folate receptors were responsible for the 
uptake of the folate conjugated system as the presence of free folic acid 
was found to inhibit transfection in these cell lines. Interestingly, the 
increase in transfection efficiency of the folate conjugated system was not 
accompanied with the increase in cellular association, suggesting that the 
folate receptor mediated uptake pathway may possibly provide a more 
efficient intracellular trafficking route with less complexes delivered into 
endosomes / lysosomes for degradation. However. the optimum 
composition of folate conjugated DMA-MPC system remains to be 
determined. 
In summary, the novel DMA-MPC copolymer has demonstrated desirable 
properties to remain a potential candidate for gene delivery. \\Tith 
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appropriate composition, the copolymer is able to condense DNA to fonn 
colloidally stable DNA complexes with minimal non-specific cellular 
interaction. Moreover, the initial results from folate conjugated system 
have shown that selective uptake to folate receptors expressing cells could 
be achieved. 
The future work should focus on the optimization of the DMA-MPC 
system by varying the composition of the diblock copolymer. For example, 
by increasing the length of DMA block of the copolymer so that better 
DNA condensation could be achieved, resulting in the fonnation of more 
compact DNA complexes that are more resistant to enzymatic degradation. 
Other components such as endosomolytic agent and nuclear localizing 
signal could be considered and included in the system so that efficiency 
could be further enhanced. 
In vivo study will be the next step to evaluate the efficacy and safety of the 
system. Work presented in this thesis has proven that MPC is able to 
provide steric stabilization and reduce cellular association in vitro. It 
would be of great interest to conduct in vivo studies in attempt to correlate 
these with in vitro prediction. For example, an in vivo biodistribution study 
would be necessary to confinn whether the presence of MPC could in fact 
prolong systemic circulation of the gene delivery system. In the case of 
folate conjugated system, parameters such as the number of ligand per 
complex and the length of the MPC spacer should be optimized. The 
particle surface of the system can be characterized to ensure that the 
ligands are properly positioned for easy access to the receptors. Again. it 
would be of particular interest to investigate whether cell specific uptake of 
the folate conjugated system could be achieved in vivo. Furthermore, 
specificity could be further enhanced by designing the therapeutic gene 
consisting of cell type specific promoters so that the gene is only expressed 
through activation by responsive elements. 
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